activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147236	CHEMBL922811	Activity of human DDR2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	87.0	CHEMBL5122	Homo sapiens	Activity	%	87.0
	2147236	CHEMBL922811	Activity of human DDR2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	87.0	CHEMBL5122	Homo sapiens	Activity	%	87.0
	2240280	CHEMBL973569	Inhibition of DDR2 by radiometric assay	B	CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL518051	=	IC50	nM	82.0	CHEMBL5122	Homo sapiens	IC50	nM	82.0
	2470151	CHEMBL1034100	Inhibition of DDR2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5122	Homo sapiens	INH	%	10.0
	2567234	CHEMBL973717	Inhibition of human DDR2 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	81.0	CHEMBL5122	Homo sapiens	Activity	%	81.0
Active	2719536	CHEMBL1059986	Inhibition of DDR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	2721587	CHEMBL1061746	Inhibition of DDR2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	2897539	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	3800.0	CHEMBL5122	Homo sapiens	Kd	nM	3800.0
	2897540	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897541	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	11.0	CHEMBL5122	Homo sapiens	Kd	nM	11.0
	2897542	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897543	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	33.0	CHEMBL5122	Homo sapiens	Kd	nM	33.0
	2897544	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897545	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897546	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	960.0	CHEMBL5122	Homo sapiens	Kd	nM	960.0
	2897547	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897548	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897549	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897550	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3.2	CHEMBL5122	Homo sapiens	Kd	nM	3.2
	2897551	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897552	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897553	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897554	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897555	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897556	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	98.0	CHEMBL5122	Homo sapiens	Kd	nM	98.0
	2897557	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	15.0	CHEMBL5122	Homo sapiens	Kd	nM	15.0
	2897558	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897559	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897560	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897561	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897562	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897563	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897564	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897565	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897566	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897567	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	1600.0	CHEMBL5122	Homo sapiens	Kd	nM	1600.0
	2897568	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	5000.0	CHEMBL5122	Homo sapiens	Kd	nM	5000.0
	2897569	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897570	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	6.6	CHEMBL5122	Homo sapiens	Kd	nM	6.6
	2897571	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	42.0	CHEMBL5122	Homo sapiens	Kd	nM	42.0
	2897572	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897573	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897574	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	230.0	CHEMBL5122	Homo sapiens	Kd	nM	230.0
	2897575	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	2897576	CHEMBL1060180	Binding constant for DDR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	320.0	CHEMBL5122	Homo sapiens	Kd	nM	320.0
	2921377	CHEMBL1055291	Inhibition of DDR2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	6.6	CHEMBL5122	Homo sapiens	Activity	%	6.6
	2928467	CHEMBL1049965	Binding affinity to DDR2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	21.0	CHEMBL5122	Homo sapiens	Activity	%	21.0
Active	2983872	CHEMBL1050685	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of DDR2 by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387		Activity			CHEMBL5122	Homo sapiens	Activity		
	3052580	CHEMBL1037121	Residual activity of DDR2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	88.0	CHEMBL5122	Homo sapiens	Residual activity	%	88.0
	3053889	CHEMBL1044289	Residual activity of DDR2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	30.0	CHEMBL5122	Homo sapiens	Residual activity	%	30.0
	3054141	CHEMBL1049458	Residual activity of DDR2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	88.0	CHEMBL5122	Homo sapiens	Residual activity	%	88.0
	3055428	CHEMBL1037121	Residual activity of DDR2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	79.0	CHEMBL5122	Homo sapiens	Residual activity	%	79.0
	3055680	CHEMBL1044289	Residual activity of DDR2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	25.0	CHEMBL5122	Homo sapiens	Residual activity	%	25.0
	3056985	CHEMBL1049458	Residual activity of DDR2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL5122	Homo sapiens	Residual activity	%	97.0
	3058305	CHEMBL1037121	Residual activity of DDR2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	99.0	CHEMBL5122	Homo sapiens	Residual activity	%	99.0
	3058557	CHEMBL1044289	Residual activity of DDR2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	42.0	CHEMBL5122	Homo sapiens	Residual activity	%	42.0
	3072903	CHEMBL1049458	Residual activity of DDR2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL5122	Homo sapiens	Residual activity	%	93.0
	3130821	CHEMBL1073718	Inhibition of DDR2 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3213790	CHEMBL1107594	Inhibition of DDR2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	102.0	CHEMBL5122	Homo sapiens	INH	%	102.0
	3331895	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3333310	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3334715	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3336135	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3339079	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3340381	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3340663	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3342079	CHEMBL1168854	Inhibition of DDR2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	3358528	CHEMBL1174316	Inhibition of DDR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	1.0	CHEMBL5122	Homo sapiens	INH	%	1.0
	3358970	CHEMBL1174316	Inhibition of DDR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	2.8	CHEMBL5122	Homo sapiens	INH	%	2.8
	3444977	CHEMBL1244792	Binding affinity to DDR2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	690.0	CHEMBL5122	Homo sapiens	Kd	nM	690.0
	3445081	CHEMBL1244792	Binding affinity to DDR2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	400.0	CHEMBL5122	Homo sapiens	Kd	nM	400.0
	3448399	CHEMBL1244792	Binding affinity to DDR2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	3448730	CHEMBL1244792	Binding affinity to DDR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	3449151	CHEMBL1244792	Binding affinity to DDR2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	6.6	CHEMBL5122	Homo sapiens	Kd	nM	6.6
	3450312	CHEMBL1244792	Binding affinity to DDR2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	3450968	CHEMBL1244792	Binding affinity to DDR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	uM	10.0
	3471362	CHEMBL1251490	Inhibition of autophosphorylation of DDR2 expressed in HEK293 cells by ELISA	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	141.0	CHEMBL5122	Homo sapiens	IC50	nM	141.0
	3471376	CHEMBL1251490	Inhibition of autophosphorylation of DDR2 expressed in HEK293 cells by ELISA	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	5.2	CHEMBL5122	Homo sapiens	IC50	nM	5.2
	5120285	CHEMBL1648386	Inhibition of human DDR2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	94.0	CHEMBL5122	Homo sapiens	INH	%	94.0
	5310423	CHEMBL1693589	Inhibition of DDR2	B	CN(C)Cc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688860	=	IC50	nM	2.6	CHEMBL5122	Homo sapiens	IC50	nM	2.6
	5310424	CHEMBL1693589	Inhibition of DDR2	B	CC(C)(N)c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688861	=	IC50	nM	7.0	CHEMBL5122	Homo sapiens	IC50	nM	7.0
	6167598	CHEMBL1769241	Binding affinity to human DDR2 phenylalanine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	31.0	CHEMBL5122	Homo sapiens	Activity	%	31.0
	6167623	CHEMBL1768483	Binding affinity to human DDR2 phenylalanine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	7.4	CHEMBL5122	Homo sapiens	Activity	%	7.4
	6204509	CHEMBL1781438	Inhibition of DDR2 at 1 uM by Ambit competition binding assay	B	O=C(c1ccc(-c2ccccn2)s1)N1N=C(c2cccnc2)CC1c1ccccc1O		CHEMBL1778666	=	Inhibition	%	60.0	CHEMBL5122	Homo sapiens	INH	%	60.0
	6339964	CHEMBL1826901	Activity of DDR2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	82.0	CHEMBL5122	Homo sapiens	Activity	%	82.0
	6343503	CHEMBL1827974	Inhibition of DDR2 at 28 uM by luciferase fragment complementation assay	B	CCOc1ccc(OCC(O)CN(C)Cc2c(C)nn(Cc3ccccc3Cl)c2C)cc1		CHEMBL1223751	>	Inhibition	%	27.0	CHEMBL5122	Homo sapiens	INH	%	27.0
	6343504	CHEMBL1827975	Inhibition of DDR2 at 16 uM by luciferase fragment complementation assay	B	Cc1nn(Cc2ccccc2Cl)c(C)c1CN(C)CC(O)COc1ccc(Cl)cc1		CHEMBL1824695	>	Inhibition	%	27.0	CHEMBL5122	Homo sapiens	INH	%	27.0
	7567171	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	48.0	CHEMBL5122	Homo sapiens	Kd	nM	48.0
	7567630	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7568101	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	15.0	CHEMBL5122	Homo sapiens	Kd	nM	15.0
	7568569	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	7600.0	CHEMBL5122	Homo sapiens	Kd	nM	7600.0
	7569001	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2900.0	CHEMBL5122	Homo sapiens	Kd	nM	2900.0
	7569144	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7569604	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7570076	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7571120	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7571577	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3.2	CHEMBL5122	Homo sapiens	Kd	nM	3.2
	7572053	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	100.0	CHEMBL5122	Homo sapiens	Kd	nM	100.0
	7572074	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7572490	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	4100.0	CHEMBL5122	Homo sapiens	Kd	nM	4100.0
	7573101	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	42.0	CHEMBL5122	Homo sapiens	Kd	nM	42.0
	7573558	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7574061	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7574469	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7575079	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7575569	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	88.0	CHEMBL5122	Homo sapiens	Kd	nM	88.0
	7576034	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	4100.0	CHEMBL5122	Homo sapiens	Kd	nM	4100.0
	7576442	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	950.0	CHEMBL5122	Homo sapiens	Kd	nM	950.0
	7577053	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	33.0	CHEMBL5122	Homo sapiens	Kd	nM	33.0
	7577070	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3.6	CHEMBL5122	Homo sapiens	Kd	nM	3.6
	7577548	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2100.0	CHEMBL5122	Homo sapiens	Kd	nM	2100.0
	7578018	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	6100.0	CHEMBL5122	Homo sapiens	Kd	nM	6100.0
	7578423	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	320.0	CHEMBL5122	Homo sapiens	Kd	nM	320.0
	7578619	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7579443	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7579917	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7580386	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7580789	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	230.0	CHEMBL5122	Homo sapiens	Kd	nM	230.0
	7580977	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	26.0	CHEMBL5122	Homo sapiens	Kd	nM	26.0
	7581362	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7581807	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7582278	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7582742	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	43.0	CHEMBL5122	Homo sapiens	Kd	nM	43.0
	7583142	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7583323	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	3800.0	CHEMBL5122	Homo sapiens	Kd	nM	3800.0
	7583720	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7584165	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7584636	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7585098	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7585653	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	1100.0	CHEMBL5122	Homo sapiens	Kd	nM	1100.0
	7586061	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7586507	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7586978	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7587614	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	5300.0	CHEMBL5122	Homo sapiens	Kd	nM	5300.0
	7588033	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	400.0	CHEMBL5122	Homo sapiens	Kd	nM	400.0
	7588486	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7588966	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	5000.0	CHEMBL5122	Homo sapiens	Kd	nM	5000.0
	7589579	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7590003	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	8600.0	CHEMBL5122	Homo sapiens	Kd	nM	8600.0
	7590470	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7590502	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	120.0	CHEMBL5122	Homo sapiens	Kd	nM	120.0
	7590953	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7591552	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	11.0	CHEMBL5122	Homo sapiens	Kd	nM	11.0
	7591974	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	960.0	CHEMBL5122	Homo sapiens	Kd	nM	960.0
	7592477	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7592930	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	140.0	CHEMBL5122	Homo sapiens	Kd	nM	140.0
	7593519	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7593984	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7594457	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	33.0	CHEMBL5122	Homo sapiens	Kd	nM	33.0
	7594909	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	6.6	CHEMBL5122	Homo sapiens	Kd	nM	6.6
	7595489	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7595963	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7596434	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	98.0	CHEMBL5122	Homo sapiens	Kd	nM	98.0
	7596881	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	42.0	CHEMBL5122	Homo sapiens	Kd	nM	42.0
	7597017	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	6600.0	CHEMBL5122	Homo sapiens	Kd	nM	6600.0
	7597470	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7597943	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5122	Homo sapiens	Kd	nM	10000.0
	7598413	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	12.0	CHEMBL5122	Homo sapiens	Kd	nM	12.0
	7598855	CHEMBL1908474	Binding constant for DDR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	9900.0	CHEMBL5122	Homo sapiens	Kd	nM	9900.0
	7922706	CHEMBL1919201	Inhibition of human recombinant DDR2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	10.0	CHEMBL5122	Homo sapiens	INH	%	10.0
	7959729	CHEMBL1932839	Inhibition of DDR2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	7000.0	CHEMBL5122	Homo sapiens	IC50	uM	7.0
	7959730	CHEMBL1932839	Inhibition of DDR2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	60.0	CHEMBL5122	Homo sapiens	IC50	uM	0.06
	8061362	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.6	CHEMBL5122	Homo sapiens	Inhibition	%	0.6
	8061539	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	5.7	CHEMBL5122	Homo sapiens	Inhibition	%	5.7
	8061870	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.85	CHEMBL5122	Homo sapiens	Inhibition	%	0.85
	8062061	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.93	CHEMBL5122	Homo sapiens	Inhibition	%	0.93
	8062401	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.53	CHEMBL5122	Homo sapiens	Inhibition	%	0.53
	8062563	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	0.35	CHEMBL5122	Homo sapiens	Inhibition	%	0.35
	8062885	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.08	CHEMBL5122	Homo sapiens	Inhibition	%	0.08
	8063241	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	9.1	CHEMBL5122	Homo sapiens	Inhibition	%	9.1
	8063408	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.69	CHEMBL5122	Homo sapiens	Inhibition	%	0.69
	8063740	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.6	CHEMBL5122	Homo sapiens	Inhibition	%	2.6
	8063922	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.03	CHEMBL5122	Homo sapiens	Inhibition	%	4.03
	8064261	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.78	CHEMBL5122	Homo sapiens	Inhibition	%	2.78
	8064471	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.79	CHEMBL5122	Homo sapiens	Inhibition	%	1.79
	8064833	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.12	CHEMBL5122	Homo sapiens	Inhibition	%	-0.12
	8064999	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.24	CHEMBL5122	Homo sapiens	Inhibition	%	3.24
	8065339	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.42	CHEMBL5122	Homo sapiens	Inhibition	%	4.42
	8065514	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.27	CHEMBL5122	Homo sapiens	Inhibition	%	1.27
	8065738	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	16.47	CHEMBL5122	Homo sapiens	Inhibition	%	16.47
	8065853	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.4	CHEMBL5122	Homo sapiens	Inhibition	%	1.4
	8066063	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.36	CHEMBL5122	Homo sapiens	Inhibition	%	3.36
	8066287	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.17	CHEMBL5122	Homo sapiens	Inhibition	%	1.17
	8066423	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.66	CHEMBL5122	Homo sapiens	Inhibition	%	5.66
	8066589	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.86	CHEMBL5122	Homo sapiens	Inhibition	%	0.86
	8066813	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.84	CHEMBL5122	Homo sapiens	Inhibition	%	0.84
	8066937	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	98.17	CHEMBL5122	Homo sapiens	Inhibition	%	98.17
	8067336	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	10.35	CHEMBL5122	Homo sapiens	Inhibition	%	10.35
	8067457	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.45	CHEMBL5122	Homo sapiens	Inhibition	%	1.45
	8067681	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.72	CHEMBL5122	Homo sapiens	Inhibition	%	1.72
	8067891	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.38	CHEMBL5122	Homo sapiens	Inhibition	%	2.38
	8068026	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.4	CHEMBL5122	Homo sapiens	Inhibition	%	1.4
	8068414	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.3	CHEMBL5122	Homo sapiens	Inhibition	%	2.3
	8068539	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	93.69	CHEMBL5122	Homo sapiens	Inhibition	%	93.69
	8068763	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.36	CHEMBL5122	Homo sapiens	Inhibition	%	0.36
	8068937	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	62.66	CHEMBL5122	Homo sapiens	Inhibition	%	62.66
	8069286	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.54	CHEMBL5122	Homo sapiens	Inhibition	%	5.54
	8069357	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	8.7	CHEMBL5122	Homo sapiens	Inhibition	%	8.7
	8069581	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.77	CHEMBL5122	Homo sapiens	Inhibition	%	1.77
	8069742	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.59	CHEMBL5122	Homo sapiens	Inhibition	%	2.59
	8070092	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.2	CHEMBL5122	Homo sapiens	Inhibition	%	-0.2
	8070264	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.35	CHEMBL5122	Homo sapiens	Inhibition	%	1.35
	8070613	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.76	CHEMBL5122	Homo sapiens	Inhibition	%	3.76
	8070911	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	18.12	CHEMBL5122	Homo sapiens	Inhibition	%	18.12
	8071068	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	5.11	CHEMBL5122	Homo sapiens	Inhibition	%	5.11
	8071418	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.57	CHEMBL5122	Homo sapiens	Inhibition	%	0.57
	8071591	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.95	CHEMBL5122	Homo sapiens	Inhibition	%	3.95
	8071815	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.37	CHEMBL5122	Homo sapiens	Inhibition	%	0.37
	8071940	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	4.98	CHEMBL5122	Homo sapiens	Inhibition	%	4.98
	8072254	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	13.17	CHEMBL5122	Homo sapiens	Inhibition	%	13.17
	8072411	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.88	CHEMBL5122	Homo sapiens	Inhibition	%	4.88
	8072635	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	77.21	CHEMBL5122	Homo sapiens	Inhibition	%	77.21
	8072760	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.86	CHEMBL5122	Homo sapiens	Inhibition	%	0.86
	8073151	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.85	CHEMBL5122	Homo sapiens	Inhibition	%	2.85
	8073276	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	62.74	CHEMBL5122	Homo sapiens	Inhibition	%	62.74
	8073619	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.42	CHEMBL5122	Homo sapiens	Inhibition	%	-0.42
	8073852	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	68.61	CHEMBL5122	Homo sapiens	Inhibition	%	68.61
	8074228	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	81.44	CHEMBL5122	Homo sapiens	Inhibition	%	81.44
	8074358	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.21	CHEMBL5122	Homo sapiens	Inhibition	%	0.21
	8074739	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.48	CHEMBL5122	Homo sapiens	Inhibition	%	0.48
	8074866	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	83.59	CHEMBL5122	Homo sapiens	Inhibition	%	83.59
	8075090	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.81	CHEMBL5122	Homo sapiens	Inhibition	%	4.81
	8075201	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.71	CHEMBL5122	Homo sapiens	Inhibition	%	-0.71
	8075438	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.3	CHEMBL5122	Homo sapiens	Inhibition	%	1.3
	8075803	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.06	CHEMBL5122	Homo sapiens	Inhibition	%	3.06
	8075945	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.91	CHEMBL5122	Homo sapiens	Inhibition	%	-0.91
	8076169	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.82	CHEMBL5122	Homo sapiens	Inhibition	%	-0.82
	8076317	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.75	CHEMBL5122	Homo sapiens	Inhibition	%	0.75
	8076675	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	8.24	CHEMBL5122	Homo sapiens	Inhibition	%	8.24
	8076777	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.11	CHEMBL5122	Homo sapiens	Inhibition	%	0.11
	8077001	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.13	CHEMBL5122	Homo sapiens	Inhibition	%	-0.13
	8077024	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	5.64	CHEMBL5122	Homo sapiens	Inhibition	%	5.64
	8077248	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.22	CHEMBL5122	Homo sapiens	Inhibition	%	-0.22
	8077376	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.88	CHEMBL5122	Homo sapiens	Inhibition	%	4.88
	8077751	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-2.22	CHEMBL5122	Homo sapiens	Inhibition	%	-2.22
	8077894	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.75	CHEMBL5122	Homo sapiens	Inhibition	%	0.75
	8078257	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.38	CHEMBL5122	Homo sapiens	Inhibition	%	-0.38
	8078583	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.82	CHEMBL5122	Homo sapiens	Inhibition	%	-0.82
	8078833	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.1	CHEMBL5122	Homo sapiens	Inhibition	%	0.1
	8078949	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.45	CHEMBL5122	Homo sapiens	Inhibition	%	1.45
	8079173	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.83	CHEMBL5122	Homo sapiens	Inhibition	%	1.83
	8079331	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.32	CHEMBL5122	Homo sapiens	Inhibition	%	0.32
	8079473	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.48	CHEMBL5122	Homo sapiens	Inhibition	%	2.48
	8079697	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.34	CHEMBL5122	Homo sapiens	Inhibition	%	0.34
	8079836	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	18.84	CHEMBL5122	Homo sapiens	Inhibition	%	18.84
	8080165	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-2.38	CHEMBL5122	Homo sapiens	Inhibition	%	-2.38
	8080417	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.05	CHEMBL5122	Homo sapiens	Inhibition	%	-1.05
	8080756	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.31	CHEMBL5122	Homo sapiens	Inhibition	%	1.31
	8080920	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.79	CHEMBL5122	Homo sapiens	Inhibition	%	0.79
	8081279	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.62	CHEMBL5122	Homo sapiens	Inhibition	%	0.62
	8081423	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.6	CHEMBL5122	Homo sapiens	Inhibition	%	0.6
	8081750	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-1.25	CHEMBL5122	Homo sapiens	Inhibition	%	-1.25
	8082002	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	2.05	CHEMBL5122	Homo sapiens	Inhibition	%	2.05
	8082339	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.34	CHEMBL5122	Homo sapiens	Inhibition	%	2.34
	8082512	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.68	CHEMBL5122	Homo sapiens	Inhibition	%	-1.68
	8082859	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.33	CHEMBL5122	Homo sapiens	Inhibition	%	0.33
	8083015	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.39	CHEMBL5122	Homo sapiens	Inhibition	%	3.39
	8083239	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.72	CHEMBL5122	Homo sapiens	Inhibition	%	0.72
	8083338	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-1.13	CHEMBL5122	Homo sapiens	Inhibition	%	-1.13
	8083592	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.11	CHEMBL5122	Homo sapiens	Inhibition	%	0.11
	8083816	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.77	CHEMBL5122	Homo sapiens	Inhibition	%	1.77
	8083926	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.93	CHEMBL5122	Homo sapiens	Inhibition	%	0.93
	8084111	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1	Outside typical range	CHEMBL1909407	=	Inhibition	%	-13.65	CHEMBL5122	Homo sapiens	Inhibition	%	-13.65
	8084335	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.92	CHEMBL5122	Homo sapiens	Inhibition	%	0.92
	8084453	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.1	CHEMBL5122	Homo sapiens	Inhibition	%	1.1
	8084838	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.93	CHEMBL5122	Homo sapiens	Inhibition	%	1.93
	8084936	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.9	CHEMBL5122	Homo sapiens	Inhibition	%	0.9
	8085160	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.99	CHEMBL5122	Homo sapiens	Inhibition	%	0.99
	8085416	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.76	CHEMBL5122	Homo sapiens	Inhibition	%	-0.76
	8085524	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.6	CHEMBL5122	Homo sapiens	Inhibition	%	1.6
	8085748	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.08	CHEMBL5122	Homo sapiens	Inhibition	%	-0.08
	8085937	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	6.09	CHEMBL5122	Homo sapiens	Inhibition	%	6.09
	8086052	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.06	CHEMBL5122	Homo sapiens	Inhibition	%	1.06
	8086276	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.09	CHEMBL5122	Homo sapiens	Inhibition	%	3.09
	8086438	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.34	CHEMBL5122	Homo sapiens	Inhibition	%	-0.34
	8086761	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.25	CHEMBL5122	Homo sapiens	Inhibition	%	0.25
	8086972	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.42	CHEMBL5122	Homo sapiens	Inhibition	%	3.42
	8087354	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.85	CHEMBL5122	Homo sapiens	Inhibition	%	1.85
	8087468	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-2.28	CHEMBL5122	Homo sapiens	Inhibition	%	-2.28
	8087830	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.23	CHEMBL5122	Homo sapiens	Inhibition	%	1.23
	8087972	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.63	CHEMBL5122	Homo sapiens	Inhibition	%	1.63
	8088196	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.68	CHEMBL5122	Homo sapiens	Inhibition	%	1.68
	8088344	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.17	CHEMBL5122	Homo sapiens	Inhibition	%	-0.17
	8088696	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.33	CHEMBL5122	Homo sapiens	Inhibition	%	1.33
	8088789	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.73	CHEMBL5122	Homo sapiens	Inhibition	%	1.73
	8089013	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.19	CHEMBL5122	Homo sapiens	Inhibition	%	2.19
	8089141	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	5.18	CHEMBL5122	Homo sapiens	Inhibition	%	5.18
	8089513	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.85	CHEMBL5122	Homo sapiens	Inhibition	%	0.85
	8089633	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	37.88	CHEMBL5122	Homo sapiens	Inhibition	%	37.88
	8089857	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.73	CHEMBL5122	Homo sapiens	Inhibition	%	3.73
	8090037	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.28	CHEMBL5122	Homo sapiens	Inhibition	%	5.28
	8090202	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.78	CHEMBL5122	Homo sapiens	Inhibition	%	-1.78
	8090593	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.13	CHEMBL5122	Homo sapiens	Inhibition	%	1.13
	8090732	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	6.02	CHEMBL5122	Homo sapiens	Inhibition	%	6.02
	8091161	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.74	CHEMBL5122	Homo sapiens	Inhibition	%	1.74
	8091298	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	21.2	CHEMBL5122	Homo sapiens	Inhibition	%	21.2
	8091677	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.57	CHEMBL5122	Homo sapiens	Inhibition	%	2.57
	8091793	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.86	CHEMBL5122	Homo sapiens	Inhibition	%	0.86
	8092017	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.42	CHEMBL5122	Homo sapiens	Inhibition	%	0.42
	8092154	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.18	CHEMBL5122	Homo sapiens	Inhibition	%	1.18
	8092529	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.67	CHEMBL5122	Homo sapiens	Inhibition	%	4.67
	8092677	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.14	CHEMBL5122	Homo sapiens	Inhibition	%	1.14
	8093030	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.58	CHEMBL5122	Homo sapiens	Inhibition	%	1.58
	8093342	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.25	CHEMBL5122	Homo sapiens	Inhibition	%	3.25
	8093482	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.57	CHEMBL5122	Homo sapiens	Inhibition	%	9.57
	8093845	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	7.39	CHEMBL5122	Homo sapiens	Inhibition	%	7.39
	8094189	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	8.46	CHEMBL5122	Homo sapiens	Inhibition	%	8.46
	8094369	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.16	CHEMBL5122	Homo sapiens	Inhibition	%	-0.16
	8094544	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.55	CHEMBL5122	Homo sapiens	Inhibition	%	-0.55
	8094768	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.99	CHEMBL5122	Homo sapiens	Inhibition	%	0.99
	8094924	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.28	CHEMBL5122	Homo sapiens	Inhibition	%	1.28
	8095064	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	53.24	CHEMBL5122	Homo sapiens	Inhibition	%	53.24
	8095288	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	88.61	CHEMBL5122	Homo sapiens	Inhibition	%	88.61
	8095491	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.07	CHEMBL5122	Homo sapiens	Inhibition	%	2.07
	8095632	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.12	CHEMBL5122	Homo sapiens	Inhibition	%	1.12
	8095856	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.26	CHEMBL5122	Homo sapiens	Inhibition	%	3.26
	8096004	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.74	CHEMBL5122	Homo sapiens	Inhibition	%	1.74
	8096345	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.39	CHEMBL5122	Homo sapiens	Inhibition	%	2.39
	8096484	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.96	CHEMBL5122	Homo sapiens	Inhibition	%	1.96
	8096708	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.28	CHEMBL5122	Homo sapiens	Inhibition	%	0.28
	8096864	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.01	CHEMBL5122	Homo sapiens	Inhibition	%	6.01
	8097011	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.48	CHEMBL5122	Homo sapiens	Inhibition	%	-0.48
	8097235	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.6	CHEMBL5122	Homo sapiens	Inhibition	%	0.6
	8097322	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.87	CHEMBL5122	Homo sapiens	Inhibition	%	0.87
	8097542	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	19.27	CHEMBL5122	Homo sapiens	Inhibition	%	19.27
	8097692	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	4.51	CHEMBL5122	Homo sapiens	Inhibition	%	4.51
	8097916	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	12.22	CHEMBL5122	Homo sapiens	Inhibition	%	12.22
	8098049	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	8.64	CHEMBL5122	Homo sapiens	Inhibition	%	8.64
	8098393	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.78	CHEMBL5122	Homo sapiens	Inhibition	%	-1.78
	8098573	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.34	CHEMBL5122	Homo sapiens	Inhibition	%	0.34
	8098982	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.35	CHEMBL5122	Homo sapiens	Inhibition	%	0.35
	8099126	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.75	CHEMBL5122	Homo sapiens	Inhibition	%	1.75
	8099492	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.54	CHEMBL5122	Homo sapiens	Inhibition	%	3.54
	8099686	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	4.32	CHEMBL5122	Homo sapiens	Inhibition	%	4.32
	8100057	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.39	CHEMBL5122	Homo sapiens	Inhibition	%	0.39
	8100203	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.78	CHEMBL5122	Homo sapiens	Inhibition	%	1.78
	8100543	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.26	CHEMBL5122	Homo sapiens	Inhibition	%	2.26
	8100907	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.54	CHEMBL5122	Homo sapiens	Inhibition	%	1.54
	8101067	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.19	CHEMBL5122	Homo sapiens	Inhibition	%	2.19
	8101433	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.74	CHEMBL5122	Homo sapiens	Inhibition	%	0.74
	8101618	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.2	CHEMBL5122	Homo sapiens	Inhibition	%	1.2
	8101871	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.82	CHEMBL5122	Homo sapiens	Inhibition	%	3.82
	8102250	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	19.94	CHEMBL5122	Homo sapiens	Inhibition	%	19.94
	8102381	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	48.83	CHEMBL5122	Homo sapiens	Inhibition	%	48.83
	8102605	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	7.09	CHEMBL5122	Homo sapiens	Inhibition	%	7.09
	8102725	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.4	CHEMBL5122	Homo sapiens	Inhibition	%	-0.4
	8102903	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.26	CHEMBL5122	Homo sapiens	Inhibition	%	0.26
	8103127	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.14	CHEMBL5122	Homo sapiens	Inhibition	%	1.14
	8103323	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.12	CHEMBL5122	Homo sapiens	Inhibition	%	1.12
	8103461	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.8	CHEMBL5122	Homo sapiens	Inhibition	%	1.8
	8103685	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.54	CHEMBL5122	Homo sapiens	Inhibition	%	-1.54
	8103835	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.22	CHEMBL5122	Homo sapiens	Inhibition	%	5.22
	8104020	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	15.81	CHEMBL5122	Homo sapiens	Inhibition	%	15.81
	8104244	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	84.21	CHEMBL5122	Homo sapiens	Inhibition	%	84.21
	8104392	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.37	CHEMBL5122	Homo sapiens	Inhibition	%	2.37
	8104538	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.59	CHEMBL5122	Homo sapiens	Inhibition	%	1.59
	8104762	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.15	CHEMBL5122	Homo sapiens	Inhibition	%	2.15
	8104876	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.23	CHEMBL5122	Homo sapiens	Inhibition	%	6.23
	8105240	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.11	CHEMBL5122	Homo sapiens	Inhibition	%	-0.11
	8105406	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.53	CHEMBL5122	Homo sapiens	Inhibition	%	2.53
	8105768	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	8.58	CHEMBL5122	Homo sapiens	Inhibition	%	8.58
	8106048	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.51	CHEMBL5122	Homo sapiens	Inhibition	%	4.51
	8106213	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	14.78	CHEMBL5122	Homo sapiens	Inhibition	%	14.78
	8106437	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	5.29	CHEMBL5122	Homo sapiens	Inhibition	%	5.29
	8106593	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	77.63	CHEMBL5122	Homo sapiens	Inhibition	%	77.63
	8106946	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	17.53	CHEMBL5122	Homo sapiens	Inhibition	%	17.53
	8107067	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.59	CHEMBL5122	Homo sapiens	Inhibition	%	2.59
	8107463	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.02	CHEMBL5122	Homo sapiens	Inhibition	%	1.02
	8107664	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.65	CHEMBL5122	Homo sapiens	Inhibition	%	1.65
	8108023	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	6.93	CHEMBL5122	Homo sapiens	Inhibition	%	6.93
	8108181	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.3	CHEMBL5122	Homo sapiens	Inhibition	%	2.3
	8108580	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	85.25	CHEMBL5122	Homo sapiens	Inhibition	%	85.25
	8108727	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.64	CHEMBL5122	Homo sapiens	Inhibition	%	2.64
	8109093	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.97	CHEMBL5122	Homo sapiens	Inhibition	%	1.97
	8109207	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.42	CHEMBL5122	Homo sapiens	Inhibition	%	6.42
	8109431	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.03	CHEMBL5122	Homo sapiens	Inhibition	%	2.03
	8109561	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.47	CHEMBL5122	Homo sapiens	Inhibition	%	0.47
	8109732	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.72	CHEMBL5122	Homo sapiens	Inhibition	%	1.72
	8109956	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.56	CHEMBL5122	Homo sapiens	Inhibition	%	4.56
	8110088	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.48	CHEMBL5122	Homo sapiens	Inhibition	%	4.48
	8110367	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	7.91	CHEMBL5122	Homo sapiens	Inhibition	%	7.91
	8110757	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	11.05	CHEMBL5122	Homo sapiens	Inhibition	%	11.05
	8110915	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.32	CHEMBL5122	Homo sapiens	Inhibition	%	3.32
	8111262	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	78.0	CHEMBL5122	Homo sapiens	Inhibition	%	78.0
	8111389	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	20.96	CHEMBL5122	Homo sapiens	Inhibition	%	20.96
	8111613	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.15	CHEMBL5122	Homo sapiens	Inhibition	%	1.15
	8111779	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.34	CHEMBL5122	Homo sapiens	Inhibition	%	1.34
	8111984	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.22	CHEMBL5122	Homo sapiens	Inhibition	%	0.22
	8112345	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.8	CHEMBL5122	Homo sapiens	Inhibition	%	0.8
	8112513	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.7	CHEMBL5122	Homo sapiens	Inhibition	%	2.7
	8112737	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.61	CHEMBL5122	Homo sapiens	Inhibition	%	2.61
	8112909	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	5.97	CHEMBL5122	Homo sapiens	Inhibition	%	5.97
	8113061	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.53	CHEMBL5122	Homo sapiens	Inhibition	%	8.53
	8113285	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.73	CHEMBL5122	Homo sapiens	Inhibition	%	1.73
	8113421	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.8	CHEMBL5122	Homo sapiens	Inhibition	%	3.8
	8113769	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.55	CHEMBL5122	Homo sapiens	Inhibition	%	2.55
	8113885	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.1	CHEMBL5122	Homo sapiens	Inhibition	%	0.1
	8114285	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.91	CHEMBL5122	Homo sapiens	Inhibition	%	0.91
	8114417	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.93	CHEMBL5122	Homo sapiens	Inhibition	%	7.93
	8114641	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.86	CHEMBL5122	Homo sapiens	Inhibition	%	3.86
	8114693	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.79	CHEMBL5122	Homo sapiens	Inhibition	%	3.79
	8114917	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	6.99	CHEMBL5122	Homo sapiens	Inhibition	%	6.99
	8115083	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	46.09	CHEMBL5122	Homo sapiens	Inhibition	%	46.09
	8115248	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.8	CHEMBL5122	Homo sapiens	Inhibition	%	3.8
	8115472	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.33	CHEMBL5122	Homo sapiens	Inhibition	%	2.33
	8115592	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	80.25	CHEMBL5122	Homo sapiens	Inhibition	%	80.25
	8115949	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.67	CHEMBL5122	Homo sapiens	Inhibition	%	2.67
	8116108	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.82	CHEMBL5122	Homo sapiens	Inhibition	%	-1.82
	8116311	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.44	CHEMBL5122	Homo sapiens	Inhibition	%	0.44
	8116535	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.94	CHEMBL5122	Homo sapiens	Inhibition	%	0.94
	8116669	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.38	CHEMBL5122	Homo sapiens	Inhibition	%	0.38
	8117065	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	11.19	CHEMBL5122	Homo sapiens	Inhibition	%	11.19
	8117236	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	7.08	CHEMBL5122	Homo sapiens	Inhibition	%	7.08
	8117618	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.04	CHEMBL5122	Homo sapiens	Inhibition	%	2.04
	8117748	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.48	CHEMBL5122	Homo sapiens	Inhibition	%	3.48
	8118110	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.67	CHEMBL5122	Homo sapiens	Inhibition	%	1.67
	8118226	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.52	CHEMBL5122	Homo sapiens	Inhibition	%	0.52
	8118450	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.62	CHEMBL5122	Homo sapiens	Inhibition	%	1.62
	8118622	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.9	CHEMBL5122	Homo sapiens	Inhibition	%	2.9
	8118982	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.41	CHEMBL5122	Homo sapiens	Inhibition	%	4.41
	8119253	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.03	CHEMBL5122	Homo sapiens	Inhibition	%	2.03
	8119412	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	79.96	CHEMBL5122	Homo sapiens	Inhibition	%	79.96
	8119803	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.71	CHEMBL5122	Homo sapiens	Inhibition	%	1.71
	8119922	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	7.7	CHEMBL5122	Homo sapiens	Inhibition	%	7.7
	8120285	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.19	CHEMBL5122	Homo sapiens	Inhibition	%	-0.19
	8120445	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.39	CHEMBL5122	Homo sapiens	Inhibition	%	3.39
	8120669	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.56	CHEMBL5122	Homo sapiens	Inhibition	%	0.56
	8120870	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.03	CHEMBL5122	Homo sapiens	Inhibition	%	1.03
	8120998	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.55	CHEMBL5122	Homo sapiens	Inhibition	%	0.55
	8121222	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.19	CHEMBL5122	Homo sapiens	Inhibition	%	0.19
	8121394	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.8	CHEMBL5122	Homo sapiens	Inhibition	%	-1.8
	8121561	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.26	CHEMBL5122	Homo sapiens	Inhibition	%	1.26
	8121948	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.76	CHEMBL5122	Homo sapiens	Inhibition	%	1.76
	8122069	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	9.08	CHEMBL5122	Homo sapiens	Inhibition	%	9.08
	8122293	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	33.64	CHEMBL5122	Homo sapiens	Inhibition	%	33.64
	8122431	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.09	CHEMBL5122	Homo sapiens	Inhibition	%	2.09
	8122775	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.64	CHEMBL5122	Homo sapiens	Inhibition	%	2.64
	8122942	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	0.54	CHEMBL5122	Homo sapiens	Inhibition	%	0.54
	8123308	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.36	CHEMBL5122	Homo sapiens	Inhibition	%	7.36
	8123586	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.4	CHEMBL5122	Homo sapiens	Inhibition	%	0.4
	8123736	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.59	CHEMBL5122	Homo sapiens	Inhibition	%	5.59
	8124127	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.19	CHEMBL5122	Homo sapiens	Inhibition	%	-0.19
	8124246	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	10.86	CHEMBL5122	Homo sapiens	Inhibition	%	10.86
	8124470	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.85	CHEMBL5122	Homo sapiens	Inhibition	%	0.85
	8124609	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	6.25	CHEMBL5122	Homo sapiens	Inhibition	%	6.25
	8124998	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.22	CHEMBL5122	Homo sapiens	Inhibition	%	0.22
	8125199	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.91	CHEMBL5122	Homo sapiens	Inhibition	%	1.91
	8125553	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.82	CHEMBL5122	Homo sapiens	Inhibition	%	-0.82
	8125721	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.26	CHEMBL5122	Homo sapiens	Inhibition	%	-1.26
	8125885	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.42	CHEMBL5122	Homo sapiens	Inhibition	%	1.42
	8126109	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.13	CHEMBL5122	Homo sapiens	Inhibition	%	1.13
	8126273	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.6	CHEMBL5122	Homo sapiens	Inhibition	%	1.6
	8126612	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	79.68	CHEMBL5122	Homo sapiens	Inhibition	%	79.68
	8126748	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.19	CHEMBL5122	Homo sapiens	Inhibition	%	1.19
	8127094	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.83	CHEMBL5122	Homo sapiens	Inhibition	%	2.83
	8127261	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.86	CHEMBL5122	Homo sapiens	Inhibition	%	3.86
	8127485	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.27	CHEMBL5122	Homo sapiens	Inhibition	%	5.27
	8127627	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.43	CHEMBL5122	Homo sapiens	Inhibition	%	7.43
	8127915	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.95	CHEMBL5122	Homo sapiens	Inhibition	%	1.95
	8128067	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	13.57	CHEMBL5122	Homo sapiens	Inhibition	%	13.57
	8128291	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.0	CHEMBL5122	Homo sapiens	Inhibition	%	4.0
	8128458	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.99	CHEMBL5122	Homo sapiens	Inhibition	%	1.99
	8128801	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.16	CHEMBL5122	Homo sapiens	Inhibition	%	4.16
	8128938	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.6	CHEMBL5122	Homo sapiens	Inhibition	%	0.6
	8129162	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.09	CHEMBL5122	Homo sapiens	Inhibition	%	1.09
	8129333	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.26	CHEMBL5122	Homo sapiens	Inhibition	%	0.26
	8129522	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.52	CHEMBL5122	Homo sapiens	Inhibition	%	3.52
	8129885	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.0	CHEMBL5122	Homo sapiens	Inhibition	%	-1.0
	8130046	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.12	CHEMBL5122	Homo sapiens	Inhibition	%	1.12
	8130442	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.17	CHEMBL5122	Homo sapiens	Inhibition	%	1.17
	8130602	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.64	CHEMBL5122	Homo sapiens	Inhibition	%	1.64
	8130942	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.29	CHEMBL5122	Homo sapiens	Inhibition	%	2.29
	8131081	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	3.5	CHEMBL5122	Homo sapiens	Inhibition	%	3.5
	8131305	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.64	CHEMBL5122	Homo sapiens	Inhibition	%	0.64
	8131425	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	14.8	CHEMBL5122	Homo sapiens	Inhibition	%	14.8
	8131816	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	28.31	CHEMBL5122	Homo sapiens	Inhibition	%	28.31
	8131957	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	63.95	CHEMBL5122	Homo sapiens	Inhibition	%	63.95
	8132243	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.6	CHEMBL5122	Homo sapiens	Inhibition	%	0.6
	8132614	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.51	CHEMBL5122	Homo sapiens	Inhibition	%	6.51
	8132782	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.31	CHEMBL5122	Homo sapiens	Inhibition	%	-0.31
	8133127	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.86	CHEMBL5122	Homo sapiens	Inhibition	%	1.86
	8133489	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.59	CHEMBL5122	Homo sapiens	Inhibition	%	1.59
	8133661	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.8	CHEMBL5122	Homo sapiens	Inhibition	%	1.8
	8133841	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	65.96	CHEMBL5122	Homo sapiens	Inhibition	%	65.96
	8134065	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	84.96	CHEMBL5122	Homo sapiens	Inhibition	%	84.96
	8134213	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.42	CHEMBL5122	Homo sapiens	Inhibition	%	-0.42
	8134373	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.22	CHEMBL5122	Homo sapiens	Inhibition	%	0.22
	8134597	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.48	CHEMBL5122	Homo sapiens	Inhibition	%	1.48
	8134781	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.64	CHEMBL5122	Homo sapiens	Inhibition	%	0.64
	8134941	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.24	CHEMBL5122	Homo sapiens	Inhibition	%	4.24
	8135165	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.22	CHEMBL5122	Homo sapiens	Inhibition	%	1.22
	8135280	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.56	CHEMBL5122	Homo sapiens	Inhibition	%	4.56
	8135645	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.03	CHEMBL5122	Homo sapiens	Inhibition	%	1.03
	8135766	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.89	CHEMBL5122	Homo sapiens	Inhibition	%	2.89
	8135990	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.5	CHEMBL5122	Homo sapiens	Inhibition	%	1.5
	8136158	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.34	CHEMBL5122	Homo sapiens	Inhibition	%	1.34
	8136302	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	79.19	CHEMBL5122	Homo sapiens	Inhibition	%	79.19
	8136526	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.32	CHEMBL5122	Homo sapiens	Inhibition	%	6.32
	8136592	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.29	CHEMBL5122	Homo sapiens	Inhibition	%	0.29
	8136816	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.56	CHEMBL5122	Homo sapiens	Inhibition	%	0.56
	8136951	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.12	CHEMBL5122	Homo sapiens	Inhibition	%	3.12
	8137114	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	6.62	CHEMBL5122	Homo sapiens	Inhibition	%	6.62
	8137338	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.93	CHEMBL5122	Homo sapiens	Inhibition	%	1.93
	8137458	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.61	CHEMBL5122	Homo sapiens	Inhibition	%	4.61
	8137830	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.68	CHEMBL5122	Homo sapiens	Inhibition	%	1.68
	8137996	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.61	CHEMBL5122	Homo sapiens	Inhibition	%	-1.61
	8138399	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.44	CHEMBL5122	Homo sapiens	Inhibition	%	5.44
	8138547	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.02	CHEMBL5122	Homo sapiens	Inhibition	%	0.02
	8138929	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.43	CHEMBL5122	Homo sapiens	Inhibition	%	2.43
	8139114	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.83	CHEMBL5122	Homo sapiens	Inhibition	%	0.83
	8139497	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.62	CHEMBL5122	Homo sapiens	Inhibition	%	5.62
	8139611	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.76	CHEMBL5122	Homo sapiens	Inhibition	%	1.76
	8139835	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.84	CHEMBL5122	Homo sapiens	Inhibition	%	1.84
	8139976	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.52	CHEMBL5122	Homo sapiens	Inhibition	%	2.52
	8140323	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.01	CHEMBL5122	Homo sapiens	Inhibition	%	1.01
	8140482	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.5	CHEMBL5122	Homo sapiens	Inhibition	%	2.5
	8140849	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.88	CHEMBL5122	Homo sapiens	Inhibition	%	7.88
	8141151	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.28	CHEMBL5122	Homo sapiens	Inhibition	%	0.28
	8141281	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.67	CHEMBL5122	Homo sapiens	Inhibition	%	3.67
	8141665	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	7.68	CHEMBL5122	Homo sapiens	Inhibition	%	7.68
	8141784	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.93	CHEMBL5122	Homo sapiens	Inhibition	%	7.93
	8142008	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	36.76	CHEMBL5122	Homo sapiens	Inhibition	%	36.76
	8142169	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	17.73	CHEMBL5122	Homo sapiens	Inhibition	%	17.73
	8142337	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.14	CHEMBL5122	Homo sapiens	Inhibition	%	-1.14
	8142561	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.18	CHEMBL5122	Homo sapiens	Inhibition	%	-1.18
	8142737	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.59	CHEMBL5122	Homo sapiens	Inhibition	%	5.59
	8142886	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.36	CHEMBL5122	Homo sapiens	Inhibition	%	-0.36
	8143110	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.09	CHEMBL5122	Homo sapiens	Inhibition	%	0.09
	8143265	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.32	CHEMBL5122	Homo sapiens	Inhibition	%	1.32
	8143452	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.45	CHEMBL5122	Homo sapiens	Inhibition	%	1.45
	8143676	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.44	CHEMBL5122	Homo sapiens	Inhibition	%	3.44
	8143835	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	6.32	CHEMBL5122	Homo sapiens	Inhibition	%	6.32
	8144173	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.43	CHEMBL5122	Homo sapiens	Inhibition	%	1.43
	8144312	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.37	CHEMBL5122	Homo sapiens	Inhibition	%	2.37
	8144666	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.98	CHEMBL5122	Homo sapiens	Inhibition	%	0.98
	8144819	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.09	CHEMBL5122	Homo sapiens	Inhibition	%	1.09
	8145043	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.38	CHEMBL5122	Homo sapiens	Inhibition	%	1.38
	8145180	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.04	CHEMBL5122	Homo sapiens	Inhibition	%	5.04
	8145493	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.74	CHEMBL5122	Homo sapiens	Inhibition	%	0.74
	8145617	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	5.94	CHEMBL5122	Homo sapiens	Inhibition	%	5.94
	8145841	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.53	CHEMBL5122	Homo sapiens	Inhibition	%	7.53
	8146002	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	11.08	CHEMBL5122	Homo sapiens	Inhibition	%	11.08
	8146346	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	56.34	CHEMBL5122	Homo sapiens	Inhibition	%	56.34
	8146506	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	79.76	CHEMBL5122	Homo sapiens	Inhibition	%	79.76
	8146897	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-4.23	CHEMBL5122	Homo sapiens	Inhibition	%	-4.23
	8147066	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.94	CHEMBL5122	Homo sapiens	Inhibition	%	1.94
	8147432	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.05	CHEMBL5122	Homo sapiens	Inhibition	%	0.05
	8147585	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.65	CHEMBL5122	Homo sapiens	Inhibition	%	0.65
	8147996	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.18	CHEMBL5122	Homo sapiens	Inhibition	%	2.18
	8148154	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	47.35	CHEMBL5122	Homo sapiens	Inhibition	%	47.35
	8148492	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.04	CHEMBL5122	Homo sapiens	Inhibition	%	1.04
	8148631	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	6.73	CHEMBL5122	Homo sapiens	Inhibition	%	6.73
	8148855	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	45.83	CHEMBL5122	Homo sapiens	Inhibition	%	45.83
	8148993	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.13	CHEMBL5122	Homo sapiens	Inhibition	%	0.13
	8149376	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.7	CHEMBL5122	Homo sapiens	Inhibition	%	0.7
	8149510	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.18	CHEMBL5122	Homo sapiens	Inhibition	%	6.18
	8149832	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.69	CHEMBL5122	Homo sapiens	Inhibition	%	1.69
	8150181	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	60.29	CHEMBL5122	Homo sapiens	Inhibition	%	60.29
	8150341	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	26.93	CHEMBL5122	Homo sapiens	Inhibition	%	26.93
	8150685	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	83.47	CHEMBL5122	Homo sapiens	Inhibition	%	83.47
	8150850	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.81	CHEMBL5122	Homo sapiens	Inhibition	%	2.81
	8151237	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.85	CHEMBL5122	Homo sapiens	Inhibition	%	-0.85
	8151414	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.34	CHEMBL5122	Homo sapiens	Inhibition	%	3.34
	8151776	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.08	CHEMBL5122	Homo sapiens	Inhibition	%	2.08
	8151930	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.63	CHEMBL5122	Homo sapiens	Inhibition	%	2.63
	8152154	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	22.0	CHEMBL5122	Homo sapiens	Inhibition	%	22.0
	8152342	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.08	CHEMBL5122	Homo sapiens	Inhibition	%	7.08
	8152500	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.39	CHEMBL5122	Homo sapiens	Inhibition	%	2.39
	8152724	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.24	CHEMBL5122	Homo sapiens	Inhibition	%	7.24
	8152838	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.23	CHEMBL5122	Homo sapiens	Inhibition	%	-0.23
	8153201	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.16	CHEMBL5122	Homo sapiens	Inhibition	%	1.16
	8153338	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.3	CHEMBL5122	Homo sapiens	Inhibition	%	0.3
	8153719	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.75	CHEMBL5122	Homo sapiens	Inhibition	%	0.75
	8153852	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.54	CHEMBL5122	Homo sapiens	Inhibition	%	1.54
	8154076	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.38	CHEMBL5122	Homo sapiens	Inhibition	%	2.38
	8154173	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.31	CHEMBL5122	Homo sapiens	Inhibition	%	4.31
	8154523	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	80.15	CHEMBL5122	Homo sapiens	Inhibition	%	80.15
	8154682	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.18	CHEMBL5122	Homo sapiens	Inhibition	%	0.18
	8154906	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.52	CHEMBL5122	Homo sapiens	Inhibition	%	4.52
	8155026	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	9.11	CHEMBL5122	Homo sapiens	Inhibition	%	9.11
	8155202	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	5.59	CHEMBL5122	Homo sapiens	Inhibition	%	5.59
	8155426	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.51	CHEMBL5122	Homo sapiens	Inhibition	%	1.51
	8155587	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.74	CHEMBL5122	Homo sapiens	Inhibition	%	-0.74
	8155765	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.02	CHEMBL5122	Homo sapiens	Inhibition	%	1.02
	8155989	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.6	CHEMBL5122	Homo sapiens	Inhibition	%	1.6
	8156127	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.46	CHEMBL5122	Homo sapiens	Inhibition	%	4.46
	8156339	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.7	CHEMBL5122	Homo sapiens	Inhibition	%	4.7
	8156563	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.26	CHEMBL5122	Homo sapiens	Inhibition	%	0.26
	8156713	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	17.85	CHEMBL5122	Homo sapiens	Inhibition	%	17.85
	8156856	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.76	CHEMBL5122	Homo sapiens	Inhibition	%	1.76
	8157080	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.71	CHEMBL5122	Homo sapiens	Inhibition	%	4.71
	8157200	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.33	CHEMBL5122	Homo sapiens	Inhibition	%	3.33
	8157565	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.31	CHEMBL5122	Homo sapiens	Inhibition	%	0.31
	8157695	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	78.72	CHEMBL5122	Homo sapiens	Inhibition	%	78.72
	8157919	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.1	CHEMBL5122	Homo sapiens	Inhibition	%	3.1
	8158080	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	8.13	CHEMBL5122	Homo sapiens	Inhibition	%	8.13
	8158330	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-5.12	CHEMBL5122	Homo sapiens	Inhibition	%	-5.12
	8158712	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	22.55	CHEMBL5122	Homo sapiens	Inhibition	%	22.55
	8158881	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.61	CHEMBL5122	Homo sapiens	Inhibition	%	2.61
	8159240	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.0	CHEMBL5122	Homo sapiens	Inhibition	%	1.0
	8159360	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.35	CHEMBL5122	Homo sapiens	Inhibition	%	1.35
	8159584	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.56	CHEMBL5122	Homo sapiens	Inhibition	%	0.56
	8159715	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.91	CHEMBL5122	Homo sapiens	Inhibition	%	3.91
	8160080	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.78	CHEMBL5122	Homo sapiens	Inhibition	%	0.78
	8160217	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.2	CHEMBL5122	Homo sapiens	Inhibition	%	2.2
	8160591	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.26	CHEMBL5122	Homo sapiens	Inhibition	%	-0.26
	8160885	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.45	CHEMBL5122	Homo sapiens	Inhibition	%	1.45
	8161035	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	24.31	CHEMBL5122	Homo sapiens	Inhibition	%	24.31
	8161402	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.85	CHEMBL5122	Homo sapiens	Inhibition	%	2.85
	8161527	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.65	CHEMBL5122	Homo sapiens	Inhibition	%	1.65
	8161751	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-0.34	CHEMBL5122	Homo sapiens	Inhibition	%	-0.34
	8161889	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.73	CHEMBL5122	Homo sapiens	Inhibition	%	0.73
	8162243	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	9.17	CHEMBL5122	Homo sapiens	Inhibition	%	9.17
	8162403	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	73.91	CHEMBL5122	Homo sapiens	Inhibition	%	73.91
	8162656	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.43	CHEMBL5122	Homo sapiens	Inhibition	%	1.43
	8163028	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	1.65	CHEMBL5122	Homo sapiens	Inhibition	%	1.65
	8163197	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.77	CHEMBL5122	Homo sapiens	Inhibition	%	4.77
	8163555	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.47	CHEMBL5122	Homo sapiens	Inhibition	%	2.47
	8163902	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.39	CHEMBL5122	Homo sapiens	Inhibition	%	-0.39
	8164036	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.62	CHEMBL5122	Homo sapiens	Inhibition	%	2.62
	8164400	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.3	CHEMBL5122	Homo sapiens	Inhibition	%	1.3
	8164555	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.97	CHEMBL5122	Homo sapiens	Inhibition	%	2.97
	8164779	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.63	CHEMBL5122	Homo sapiens	Inhibition	%	2.63
	8164923	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	13.32	CHEMBL5122	Homo sapiens	Inhibition	%	13.32
	8165217	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.33	CHEMBL5122	Homo sapiens	Inhibition	%	2.33
	8165358	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	76.02	CHEMBL5122	Homo sapiens	Inhibition	%	76.02
	8165582	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.07	CHEMBL5122	Homo sapiens	Inhibition	%	5.07
	8165725	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.07	CHEMBL5122	Homo sapiens	Inhibition	%	2.07
	8166075	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-0.1	CHEMBL5122	Homo sapiens	Inhibition	%	-0.1
	8166213	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.4	CHEMBL5122	Homo sapiens	Inhibition	%	0.4
	8166567	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.82	CHEMBL5122	Homo sapiens	Inhibition	%	2.82
	8166892	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	43.06	CHEMBL5122	Homo sapiens	Inhibition	%	43.06
	8166980	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.61	CHEMBL5122	Homo sapiens	Inhibition	%	1.61
	8167204	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.27	CHEMBL5122	Homo sapiens	Inhibition	%	1.27
	8167345	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	6.94	CHEMBL5122	Homo sapiens	Inhibition	%	6.94
	8167509	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.55	CHEMBL5122	Homo sapiens	Inhibition	%	2.55
	8167733	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.6	CHEMBL5122	Homo sapiens	Inhibition	%	2.6
	8167866	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	0.92	CHEMBL5122	Homo sapiens	Inhibition	%	0.92
	8168214	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.44	CHEMBL5122	Homo sapiens	Inhibition	%	0.44
	8168355	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.82	CHEMBL5122	Homo sapiens	Inhibition	%	4.82
	8168579	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.1	CHEMBL5122	Homo sapiens	Inhibition	%	4.1
	8168715	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.87	CHEMBL5122	Homo sapiens	Inhibition	%	-0.87
	8169103	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.43	CHEMBL5122	Homo sapiens	Inhibition	%	7.43
	8169245	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.42	CHEMBL5122	Homo sapiens	Inhibition	%	1.42
	8169549	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.8	CHEMBL5122	Homo sapiens	Inhibition	%	3.8
	8169907	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.45	CHEMBL5122	Homo sapiens	Inhibition	%	4.45
	8170052	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	67.74	CHEMBL5122	Homo sapiens	Inhibition	%	67.74
	8170401	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.44	CHEMBL5122	Homo sapiens	Inhibition	%	1.44
	8170541	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.6	CHEMBL5122	Homo sapiens	Inhibition	%	2.6
	8170765	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.24	CHEMBL5122	Homo sapiens	Inhibition	%	-0.24
	8170900	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	10.92	CHEMBL5122	Homo sapiens	Inhibition	%	10.92
	8171097	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	83.59	CHEMBL5122	Homo sapiens	Inhibition	%	83.59
	8171321	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	9.87	CHEMBL5122	Homo sapiens	Inhibition	%	9.87
	8171538	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-0.68	CHEMBL5122	Homo sapiens	Inhibition	%	-0.68
	8171679	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.88	CHEMBL5122	Homo sapiens	Inhibition	%	4.88
	8172056	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.22	CHEMBL5122	Homo sapiens	Inhibition	%	1.22
	8172188	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.58	CHEMBL5122	Homo sapiens	Inhibition	%	4.58
	8172412	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.46	CHEMBL5122	Homo sapiens	Inhibition	%	5.46
	8172540	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.08	CHEMBL5122	Homo sapiens	Inhibition	%	0.08
	8172906	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	22.41	CHEMBL5122	Homo sapiens	Inhibition	%	22.41
	8173042	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.11	CHEMBL5122	Homo sapiens	Inhibition	%	-0.11
	8173431	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.12	CHEMBL5122	Homo sapiens	Inhibition	%	2.12
	8173572	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.51	CHEMBL5122	Homo sapiens	Inhibition	%	0.51
	8173796	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.03	CHEMBL5122	Homo sapiens	Inhibition	%	2.03
	8173883	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.41	CHEMBL5122	Homo sapiens	Inhibition	%	1.41
	8174239	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.69	CHEMBL5122	Homo sapiens	Inhibition	%	1.69
	8174387	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	84.38	CHEMBL5122	Homo sapiens	Inhibition	%	84.38
	8174611	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.92	CHEMBL5122	Homo sapiens	Inhibition	%	4.92
	8174733	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.81	CHEMBL5122	Homo sapiens	Inhibition	%	1.81
	8175100	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.71	CHEMBL5122	Homo sapiens	Inhibition	%	1.71
	8175236	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.04	CHEMBL5122	Homo sapiens	Inhibition	%	1.04
	8175492	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	-0.37	CHEMBL5122	Homo sapiens	Inhibition	%	-0.37
	8175716	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	0.37	CHEMBL5122	Homo sapiens	Inhibition	%	0.37
	8175879	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-2.88	CHEMBL5122	Homo sapiens	Inhibition	%	-2.88
	8176032	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.72	CHEMBL5122	Homo sapiens	Inhibition	%	1.72
	8176256	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.78	CHEMBL5122	Homo sapiens	Inhibition	%	2.78
	8176405	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.49	CHEMBL5122	Homo sapiens	Inhibition	%	2.49
	8176761	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.62	CHEMBL5122	Homo sapiens	Inhibition	%	8.62
	8176891	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.36	CHEMBL5122	Homo sapiens	Inhibition	%	0.36
	8177257	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.73	CHEMBL5122	Homo sapiens	Inhibition	%	1.73
	8177395	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-9.65	CHEMBL5122	Homo sapiens	Inhibition	%	-9.65
	8177619	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.8	CHEMBL5122	Homo sapiens	Inhibition	%	2.8
	8177783	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.37	CHEMBL5122	Homo sapiens	Inhibition	%	9.37
	8178147	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.97	CHEMBL5122	Homo sapiens	Inhibition	%	5.97
	8178235	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.19	CHEMBL5122	Homo sapiens	Inhibition	%	5.19
	8178459	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.62	CHEMBL5122	Homo sapiens	Inhibition	%	1.62
	8178586	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	10.33	CHEMBL5122	Homo sapiens	Inhibition	%	10.33
	8178959	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	7.61	CHEMBL5122	Homo sapiens	Inhibition	%	7.61
	8179082	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.66	CHEMBL5122	Homo sapiens	Inhibition	%	2.66
	8179306	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.39	CHEMBL5122	Homo sapiens	Inhibition	%	1.39
	8179450	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-0.45	CHEMBL5122	Homo sapiens	Inhibition	%	-0.45
	8179587	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.75	CHEMBL5122	Homo sapiens	Inhibition	%	0.75
	8179811	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.06	CHEMBL5122	Homo sapiens	Inhibition	%	1.06
	8180068	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.55	CHEMBL5122	Homo sapiens	Inhibition	%	0.55
	8180222	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl	Outside typical range	CHEMBL1794073	=	Inhibition	%	-16.01	CHEMBL5122	Homo sapiens	Inhibition	%	-16.01
	8180602	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.01	CHEMBL5122	Homo sapiens	Inhibition	%	3.01
	8180750	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.03	CHEMBL5122	Homo sapiens	Inhibition	%	1.03
	8181107	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	59.81	CHEMBL5122	Homo sapiens	Inhibition	%	59.81
	8181238	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.9	CHEMBL5122	Homo sapiens	Inhibition	%	1.9
	8181462	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.09	CHEMBL5122	Homo sapiens	Inhibition	%	-0.09
	8181602	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	6.08	CHEMBL5122	Homo sapiens	Inhibition	%	6.08
	8181965	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	16.79	CHEMBL5122	Homo sapiens	Inhibition	%	16.79
	8182128	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.01	CHEMBL5122	Homo sapiens	Inhibition	%	0.01
	8182492	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.84	CHEMBL5122	Homo sapiens	Inhibition	%	0.84
	8182808	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.98	CHEMBL5122	Homo sapiens	Inhibition	%	1.98
	8182930	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.69	CHEMBL5122	Homo sapiens	Inhibition	%	1.69
	8183154	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.36	CHEMBL5122	Homo sapiens	Inhibition	%	4.36
	8183303	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.76	CHEMBL5122	Homo sapiens	Inhibition	%	3.76
	8183656	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	8.59	CHEMBL5122	Homo sapiens	Inhibition	%	8.59
	8183798	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.57	CHEMBL5122	Homo sapiens	Inhibition	%	3.57
	8184158	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.68	CHEMBL5122	Homo sapiens	Inhibition	%	1.68
	8184424	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.0	CHEMBL5122	Homo sapiens	Inhibition	%	1.0
	8184571	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.15	CHEMBL5122	Homo sapiens	Inhibition	%	0.15
	8184795	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.0	CHEMBL5122	Homo sapiens	Inhibition	%	-1.0
	8184952	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	37.2	CHEMBL5122	Homo sapiens	Inhibition	%	37.2
	8185101	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.54	CHEMBL5122	Homo sapiens	Inhibition	%	2.54
	8185325	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.32	CHEMBL5122	Homo sapiens	Inhibition	%	1.32
	8185456	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	79.69	CHEMBL5122	Homo sapiens	Inhibition	%	79.69
	8185811	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.07	CHEMBL5122	Homo sapiens	Inhibition	%	0.07
	8185950	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.43	CHEMBL5122	Homo sapiens	Inhibition	%	1.43
	8186174	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.94	CHEMBL5122	Homo sapiens	Inhibition	%	5.94
	8186315	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.41	CHEMBL5122	Homo sapiens	Inhibition	%	4.41
	8186479	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-5.99	CHEMBL5122	Homo sapiens	Inhibition	%	-5.99
	8186703	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.75	CHEMBL5122	Homo sapiens	Inhibition	%	1.75
	8186842	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.01	CHEMBL5122	Homo sapiens	Inhibition	%	1.01
	8187164	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.69	CHEMBL5122	Homo sapiens	Inhibition	%	2.69
	8187512	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.53	CHEMBL5122	Homo sapiens	Inhibition	%	1.53
	8187660	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	20.0	CHEMBL5122	Homo sapiens	Inhibition	%	20.0
	8188013	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	24.95	CHEMBL5122	Homo sapiens	Inhibition	%	24.95
	8188156	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.3	CHEMBL5122	Homo sapiens	Inhibition	%	0.3
	8188380	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.13	CHEMBL5122	Homo sapiens	Inhibition	%	3.13
	8188515	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.49	CHEMBL5122	Homo sapiens	Inhibition	%	1.49
	8188789	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.39	CHEMBL5122	Homo sapiens	Inhibition	%	0.39
	8189161	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.03	CHEMBL5122	Homo sapiens	Inhibition	%	-0.03
	8189317	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	82.52	CHEMBL5122	Homo sapiens	Inhibition	%	82.52
	8189690	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.46	CHEMBL5122	Homo sapiens	Inhibition	%	1.46
	8189822	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.72	CHEMBL5122	Homo sapiens	Inhibition	%	4.72
	8190046	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	9.88	CHEMBL5122	Homo sapiens	Inhibition	%	9.88
	8190178	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.75	CHEMBL5122	Homo sapiens	Inhibition	%	2.75
	8190542	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.49	CHEMBL5122	Homo sapiens	Inhibition	%	4.49
	8190679	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	34.74	CHEMBL5122	Homo sapiens	Inhibition	%	34.74
	8191067	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.87	CHEMBL5122	Homo sapiens	Inhibition	%	1.87
	8191205	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.92	CHEMBL5122	Homo sapiens	Inhibition	%	0.92
	8191429	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.89	CHEMBL5122	Homo sapiens	Inhibition	%	9.89
	8191525	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	9.65	CHEMBL5122	Homo sapiens	Inhibition	%	9.65
	8191871	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.16	CHEMBL5122	Homo sapiens	Inhibition	%	3.16
	8192020	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.3	CHEMBL5122	Homo sapiens	Inhibition	%	1.3
	8192244	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.62	CHEMBL5122	Homo sapiens	Inhibition	%	6.62
	8192373	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.36	CHEMBL5122	Homo sapiens	Inhibition	%	4.36
	8192741	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.33	CHEMBL5122	Homo sapiens	Inhibition	%	0.33
	8192877	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	7.83	CHEMBL5122	Homo sapiens	Inhibition	%	7.83
	8193149	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.86	CHEMBL5122	Homo sapiens	Inhibition	%	-0.86
	8193518	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-1.45	CHEMBL5122	Homo sapiens	Inhibition	%	-1.45
	8193675	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.35	CHEMBL5122	Homo sapiens	Inhibition	%	4.35
	8193899	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	6.0	CHEMBL5122	Homo sapiens	Inhibition	%	6.0
	8194048	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.93	CHEMBL5122	Homo sapiens	Inhibition	%	0.93
	8194403	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.29	CHEMBL5122	Homo sapiens	Inhibition	%	2.29
	8194534	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	10.57	CHEMBL5122	Homo sapiens	Inhibition	%	10.57
	8194901	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	27.57	CHEMBL5122	Homo sapiens	Inhibition	%	27.57
	8195034	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.1	CHEMBL5122	Homo sapiens	Inhibition	%	2.1
	8195258	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.08	CHEMBL5122	Homo sapiens	Inhibition	%	3.08
	8195422	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.1	CHEMBL5122	Homo sapiens	Inhibition	%	2.1
	8195785	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.68	CHEMBL5122	Homo sapiens	Inhibition	%	2.68
	8195883	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.54	CHEMBL5122	Homo sapiens	Inhibition	%	1.54
	8196107	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	6.22	CHEMBL5122	Homo sapiens	Inhibition	%	6.22
	8196224	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.85	CHEMBL5122	Homo sapiens	Inhibition	%	0.85
	8196598	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	31.16	CHEMBL5122	Homo sapiens	Inhibition	%	31.16
	8196726	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.67	CHEMBL5122	Homo sapiens	Inhibition	%	4.67
	8197091	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.42	CHEMBL5122	Homo sapiens	Inhibition	%	5.42
	8197228	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.19	CHEMBL5122	Homo sapiens	Inhibition	%	-0.19
	8197452	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.4	CHEMBL5122	Homo sapiens	Inhibition	%	1.4
	8197503	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.42	CHEMBL5122	Homo sapiens	Inhibition	%	1.42
	8197727	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.13	CHEMBL5122	Homo sapiens	Inhibition	%	2.13
	8197867	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.71	CHEMBL5122	Homo sapiens	Inhibition	%	0.71
	8198248	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.36	CHEMBL5122	Homo sapiens	Inhibition	%	2.36
	8198386	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.39	CHEMBL5122	Homo sapiens	Inhibition	%	1.39
	8198740	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	9.45	CHEMBL5122	Homo sapiens	Inhibition	%	9.45
	8198871	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.2	CHEMBL5122	Homo sapiens	Inhibition	%	3.2
	8199095	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.8	CHEMBL5122	Homo sapiens	Inhibition	%	8.8
	8199243	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.16	CHEMBL5122	Homo sapiens	Inhibition	%	3.16
	8199601	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.28	CHEMBL5122	Homo sapiens	Inhibition	%	1.28
	8199764	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.8	CHEMBL5122	Homo sapiens	Inhibition	%	6.8
	8200126	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.73	CHEMBL5122	Homo sapiens	Inhibition	%	4.73
	8200454	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.0	CHEMBL5122	Homo sapiens	Inhibition	%	3.0
	8200569	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.06	CHEMBL5122	Homo sapiens	Inhibition	%	1.06
	8200943	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	83.31	CHEMBL5122	Homo sapiens	Inhibition	%	83.31
	8201073	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.95	CHEMBL5122	Homo sapiens	Inhibition	%	3.95
	8201297	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.63	CHEMBL5122	Homo sapiens	Inhibition	%	4.63
	8201432	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.3	CHEMBL5122	Homo sapiens	Inhibition	%	1.3
	8201789	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-2.64	CHEMBL5122	Homo sapiens	Inhibition	%	-2.64
	8202068	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.18	CHEMBL5122	Homo sapiens	Inhibition	%	1.18
	8202208	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.75	CHEMBL5122	Homo sapiens	Inhibition	%	0.75
	8202599	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.83	CHEMBL5122	Homo sapiens	Inhibition	%	4.83
	8202724	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.07	CHEMBL5122	Homo sapiens	Inhibition	%	1.07
	8202948	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.14	CHEMBL5122	Homo sapiens	Inhibition	%	1.14
	8203078	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.88	CHEMBL5122	Homo sapiens	Inhibition	%	1.88
	8203433	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	11.43	CHEMBL5122	Homo sapiens	Inhibition	%	11.43
	8203579	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.23	CHEMBL5122	Homo sapiens	Inhibition	%	7.23
	8203937	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.92	CHEMBL5122	Homo sapiens	Inhibition	%	1.92
	8204103	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.51	CHEMBL5122	Homo sapiens	Inhibition	%	1.51
	8204327	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.49	CHEMBL5122	Homo sapiens	Inhibition	%	2.49
	8204464	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	20.3	CHEMBL5122	Homo sapiens	Inhibition	%	20.3
	8204793	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	76.7	CHEMBL5122	Homo sapiens	Inhibition	%	76.7
	8204908	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.42	CHEMBL5122	Homo sapiens	Inhibition	%	1.42
	8205132	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.31	CHEMBL5122	Homo sapiens	Inhibition	%	2.31
	8205281	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.38	CHEMBL5122	Homo sapiens	Inhibition	%	1.38
	8205641	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.52	CHEMBL5122	Homo sapiens	Inhibition	%	4.52
	8205780	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.48	CHEMBL5122	Homo sapiens	Inhibition	%	2.48
	8206136	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-4.31	CHEMBL5122	Homo sapiens	Inhibition	%	-4.31
	8206412	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.88	CHEMBL5122	Homo sapiens	Inhibition	%	0.88
	8206555	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.46	CHEMBL5122	Homo sapiens	Inhibition	%	0.46
	8206779	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.46	CHEMBL5122	Homo sapiens	Inhibition	%	2.46
	8206959	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.29	CHEMBL5122	Homo sapiens	Inhibition	%	1.29
	8207309	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-0.28	CHEMBL5122	Homo sapiens	Inhibition	%	-0.28
	8207439	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.14	CHEMBL5122	Homo sapiens	Inhibition	%	3.14
	8207795	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	64.97	CHEMBL5122	Homo sapiens	Inhibition	%	64.97
	8207940	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.03	CHEMBL5122	Homo sapiens	Inhibition	%	2.03
	8208164	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.44	CHEMBL5122	Homo sapiens	Inhibition	%	1.44
	8208296	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.09	CHEMBL5122	Homo sapiens	Inhibition	%	2.09
	8208686	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.3	CHEMBL5122	Homo sapiens	Inhibition	%	1.3
	8208819	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	73.99	CHEMBL5122	Homo sapiens	Inhibition	%	73.99
	8209148	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	4.99	CHEMBL5122	Homo sapiens	Inhibition	%	4.99
	8209488	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.14	CHEMBL5122	Homo sapiens	Inhibition	%	3.14
	8209638	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.9	CHEMBL5122	Homo sapiens	Inhibition	%	3.9
	8209998	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.68	CHEMBL5122	Homo sapiens	Inhibition	%	5.68
	8210139	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.18	CHEMBL5122	Homo sapiens	Inhibition	%	2.18
	8210363	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.56	CHEMBL5122	Homo sapiens	Inhibition	%	5.56
	8210499	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.58	CHEMBL5122	Homo sapiens	Inhibition	%	-0.58
	8210758	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.22	CHEMBL5122	Homo sapiens	Inhibition	%	0.22
	8211126	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.46	CHEMBL5122	Homo sapiens	Inhibition	%	2.46
	8211296	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.57	CHEMBL5122	Homo sapiens	Inhibition	%	1.57
	8211643	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-6.1	CHEMBL5122	Homo sapiens	Inhibition	%	-6.1
	8211772	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.17	CHEMBL5122	Homo sapiens	Inhibition	%	2.17
	8211996	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.12	CHEMBL5122	Homo sapiens	Inhibition	%	4.12
	8212128	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.4	CHEMBL5122	Homo sapiens	Inhibition	%	1.4
	8212493	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.28	CHEMBL5122	Homo sapiens	Inhibition	%	2.28
	8212626	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.66	CHEMBL5122	Homo sapiens	Inhibition	%	3.66
	8212850	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.21	CHEMBL5122	Homo sapiens	Inhibition	%	2.21
	8213020	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.24	CHEMBL5122	Homo sapiens	Inhibition	%	0.24
	8213149	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.46	CHEMBL5122	Homo sapiens	Inhibition	%	1.46
	8213373	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.24	CHEMBL5122	Homo sapiens	Inhibition	%	2.24
	8213477	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	30.82	CHEMBL5122	Homo sapiens	Inhibition	%	30.82
	8213814	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-1.29	CHEMBL5122	Homo sapiens	Inhibition	%	-1.29
	8213961	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.39	CHEMBL5122	Homo sapiens	Inhibition	%	0.39
	8214185	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.56	CHEMBL5122	Homo sapiens	Inhibition	%	1.56
	8214322	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	8.95	CHEMBL5122	Homo sapiens	Inhibition	%	8.95
	8214680	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	5.32	CHEMBL5122	Homo sapiens	Inhibition	%	5.32
	8214832	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.03	CHEMBL5122	Homo sapiens	Inhibition	%	0.03
	8215083	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.21	CHEMBL5122	Homo sapiens	Inhibition	%	-0.21
	8215307	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.61	CHEMBL5122	Homo sapiens	Inhibition	%	-0.61
	8215460	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.44	CHEMBL5122	Homo sapiens	Inhibition	%	2.44
	8215624	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.04	CHEMBL5122	Homo sapiens	Inhibition	%	2.04
	8215848	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.8	CHEMBL5122	Homo sapiens	Inhibition	%	2.8
	8215967	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.31	CHEMBL5122	Homo sapiens	Inhibition	%	0.31
	8216310	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.6	CHEMBL5122	Homo sapiens	Inhibition	%	1.6
	8216446	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.85	CHEMBL5122	Homo sapiens	Inhibition	%	6.85
	8216670	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.06	CHEMBL5122	Homo sapiens	Inhibition	%	2.06
	8216808	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.71	CHEMBL5122	Homo sapiens	Inhibition	%	1.71
	8217166	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.42	CHEMBL5122	Homo sapiens	Inhibition	%	3.42
	8217340	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.51	CHEMBL5122	Homo sapiens	Inhibition	%	0.51
	8217695	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.02	CHEMBL5122	Homo sapiens	Inhibition	%	2.02
	8217796	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.03	CHEMBL5122	Homo sapiens	Inhibition	%	0.03
	8218020	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.46	CHEMBL5122	Homo sapiens	Inhibition	%	2.46
	8218135	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.41	CHEMBL5122	Homo sapiens	Inhibition	%	1.41
	8218486	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	7.86	CHEMBL5122	Homo sapiens	Inhibition	%	7.86
	8218629	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	12.0	CHEMBL5122	Homo sapiens	Inhibition	%	12.0
	8218853	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	56.32	CHEMBL5122	Homo sapiens	Inhibition	%	56.32
	8218984	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	30.01	CHEMBL5122	Homo sapiens	Inhibition	%	30.01
	8219144	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.59	CHEMBL5122	Homo sapiens	Inhibition	%	7.59
	8219368	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.75	CHEMBL5122	Homo sapiens	Inhibition	%	7.75
	8219618	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-1.04	CHEMBL5122	Homo sapiens	Inhibition	%	-1.04
	8219779	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.79	CHEMBL5122	Homo sapiens	Inhibition	%	2.79
	8220172	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.37	CHEMBL5122	Homo sapiens	Inhibition	%	2.37
	8220301	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.21	CHEMBL5122	Homo sapiens	Inhibition	%	1.21
	8220639	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.21	CHEMBL5122	Homo sapiens	Inhibition	%	0.21
	8221001	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.76	CHEMBL5122	Homo sapiens	Inhibition	%	3.76
	8221137	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.25	CHEMBL5122	Homo sapiens	Inhibition	%	1.25
	8221494	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.68	CHEMBL5122	Homo sapiens	Inhibition	%	1.68
	8221659	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.6	CHEMBL5122	Homo sapiens	Inhibition	%	0.6
	8222014	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	8.19	CHEMBL5122	Homo sapiens	Inhibition	%	8.19
	8222336	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.31	CHEMBL5122	Homo sapiens	Inhibition	%	3.31
	8222470	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.64	CHEMBL5122	Homo sapiens	Inhibition	%	0.64
	8222812	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	40.96	CHEMBL5122	Homo sapiens	Inhibition	%	40.96
	8223180	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	87.35	CHEMBL5122	Homo sapiens	Inhibition	%	87.35
	8223309	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	24.38	CHEMBL5122	Homo sapiens	Inhibition	%	24.38
	8223694	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	8.57	CHEMBL5122	Homo sapiens	Inhibition	%	8.57
	8223944	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-1.21	CHEMBL5122	Homo sapiens	Inhibition	%	-1.21
	8224106	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.69	CHEMBL5122	Homo sapiens	Inhibition	%	2.69
	8224330	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.77	CHEMBL5122	Homo sapiens	Inhibition	%	3.77
	8224500	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.04	CHEMBL5122	Homo sapiens	Inhibition	%	3.04
	8224635	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-0.02	CHEMBL5122	Homo sapiens	Inhibition	%	-0.02
	8224859	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.01	CHEMBL5122	Homo sapiens	Inhibition	%	3.01
	8224973	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.75	CHEMBL5122	Homo sapiens	Inhibition	%	1.75
	8225331	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.49	CHEMBL5122	Homo sapiens	Inhibition	%	2.49
	8225469	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.96	CHEMBL5122	Homo sapiens	Inhibition	%	0.96
	8225693	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.99	CHEMBL5122	Homo sapiens	Inhibition	%	0.99
	8225828	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.98	CHEMBL5122	Homo sapiens	Inhibition	%	1.98
	8225986	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.35	CHEMBL5122	Homo sapiens	Inhibition	%	1.35
	8226210	CHEMBL1962257	GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.32	CHEMBL5122	Homo sapiens	Inhibition	%	0.32
	8226335	CHEMBL1962256	GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.14	CHEMBL5122	Homo sapiens	Inhibition	%	1.14
	10838560	CHEMBL2014133	Inhibition of DDR2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	7.0	CHEMBL5122	Homo sapiens	INH	%	7.0
	12116239	CHEMBL2172945	Inhibition of DDR2	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL2171124	=	IC50	nM	524.0	CHEMBL5122	Homo sapiens	IC50	nM	524.0
	12170824	CHEMBL2212691	Inhibition of DDR2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	107.0	CHEMBL5122	Homo sapiens	Activity	%	107.0
	12172125	CHEMBL2213950	Inhibition of DDR2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	12173662	CHEMBL2216441	Inhibition of DDR2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	12220038	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	115.0	CHEMBL5122	Homo sapiens	Residual Activity	%	115.0
	12220039	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12220040	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	81.0	CHEMBL5122	Homo sapiens	Residual Activity	%	81.0
	12220041	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	83.0	CHEMBL5122	Homo sapiens	Residual Activity	%	83.0
	12220042	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	84.0	CHEMBL5122	Homo sapiens	Residual Activity	%	84.0
	12220043	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12220044	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220045	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12220046	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	111.0	CHEMBL5122	Homo sapiens	Residual Activity	%	111.0
	12220047	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	75.0	CHEMBL5122	Homo sapiens	Residual Activity	%	75.0
	12220048	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12220049	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	110.0	CHEMBL5122	Homo sapiens	Residual Activity	%	110.0
	12220050	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12220051	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	75.0	CHEMBL5122	Homo sapiens	Residual Activity	%	75.0
	12220052	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12220053	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12220054	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	116.0	CHEMBL5122	Homo sapiens	Residual Activity	%	116.0
	12220055	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	102.0	CHEMBL5122	Homo sapiens	Residual Activity	%	102.0
	12220056	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12220057	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	110.0	CHEMBL5122	Homo sapiens	Residual Activity	%	110.0
	12220058	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12220059	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12220060	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12220061	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	88.0	CHEMBL5122	Homo sapiens	Residual Activity	%	88.0
	12220062	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	109.0	CHEMBL5122	Homo sapiens	Residual Activity	%	109.0
	12220063	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12220064	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	95.0	CHEMBL5122	Homo sapiens	Residual Activity	%	95.0
	12220065	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12220066	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	106.0	CHEMBL5122	Homo sapiens	Residual Activity	%	106.0
	12220067	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	114.0	CHEMBL5122	Homo sapiens	Residual Activity	%	114.0
	12220068	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	102.0	CHEMBL5122	Homo sapiens	Residual Activity	%	102.0
	12220069	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	1.0	CHEMBL5122	Homo sapiens	Residual Activity	%	1.0
	12220070	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	109.0	CHEMBL5122	Homo sapiens	Residual Activity	%	109.0
	12220071	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	106.0	CHEMBL5122	Homo sapiens	Residual Activity	%	106.0
	12220072	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	112.0	CHEMBL5122	Homo sapiens	Residual Activity	%	112.0
	12220073	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	113.0	CHEMBL5122	Homo sapiens	Residual Activity	%	113.0
	12220074	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12220075	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	115.0	CHEMBL5122	Homo sapiens	Residual Activity	%	115.0
	12220076	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	121.0	CHEMBL5122	Homo sapiens	Residual Activity	%	121.0
	12220077	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	110.0	CHEMBL5122	Homo sapiens	Residual Activity	%	110.0
	12220078	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	115.0	CHEMBL5122	Homo sapiens	Residual Activity	%	115.0
	12220079	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	112.0	CHEMBL5122	Homo sapiens	Residual Activity	%	112.0
	12220080	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12220081	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	110.0	CHEMBL5122	Homo sapiens	Residual Activity	%	110.0
	12220082	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	26.0	CHEMBL5122	Homo sapiens	Residual Activity	%	26.0
	12220083	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	129.0	CHEMBL5122	Homo sapiens	Residual Activity	%	129.0
	12220084	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	111.0	CHEMBL5122	Homo sapiens	Residual Activity	%	111.0
	12220085	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	110.0	CHEMBL5122	Homo sapiens	Residual Activity	%	110.0
	12220086	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	115.0	CHEMBL5122	Homo sapiens	Residual Activity	%	115.0
	12220087	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	107.0	CHEMBL5122	Homo sapiens	Residual Activity	%	107.0
	12220088	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	111.0	CHEMBL5122	Homo sapiens	Residual Activity	%	111.0
	12220089	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12220090	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	113.0	CHEMBL5122	Homo sapiens	Residual Activity	%	113.0
	12220091	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	126.0	CHEMBL5122	Homo sapiens	Residual Activity	%	126.0
	12220092	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	119.0	CHEMBL5122	Homo sapiens	Residual Activity	%	119.0
	12220093	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	110.0	CHEMBL5122	Homo sapiens	Residual Activity	%	110.0
	12220094	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	119.0	CHEMBL5122	Homo sapiens	Residual Activity	%	119.0
	12220095	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12220096	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	111.0	CHEMBL5122	Homo sapiens	Residual Activity	%	111.0
	12220097	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12220098	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12220099	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	106.0	CHEMBL5122	Homo sapiens	Residual Activity	%	106.0
	12220100	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	116.0	CHEMBL5122	Homo sapiens	Residual Activity	%	116.0
	12220101	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	111.0	CHEMBL5122	Homo sapiens	Residual Activity	%	111.0
	12220102	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	118.0	CHEMBL5122	Homo sapiens	Residual Activity	%	118.0
	12220103	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12220104	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12220105	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	109.0	CHEMBL5122	Homo sapiens	Residual Activity	%	109.0
	12220106	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	109.0	CHEMBL5122	Homo sapiens	Residual Activity	%	109.0
	12220107	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	113.0	CHEMBL5122	Homo sapiens	Residual Activity	%	113.0
	12220108	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	102.0	CHEMBL5122	Homo sapiens	Residual Activity	%	102.0
	12220109	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	79.0	CHEMBL5122	Homo sapiens	Residual Activity	%	79.0
	12220110	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	113.0	CHEMBL5122	Homo sapiens	Residual Activity	%	113.0
	12220111	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	108.0	CHEMBL5122	Homo sapiens	Residual Activity	%	108.0
	12220112	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12220113	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12220114	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	130.0	CHEMBL5122	Homo sapiens	Residual Activity	%	130.0
	12220115	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220116	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12220117	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	6.0	CHEMBL5122	Homo sapiens	Residual Activity	%	6.0
	12220118	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12220119	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12220120	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12220121	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	108.0	CHEMBL5122	Homo sapiens	Residual Activity	%	108.0
	12220122	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12220123	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12220124	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12220125	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220126	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12220127	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220128	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12220129	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220130	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	71.0	CHEMBL5122	Homo sapiens	Residual Activity	%	71.0
	12220131	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	89.0	CHEMBL5122	Homo sapiens	Residual Activity	%	89.0
	12220132	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	86.0	CHEMBL5122	Homo sapiens	Residual Activity	%	86.0
	12220133	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12220134	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	102.0	CHEMBL5122	Homo sapiens	Residual Activity	%	102.0
	12220135	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12220136	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220137	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12220138	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	85.0	CHEMBL5122	Homo sapiens	Residual Activity	%	85.0
	12220139	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	56.0	CHEMBL5122	Homo sapiens	Residual Activity	%	56.0
	12220140	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12220141	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	77.0	CHEMBL5122	Homo sapiens	Residual Activity	%	77.0
	12220142	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12220143	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL5122	Homo sapiens	Residual Activity	%	87.0
	12220144	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	88.0	CHEMBL5122	Homo sapiens	Residual Activity	%	88.0
	12220145	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	78.0	CHEMBL5122	Homo sapiens	Residual Activity	%	78.0
	12220146	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12220147	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	89.0	CHEMBL5122	Homo sapiens	Residual Activity	%	89.0
	12220148	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	77.0	CHEMBL5122	Homo sapiens	Residual Activity	%	77.0
	12220149	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	50.0	CHEMBL5122	Homo sapiens	Residual Activity	%	50.0
	12220150	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12220151	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220152	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12220153	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	78.0	CHEMBL5122	Homo sapiens	Residual Activity	%	78.0
	12220154	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	77.0	CHEMBL5122	Homo sapiens	Residual Activity	%	77.0
	12220155	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12220156	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220157	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	83.0	CHEMBL5122	Homo sapiens	Residual Activity	%	83.0
	12220158	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	71.0	CHEMBL5122	Homo sapiens	Residual Activity	%	71.0
	12220159	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12220160	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220161	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	86.0	CHEMBL5122	Homo sapiens	Residual Activity	%	86.0
	12220162	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	76.0	CHEMBL5122	Homo sapiens	Residual Activity	%	76.0
	12220163	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12220164	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12220165	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12220166	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	71.0	CHEMBL5122	Homo sapiens	Residual Activity	%	71.0
	12220167	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	74.0	CHEMBL5122	Homo sapiens	Residual Activity	%	74.0
	12220168	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12220169	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	88.0	CHEMBL5122	Homo sapiens	Residual Activity	%	88.0
	12220170	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12220171	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL5122	Homo sapiens	Residual Activity	%	89.0
	12220172	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	23.0	CHEMBL5122	Homo sapiens	Residual Activity	%	23.0
	12220173	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	95.0	CHEMBL5122	Homo sapiens	Residual Activity	%	95.0
	12220174	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12220175	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12220176	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	74.0	CHEMBL5122	Homo sapiens	Residual Activity	%	74.0
	12220177	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12220178	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12220179	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12220180	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12220181	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12220182	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12220183	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12220184	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12222561	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12222562	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	95.0	CHEMBL5122	Homo sapiens	Residual Activity	%	95.0
	12222563	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222564	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	87.0	CHEMBL5122	Homo sapiens	Residual Activity	%	87.0
	12222565	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222566	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12222567	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222568	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222569	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12222570	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	69.0	CHEMBL5122	Homo sapiens	Residual Activity	%	69.0
	12222571	CHEMBL2219026	Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	80.0	CHEMBL5122	Homo sapiens	Residual Activity	%	80.0
	12222572	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	87.0	CHEMBL5122	Homo sapiens	Residual Activity	%	87.0
	12222573	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	85.0	CHEMBL5122	Homo sapiens	Residual Activity	%	85.0
	12222574	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12222575	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	39.0	CHEMBL5122	Homo sapiens	Residual Activity	%	39.0
	12222576	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	68.0	CHEMBL5122	Homo sapiens	Residual Activity	%	68.0
	12222577	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222578	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12222579	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	74.0	CHEMBL5122	Homo sapiens	Residual Activity	%	74.0
	12222580	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222581	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	60.0	CHEMBL5122	Homo sapiens	Residual Activity	%	60.0
	12222582	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222583	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	112.0	CHEMBL5122	Homo sapiens	Residual Activity	%	112.0
	12222584	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	82.0	CHEMBL5122	Homo sapiens	Residual Activity	%	82.0
	12222585	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	29.0	CHEMBL5122	Homo sapiens	Residual Activity	%	29.0
	12222586	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12222587	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12222588	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	88.0	CHEMBL5122	Homo sapiens	Residual Activity	%	88.0
	12222589	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12222590	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12222591	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222592	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12222593	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	51.0	CHEMBL5122	Homo sapiens	Residual Activity	%	51.0
	12222594	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222595	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	36.0	CHEMBL5122	Homo sapiens	Residual Activity	%	36.0
	12222596	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12222597	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	66.0	CHEMBL5122	Homo sapiens	Residual Activity	%	66.0
	12222598	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	60.0	CHEMBL5122	Homo sapiens	Residual Activity	%	60.0
	12222599	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	55.0	CHEMBL5122	Homo sapiens	Residual Activity	%	55.0
	12222600	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	117.0	CHEMBL5122	Homo sapiens	Residual Activity	%	117.0
	12222601	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	95.0	CHEMBL5122	Homo sapiens	Residual Activity	%	95.0
	12222602	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12222603	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	0.0	CHEMBL5122	Homo sapiens	Residual Activity	%	0.0
	12222604	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	85.0	CHEMBL5122	Homo sapiens	Residual Activity	%	85.0
	12222605	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12222606	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222607	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222608	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	38.0	CHEMBL5122	Homo sapiens	Residual Activity	%	38.0
	12222609	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	110.0	CHEMBL5122	Homo sapiens	Residual Activity	%	110.0
	12222610	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12222611	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222612	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12222613	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222614	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	86.0	CHEMBL5122	Homo sapiens	Residual Activity	%	86.0
	12222615	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	64.0	CHEMBL5122	Homo sapiens	Residual Activity	%	64.0
	12222616	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	11.0	CHEMBL5122	Homo sapiens	Residual Activity	%	11.0
	12222617	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222618	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12222619	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222620	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222621	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12222622	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	86.0	CHEMBL5122	Homo sapiens	Residual Activity	%	86.0
	12222623	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	53.0	CHEMBL5122	Homo sapiens	Residual Activity	%	53.0
	12222624	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	82.0	CHEMBL5122	Homo sapiens	Residual Activity	%	82.0
	12222625	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12222626	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222627	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12222628	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	89.0	CHEMBL5122	Homo sapiens	Residual Activity	%	89.0
	12222629	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	87.0	CHEMBL5122	Homo sapiens	Residual Activity	%	87.0
	12222630	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222631	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12222632	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	22.0	CHEMBL5122	Homo sapiens	Residual Activity	%	22.0
	12222633	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	69.0	CHEMBL5122	Homo sapiens	Residual Activity	%	69.0
	12222634	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222635	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222636	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12222637	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12222638	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12222639	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12222640	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12222641	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222642	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12222643	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	30.0	CHEMBL5122	Homo sapiens	Residual Activity	%	30.0
	12222644	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	82.0	CHEMBL5122	Homo sapiens	Residual Activity	%	82.0
	12222645	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222646	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	48.0	CHEMBL5122	Homo sapiens	Residual Activity	%	48.0
	12222647	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	68.0	CHEMBL5122	Homo sapiens	Residual Activity	%	68.0
	12222648	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12222649	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	44.0	CHEMBL5122	Homo sapiens	Residual Activity	%	44.0
	12222650	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222651	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL5122	Homo sapiens	Residual Activity	%	-1.0
	12222652	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12222653	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	87.0	CHEMBL5122	Homo sapiens	Residual Activity	%	87.0
	12222654	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL5122	Homo sapiens	Residual Activity	%	98.0
	12222655	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	105.0	CHEMBL5122	Homo sapiens	Residual Activity	%	105.0
	12222656	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12222657	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	111.0	CHEMBL5122	Homo sapiens	Residual Activity	%	111.0
	12222658	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222659	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	46.0	CHEMBL5122	Homo sapiens	Residual Activity	%	46.0
	12222660	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12222661	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	87.0	CHEMBL5122	Homo sapiens	Residual Activity	%	87.0
	12222662	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222663	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	74.0	CHEMBL5122	Homo sapiens	Residual Activity	%	74.0
	12222664	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	41.0	CHEMBL5122	Homo sapiens	Residual Activity	%	41.0
	12222665	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222666	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	36.0	CHEMBL5122	Homo sapiens	Residual Activity	%	36.0
	12222667	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL5122	Homo sapiens	Residual Activity	%	106.0
	12222668	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12222669	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12222670	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12222671	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	95.0	CHEMBL5122	Homo sapiens	Residual Activity	%	95.0
	12222672	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12222673	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	17.0	CHEMBL5122	Homo sapiens	Residual Activity	%	17.0
	12222674	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12222675	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	81.0	CHEMBL5122	Homo sapiens	Residual Activity	%	81.0
	12222676	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222677	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	91.0	CHEMBL5122	Homo sapiens	Residual Activity	%	91.0
	12222678	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	88.0	CHEMBL5122	Homo sapiens	Residual Activity	%	88.0
	12222679	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	84.0	CHEMBL5122	Homo sapiens	Residual Activity	%	84.0
	12222680	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12222681	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	85.0	CHEMBL5122	Homo sapiens	Residual Activity	%	85.0
	12222682	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	52.0	CHEMBL5122	Homo sapiens	Residual Activity	%	52.0
	12222683	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	36.0	CHEMBL5122	Homo sapiens	Residual Activity	%	36.0
	12222684	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	84.0	CHEMBL5122	Homo sapiens	Residual Activity	%	84.0
	12222685	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL5122	Homo sapiens	Residual Activity	%	88.0
	12222686	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	102.0	CHEMBL5122	Homo sapiens	Residual Activity	%	102.0
	12222687	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12222688	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	40.0	CHEMBL5122	Homo sapiens	Residual Activity	%	40.0
	12222689	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222690	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	73.0	CHEMBL5122	Homo sapiens	Residual Activity	%	73.0
	12222691	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	35.0	CHEMBL5122	Homo sapiens	Residual Activity	%	35.0
	12222692	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	36.0	CHEMBL5122	Homo sapiens	Residual Activity	%	36.0
	12222693	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	78.0	CHEMBL5122	Homo sapiens	Residual Activity	%	78.0
	12222694	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	93.0	CHEMBL5122	Homo sapiens	Residual Activity	%	93.0
	12222695	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	82.0	CHEMBL5122	Homo sapiens	Residual Activity	%	82.0
	12222696	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	46.0	CHEMBL5122	Homo sapiens	Residual Activity	%	46.0
	12222697	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	103.0	CHEMBL5122	Homo sapiens	Residual Activity	%	103.0
	12222698	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222699	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12222700	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	59.0	CHEMBL5122	Homo sapiens	Residual Activity	%	59.0
	12222701	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	28.0	CHEMBL5122	Homo sapiens	Residual Activity	%	28.0
	12222702	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12222703	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	72.0	CHEMBL5122	Homo sapiens	Residual Activity	%	72.0
	12222704	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222705	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	106.0	CHEMBL5122	Homo sapiens	Residual Activity	%	106.0
	12222706	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	4.0	CHEMBL5122	Homo sapiens	Residual Activity	%	4.0
	12222707	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	88.0	CHEMBL5122	Homo sapiens	Residual Activity	%	88.0
	12222708	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12222709	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	66.0	CHEMBL5122	Homo sapiens	Residual Activity	%	66.0
	12222710	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	37.0	CHEMBL5122	Homo sapiens	Residual Activity	%	37.0
	12222711	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	104.0	CHEMBL5122	Homo sapiens	Residual Activity	%	104.0
	12222712	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	108.0	CHEMBL5122	Homo sapiens	Residual Activity	%	108.0
	12222713	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	106.0	CHEMBL5122	Homo sapiens	Residual Activity	%	106.0
	12222714	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	101.0	CHEMBL5122	Homo sapiens	Residual Activity	%	101.0
	12222715	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	69.0	CHEMBL5122	Homo sapiens	Residual Activity	%	69.0
	12222716	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	97.0	CHEMBL5122	Homo sapiens	Residual Activity	%	97.0
	12222717	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	94.0	CHEMBL5122	Homo sapiens	Residual Activity	%	94.0
	12222718	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	71.0	CHEMBL5122	Homo sapiens	Residual Activity	%	71.0
	12222719	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	75.0	CHEMBL5122	Homo sapiens	Residual Activity	%	75.0
	12222720	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222721	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	92.0	CHEMBL5122	Homo sapiens	Residual Activity	%	92.0
	12222722	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	89.0	CHEMBL5122	Homo sapiens	Residual Activity	%	89.0
	12222723	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	95.0	CHEMBL5122	Homo sapiens	Residual Activity	%	95.0
	12222724	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	99.0	CHEMBL5122	Homo sapiens	Residual Activity	%	99.0
	12222725	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	96.0	CHEMBL5122	Homo sapiens	Residual Activity	%	96.0
	12222726	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	100.0	CHEMBL5122	Homo sapiens	Residual Activity	%	100.0
	12222727	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	90.0	CHEMBL5122	Homo sapiens	Residual Activity	%	90.0
	12222728	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	20.0	CHEMBL5122	Homo sapiens	Residual Activity	%	20.0
	12222729	CHEMBL2219027	Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	53.0	CHEMBL5122	Homo sapiens	Residual Activity	%	53.0
	12617266	CHEMBL2319224	Binding affinity to human DDR2	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL2311806	=	Kd	nM	5.6	CHEMBL5122	Homo sapiens	Kd	nM	5.6
	12617274	CHEMBL2319494	Inhibition of human DDR2 using KKSRGDYMTMQIG peptide substrate	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL2311806	=	IC50	nM	17.22	CHEMBL5122	Homo sapiens	IC50	nM	17.22
	12617285	CHEMBL2319224	Binding affinity to human DDR2	B	Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311807	=	Kd	nM	14.0	CHEMBL5122	Homo sapiens	Kd	nM	14.0
	12617293	CHEMBL2319494	Inhibition of human DDR2 using KKSRGDYMTMQIG peptide substrate	B	Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311807	=	IC50	nM	178.6	CHEMBL5122	Homo sapiens	IC50	nM	178.6
	12617304	CHEMBL2319224	Binding affinity to human DDR2	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311808	=	Kd	nM	320.0	CHEMBL5122	Homo sapiens	Kd	nM	320.0
	12617312	CHEMBL2319494	Inhibition of human DDR2 using KKSRGDYMTMQIG peptide substrate	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311808	=	IC50	nM	653.3	CHEMBL5122	Homo sapiens	IC50	nM	653.3
	12617323	CHEMBL2319224	Binding affinity to human DDR2	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	6.2	CHEMBL5122	Homo sapiens	Kd	nM	6.2
	12617331	CHEMBL2319494	Inhibition of human DDR2 using KKSRGDYMTMQIG peptide substrate	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	<	IC50	nM	2.54	CHEMBL5122	Homo sapiens	IC50	nM	2.54
	12685263	CHEMBL2342526	Inhibition of DDR2 (unknown origin) assessed as residual activity at 100 nM after 1 hr by competitive binding assay relative to control	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	Activity	%	28.0	CHEMBL5122	Homo sapiens	Activity	%	28.0
	12688052	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	CN1CCN(Cc2cc(NC(=O)c3cccc(C#Cc4cnc5ccnn5c4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL2336017	=	IC50	nM	93.65	CHEMBL5122	Homo sapiens	IC50	nM	93.65
	12688053	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	CN1CCN(Cc2cc(NC(=O)c3ccc(Cl)c(C#Cc4cnc5ccnn5c4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL2336016	=	IC50	nM	172.65	CHEMBL5122	Homo sapiens	IC50	nM	172.65
	12688054	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	IC50	nM	101.4	CHEMBL5122	Homo sapiens	IC50	nM	101.4
	12688055	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(CN3CCCC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336014	=	IC50	nM	131.36	CHEMBL5122	Homo sapiens	IC50	nM	131.36
	12688056	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(CN3CCCCC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336013	=	IC50	nM	214.0	CHEMBL5122	Homo sapiens	IC50	nM	214.0
	12688057	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(CN3CCOCC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336012	=	IC50	nM	775.9	CHEMBL5122	Homo sapiens	IC50	nM	775.9
	12688058	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	COc1cc(CN2CCN(C)CC2)cc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)c1		CHEMBL2336011	=	IC50	nM	125.0	CHEMBL5122	Homo sapiens	IC50	nM	125.0
	12688059	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(Cl)cc(CN3CCN(C)CC3)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336010	=	IC50	nM	103.0	CHEMBL5122	Homo sapiens	IC50	nM	103.0
	12688060	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1cc(CN2CCN(C)CC2)cc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)c1		CHEMBL2336009	=	IC50	nM	37.1	CHEMBL5122	Homo sapiens	IC50	nM	37.1
	12688061	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336008	=	IC50	nM	100.56	CHEMBL5122	Homo sapiens	IC50	nM	100.56
	12688062	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1cc(Cl)cc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)c1		CHEMBL2336007	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688063	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1cc(C)cc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)c1		CHEMBL2336006	=	IC50	nM	116.0	CHEMBL5122	Homo sapiens	IC50	nM	116.0
	12688064	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	11.7	CHEMBL5122	Homo sapiens	IC50	nM	11.7
	12688065	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	105.0	CHEMBL5122	Homo sapiens	IC50	nM	105.0
	12688066	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(CN3CCN(C)CC3)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336027	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688067	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(C#Cc4cnc5ccnn5c4)c3)c2)cn1		CHEMBL2336026	=	IC50	nM	2270.0	CHEMBL5122	Homo sapiens	IC50	nM	2270.0
	12688068	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(-n3ccnc3)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336025	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688069	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(N(C)C)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336024	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688070	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(OC(C)C)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336023	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688071	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336022	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688072	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336021	=	IC50	nM	73.84	CHEMBL5122	Homo sapiens	IC50	nM	73.84
	12688073	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(I)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336020	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688074	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(Br)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336019	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688075	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	COc1ccc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)cc1		CHEMBL2336018	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688076	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	COc1cccc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)c1		CHEMBL2336040	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688077	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	COc1ccccc1NC(=O)c1ccc(C)c(C#Cc2cnc3ccnn3c2)c1		CHEMBL2336039	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688078	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336038	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688079	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cccc(Cl)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336037	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688080	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2ccccc2Cl)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336036	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688081	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)cc1		CHEMBL2336035	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688082	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1cccc(NC(=O)c2ccc(C)c(C#Cc3cnc4ccnn4c3)c2)c1		CHEMBL2331602	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688083	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2ccccc2C)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336034	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688084	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)Nc2ccccc2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336033	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688085	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)NC2CCCC2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336032	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688086	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)NC2CCCCC2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336031	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688087	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)NCC(C)C)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336030	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688088	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	CCCCNC(=O)c1ccc(C)c(C#Cc2cnc3ccnn3c2)c1		CHEMBL2336029	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688089	CHEMBL2342536	Inhibition of DDR2 (unknown origin) using fluorescein-labeled poly GAT as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by TR-FRET assay	B	Cc1ccc(C(=O)NC(C)C)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336028	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	12688128	CHEMBL2342538	Inhibition of type 1 collagen-induced autophosphorylation of human recombinant DDR2 expressed in HEK293 cells by Western blotting analysis	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	171.0	CHEMBL5122	Homo sapiens	IC50	nM	171.0
	12693240	CHEMBL2343925	Inhibition of DDR2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	12730877	CHEMBL2352477	Inhibition of DDR2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	96.0	CHEMBL5122	Homo sapiens	Activity	%	96.0
	13342323	CHEMBL2394155	Competitive binding affinity to DDR2 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	30.0	CHEMBL5122	Homo sapiens	Activity	%	30.0
Not Active	13360652	CHEMBL2400317	Inhibition of human DDR2	B	COc1ccc2c(c1)C=C(C(=O)/C=C/c1c(OC)cc(OC)cc1OC)CO2		CHEMBL2396883		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	13375894	CHEMBL2405303	Inhibition of DDR2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL5122	Homo sapiens	INH	%	6.0
	13439869	CHEMBL2428159	Competitive binding affinity to DDR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	13440864	CHEMBL2429607	Inhibition of DDR2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-100.0	CHEMBL5122	Homo sapiens	INH	%	-100.0
	13445702	CHEMBL2428159	Competitive binding affinity to DDR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	13451689	CHEMBL2428159	Competitive binding affinity to DDR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
Not Determined	13453042	CHEMBL2429607	Inhibition of DDR2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	13453090	CHEMBL2429607	Inhibition of DDR2 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-100.0	CHEMBL5122	Homo sapiens	INH	%	-100.0
	13872168	CHEMBL3101921	Inhibition of human DDR2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	119.0	CHEMBL5122	Homo sapiens	Activity	%	119.0
	13953260	CHEMBL3130681	Inhibition of human DDR2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	101.0	CHEMBL5122	Homo sapiens	Activity	%	101.0
	13954653	CHEMBL3130681	Inhibition of human DDR2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	101.0	CHEMBL5122	Homo sapiens	Activity	%	101.0
	13954668	CHEMBL3130681	Inhibition of human DDR2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	14582476	CHEMBL3240436	Inhibition of human DDR2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	14665023	CHEMBL3265731	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by fluorescence spectroscopy	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	Kd	nM	3.8	CHEMBL5122	Homo sapiens	Kd	nM	3.8
Active	14665024	CHEMBL3265732	Reversible binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) at 100 nM by fluorescence spectroscopy	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947		Activity			CHEMBL5122	Homo sapiens	Activity		
	14665025	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	Kd	nM	15.0	CHEMBL5122	Homo sapiens	Kd	uM	0.015
	14665026	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL583263	=	Kd	nM	412.0	CHEMBL5122	Homo sapiens	Kd	uM	0.412
	14665027	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)c1		CHEMBL568875	=	Kd	nM	15.0	CHEMBL5122	Homo sapiens	Kd	uM	0.015
	14665028	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665029	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	Kd	nM	178.0	CHEMBL5122	Homo sapiens	Kd	uM	0.178
	14665030	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172	=	Kd	nM	428.0	CHEMBL5122	Homo sapiens	Kd	uM	0.428
	14665031	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	Kd	nM	252.0	CHEMBL5122	Homo sapiens	Kd	uM	0.252
	14665032	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1738946	=	Kd	nM	702.0	CHEMBL5122	Homo sapiens	Kd	uM	0.702
	14665033	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2nccs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738942	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665034	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccncc3)cs2)cc1		CHEMBL1738943	=	Kd	nM	63.0	CHEMBL5122	Homo sapiens	Kd	uM	0.063
	14665035	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)cc1		CHEMBL1940500	=	Kd	nM	406.0	CHEMBL5122	Homo sapiens	Kd	uM	0.406
	14665036	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738945	=	Kd	nM	382.0	CHEMBL5122	Homo sapiens	Kd	uM	0.382
	14665037	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	O=C(O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)c1		CHEMBL1940504	=	Kd	nM	385.0	CHEMBL5122	Homo sapiens	Kd	uM	0.385
	14665038	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2cccc(CC(=O)O)c2)n1		CHEMBL1940503	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665039	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	O=C(O)Cc1ccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)cc1		CHEMBL1940505	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665040	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL3261116	=	Kd	nM	424.0	CHEMBL5122	Homo sapiens	Kd	uM	0.424
	14665041	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL344800	=	Kd	nM	20.0	CHEMBL5122	Homo sapiens	Kd	uM	0.02
	14665042	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CCOCCNc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL3261117	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665939	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CCC(=O)Nc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL3261118	=	Kd	nM	30.0	CHEMBL5122	Homo sapiens	Kd	uM	0.03
	14665940	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4ccccc34)c2)n(-c2cccc(N)c2)n1		CHEMBL2403875	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665941	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4ccccc34)cc2)n(-c2cccc(N)c2)n1		CHEMBL2403816	=	Kd	nM	93.0	CHEMBL5122	Homo sapiens	Kd	uM	0.093
	14665942	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)c1cc(F)cc(N2CCOCC2)c1		CHEMBL3261119	=	Kd	nM	915.0	CHEMBL5122	Homo sapiens	Kd	uM	0.915
	14665943	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CSc1ccc(-c2nc3cnccn3c2NC2CCCCC2)cc1		CHEMBL3261120	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665944	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Nc1c(-c2ccccc2)oc2ccccc2c1=O		CHEMBL476011	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665945	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	COc1ccccc1NC(=O)c1sc2nc(C)c(C(=O)Nc3ccc(C)cc3C)c(-c3ccc(NC(C)=O)cc3)c2c1N		CHEMBL3261121	>	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd	uM	1.0
	14665946	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	422.0	CHEMBL5122	Homo sapiens	Kd	uM	0.422
	14665947	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	21.0	CHEMBL5122	Homo sapiens	Kd	uM	0.021
	14665948	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	18.0	CHEMBL5122	Homo sapiens	Kd	uM	0.018
	14665949	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	2500.0	CHEMBL5122	Homo sapiens	Kd	uM	2.5
	14665950	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	581.0	CHEMBL5122	Homo sapiens	Kd	uM	0.581
	14665951	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	75.0	CHEMBL5122	Homo sapiens	Kd	uM	0.075
	14665952	CHEMBL3265733	Binding affinity to human acrylodan-labeled N-terminal His-tagged DDR2 (558 to 855 aa) by FLiK assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	313.0	CHEMBL5122	Homo sapiens	Kd	uM	0.313
	14665953	CHEMBL3265734	Binding affinity to human DDR2 by Ambit assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	Kd	nM	15.0	CHEMBL5122	Homo sapiens	Kd	nM	15.0
	14665954	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	IC50	nM	558.0	CHEMBL5122	Homo sapiens	IC50	uM	0.558
	14665955	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL583263	=	IC50	nM	856.0	CHEMBL5122	Homo sapiens	IC50	uM	0.856
	14665956	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)c1		CHEMBL568875	=	IC50	nM	183.0	CHEMBL5122	Homo sapiens	IC50	uM	0.183
	14665957	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	=	IC50	nM	9410.0	CHEMBL5122	Homo sapiens	IC50	uM	9.41
	14665958	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	IC50	nM	487.0	CHEMBL5122	Homo sapiens	IC50	uM	0.487
	14665959	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172	=	IC50	nM	332.0	CHEMBL5122	Homo sapiens	IC50	uM	0.332
	14665960	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	IC50	nM	408.0	CHEMBL5122	Homo sapiens	IC50	uM	0.408
	14665961	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1738946	=	IC50	nM	4700.0	CHEMBL5122	Homo sapiens	IC50	uM	4.7
	14665962	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nccs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738942	=	IC50	nM	9170.0	CHEMBL5122	Homo sapiens	IC50	uM	9.17
	14665963	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccncc3)cs2)cc1		CHEMBL1738943	=	IC50	nM	19.0	CHEMBL5122	Homo sapiens	IC50	uM	0.019
	14665964	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)cc1		CHEMBL1940500	=	IC50	nM	3040.0	CHEMBL5122	Homo sapiens	IC50	uM	3.04
	14665965	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738945	=	IC50	nM	2230.0	CHEMBL5122	Homo sapiens	IC50	uM	2.23
	14665966	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	O=C(O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)c1		CHEMBL1940504	=	IC50	nM	1560.0	CHEMBL5122	Homo sapiens	IC50	uM	1.56
	14665967	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2cccc(CC(=O)O)c2)n1		CHEMBL1940503	=	IC50	nM	10700.0	CHEMBL5122	Homo sapiens	IC50	uM	10.7
	14665968	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	O=C(O)Cc1ccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)cc1		CHEMBL1940505	=	IC50	nM	2170.0	CHEMBL5122	Homo sapiens	IC50	uM	2.17
	14665969	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL3261116	=	IC50	nM	1230.0	CHEMBL5122	Homo sapiens	IC50	uM	1.23
	14665970	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL344800	=	IC50	nM	8.0	CHEMBL5122	Homo sapiens	IC50	uM	0.008
	14665971	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CCOCCNc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL3261117	=	IC50	nM	14400.0	CHEMBL5122	Homo sapiens	IC50	uM	14.4
	14665972	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CCC(=O)Nc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL3261118	=	IC50	nM	29.0	CHEMBL5122	Homo sapiens	IC50	uM	0.029
	14665973	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4ccccc34)c2)n(-c2cccc(N)c2)n1		CHEMBL2403875	=	IC50	nM	2.0	CHEMBL5122	Homo sapiens	IC50	uM	0.002
	14665974	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4ccccc34)cc2)n(-c2cccc(N)c2)n1		CHEMBL2403816	=	IC50	nM	3.0	CHEMBL5122	Homo sapiens	IC50	uM	0.003
	14665975	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)c1cc(F)cc(N2CCOCC2)c1		CHEMBL3261119	=	IC50	nM	10900.0	CHEMBL5122	Homo sapiens	IC50	uM	10.9
	14665976	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Nc1c(-c2ccccc2)oc2ccccc2c1=O		CHEMBL476011	=	IC50	nM	80800.0	CHEMBL5122	Homo sapiens	IC50	uM	80.8
	14665977	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	24.0	CHEMBL5122	Homo sapiens	IC50	uM	0.024
	14665978	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	10.0	CHEMBL5122	Homo sapiens	IC50	uM	0.01
	14665979	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	0.4	CHEMBL5122	Homo sapiens	IC50	uM	0.0004
	14665980	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	241.0	CHEMBL5122	Homo sapiens	IC50	uM	0.241
	14665981	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	50.0	CHEMBL5122	Homo sapiens	IC50	uM	0.05
	14665982	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	2.0	CHEMBL5122	Homo sapiens	IC50	uM	0.002
	14665983	CHEMBL3265735	Inhibition of wild type DDR2 (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	7.0	CHEMBL5122	Homo sapiens	IC50	uM	0.007
	14665984	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	IC50	nM	717.0	CHEMBL5122	Homo sapiens	IC50	uM	0.717
	14665985	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL583263	=	IC50	nM	1233.0	CHEMBL5122	Homo sapiens	IC50	uM	1.233
	14665986	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)c1		CHEMBL568875	=	IC50	nM	808.0	CHEMBL5122	Homo sapiens	IC50	uM	0.808
	14665987	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	=	IC50	nM	2500.0	CHEMBL5122	Homo sapiens	IC50	uM	2.5
	14665988	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	IC50	nM	10800.0	CHEMBL5122	Homo sapiens	IC50	uM	10.8
	14665989	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172	>=	IC50	nM	100000.0	CHEMBL5122	Homo sapiens	IC50	uM	100.0
	14665990	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	>=	IC50	nM	100000.0	CHEMBL5122	Homo sapiens	IC50	uM	100.0
	14665991	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1738946	=	IC50	nM	1150.0	CHEMBL5122	Homo sapiens	IC50	uM	1.15
	14665992	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nccs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738942	=	IC50	nM	820.0	CHEMBL5122	Homo sapiens	IC50	uM	0.82
	14665993	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccncc3)cs2)cc1		CHEMBL1738943	=	IC50	nM	2.0	CHEMBL5122	Homo sapiens	IC50	uM	0.002
	14665994	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)cc1		CHEMBL1940500	=	IC50	nM	230.0	CHEMBL5122	Homo sapiens	IC50	uM	0.23
	14665995	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738945	=	IC50	nM	670.0	CHEMBL5122	Homo sapiens	IC50	uM	0.67
	14665996	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	O=C(O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)c1		CHEMBL1940504	=	IC50	nM	380.0	CHEMBL5122	Homo sapiens	IC50	uM	0.38
	14665997	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2cccc(CC(=O)O)c2)n1		CHEMBL1940503	=	IC50	nM	1670.0	CHEMBL5122	Homo sapiens	IC50	uM	1.67
	14665998	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	O=C(O)Cc1ccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)cc1		CHEMBL1940505	=	IC50	nM	1840.0	CHEMBL5122	Homo sapiens	IC50	uM	1.84
	14665999	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL3261116	=	IC50	nM	76.0	CHEMBL5122	Homo sapiens	IC50	uM	0.076
	14666000	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL344800	=	IC50	nM	72.0	CHEMBL5122	Homo sapiens	IC50	uM	0.072
	14666001	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CCC(=O)Nc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL3261118	=	IC50	nM	687.0	CHEMBL5122	Homo sapiens	IC50	uM	0.687
	14666002	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4ccccc34)c2)n(-c2cccc(N)c2)n1		CHEMBL2403875	=	IC50	nM	73.0	CHEMBL5122	Homo sapiens	IC50	uM	0.073
	14666003	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4ccccc34)cc2)n(-c2cccc(N)c2)n1		CHEMBL2403816	=	IC50	nM	1.0	CHEMBL5122	Homo sapiens	IC50	uM	0.001
	14666004	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Nc1c(-c2ccccc2)oc2ccccc2c1=O		CHEMBL476011	>=	IC50	nM	100000.0	CHEMBL5122	Homo sapiens	IC50	uM	100.0
	14666005	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	450.0	CHEMBL5122	Homo sapiens	IC50	uM	0.45
	14666006	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	13.0	CHEMBL5122	Homo sapiens	IC50	uM	0.013
	14666007	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	833.0	CHEMBL5122	Homo sapiens	IC50	uM	0.833
	14666008	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	18.0	CHEMBL5122	Homo sapiens	IC50	uM	0.018
	14666009	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	51.0	CHEMBL5122	Homo sapiens	IC50	uM	0.051
	14666010	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	18.0	CHEMBL5122	Homo sapiens	IC50	uM	0.018
	14666011	CHEMBL3265736	Inhibition of DDR2 T654M mutant (unknown origin) preincubated for 30 mins before substrate addition by FRET assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	36.0	CHEMBL5122	Homo sapiens	IC50	uM	0.036
Not Active	14666012	CHEMBL3265737	Inhibition of wild type DDR2 (unknown origin) preincubated at 100 uM for 30 mins before substrate addition by FRET assay	B	CSc1ccc(-c2nc3cnccn3c2NC2CCCCC2)cc1		CHEMBL3261120		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Not Active	14666013	CHEMBL3265737	Inhibition of wild type DDR2 (unknown origin) preincubated at 100 uM for 30 mins before substrate addition by FRET assay	B	COc1ccccc1NC(=O)c1sc2nc(C)c(C(=O)Nc3ccc(C)cc3C)c(-c3ccc(NC(C)=O)cc3)c2c1N		CHEMBL3261121		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Not Active	14666014	CHEMBL3265738	Inhibition of DDR2 T654M mutant (unknown origin) preincubated at 100 uM for 30 mins before substrate addition by FRET assay	B	CCOCCNc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL3261117		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Not Active	14666015	CHEMBL3265738	Inhibition of DDR2 T654M mutant (unknown origin) preincubated at 100 uM for 30 mins before substrate addition by FRET assay	B	O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)c1cc(F)cc(N2CCOCC2)c1		CHEMBL3261119		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Not Active	14666016	CHEMBL3265738	Inhibition of DDR2 T654M mutant (unknown origin) preincubated at 100 uM for 30 mins before substrate addition by FRET assay	B	CSc1ccc(-c2nc3cnccn3c2NC2CCCCC2)cc1		CHEMBL3261120		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Not Active	14666017	CHEMBL3265738	Inhibition of DDR2 T654M mutant (unknown origin) preincubated at 100 uM for 30 mins before substrate addition by FRET assay	B	COc1ccccc1NC(=O)c1sc2nc(C)c(C(=O)Nc3ccc(C)cc3C)c(-c3ccc(NC(C)=O)cc3)c2c1N		CHEMBL3261121		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	14666018	CHEMBL3265739	Binding affinity to wild type DDR2 (unknown origin) by FLiK assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	33.0	CHEMBL5122	Homo sapiens	Kd	uM	0.033
	14666019	CHEMBL3265739	Binding affinity to wild type DDR2 (unknown origin) by FLiK assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3.0	CHEMBL5122	Homo sapiens	Kd	uM	0.003
	14666020	CHEMBL3265739	Binding affinity to wild type DDR2 (unknown origin) by FLiK assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	230.0	CHEMBL5122	Homo sapiens	Kd	uM	0.23
	14666021	CHEMBL3265739	Binding affinity to wild type DDR2 (unknown origin) by FLiK assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	98.0	CHEMBL5122	Homo sapiens	Kd	uM	0.098
	14666022	CHEMBL3265739	Binding affinity to wild type DDR2 (unknown origin) by FLiK assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	6.0	CHEMBL5122	Homo sapiens	Kd	uM	0.006
	14666023	CHEMBL3265739	Binding affinity to wild type DDR2 (unknown origin) by FLiK assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7.0	CHEMBL5122	Homo sapiens	Kd	uM	0.007
	14666027	CHEMBL3266102	Inhibition of DDR2 (unknown origin) after 120 mins by radiometric assay in presence of gamma-[33P]-ATP	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccncc3)cs2)cc1		CHEMBL1738943	=	IC50	nM	65.0	CHEMBL5122	Homo sapiens	IC50	uM	0.065
	14666028	CHEMBL3266102	Inhibition of DDR2 (unknown origin) after 120 mins by radiometric assay in presence of gamma-[33P]-ATP	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Nc3ncnc4ccccc34)c2)n(-c2cccc(N)c2)n1		CHEMBL2403875	=	IC50	nM	75.0	CHEMBL5122	Homo sapiens	IC50	uM	0.075
	14666029	CHEMBL3266102	Inhibition of DDR2 (unknown origin) after 120 mins by radiometric assay in presence of gamma-[33P]-ATP	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4ccccc34)cc2)n(-c2cccc(N)c2)n1		CHEMBL2403816	=	IC50	nM	18.0	CHEMBL5122	Homo sapiens	IC50	uM	0.018
	14979252	CHEMBL3379621	Inhibition of DDR2 (unknown origin) at 1 uM	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	Inhibition	%	93.0	CHEMBL5122	Homo sapiens	INH	%	93.0
	14979253	CHEMBL3379622	Inhibition of DDR2 (unknown origin)	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	IC50	nM	290.0	CHEMBL5122	Homo sapiens	IC50	nM	290.0
	15072612	CHEMBL3382672	Inhibition of DDR2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	113.0	CHEMBL5122	Homo sapiens	Activity	%	113.0
	15240069	CHEMBL3424215	Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-2-induced DDR2 phosphorylation	B	CC(=O)Nc1cc(Oc2ccc(CNC(=O)Nc3cc(C)c(Cl)cc3OCCN(C)C)cc2C)ccn1		CHEMBL3422262	=	IC50	nM	6.0	CHEMBL5122	Homo sapiens	IC50	nM	6.0
	15240070	CHEMBL3424215	Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-2-induced DDR2 phosphorylation	B	CNC(=O)c1cc(Oc2ccc(CNC(=O)Nc3cc(C(F)(F)F)ccc3OC3CCNCC3)cc2)ccn1		CHEMBL3422261	=	IC50	nM	20.0	CHEMBL5122	Homo sapiens	IC50	nM	20.0
	15240071	CHEMBL3424215	Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-2-induced DDR2 phosphorylation	B	Cn1cc(C(F)(F)F)cc(NC(=O)NCc2ccc(Oc3ccnc4c3CNC(=O)N4)cc2)c1=O		CHEMBL3422260	=	IC50	nM	15.0	CHEMBL5122	Homo sapiens	IC50	nM	15.0
	15240072	CHEMBL3424215	Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-2-induced DDR2 phosphorylation	B	CNC(=O)c1cc(Oc2ccc(CNC(=O)Nc3cc(Cl)ccc3OC)cc2C)ccn1		CHEMBL3422259	=	IC50	nM	30.0	CHEMBL5122	Homo sapiens	IC50	nM	30.0
	15240080	CHEMBL3424171	Binding affinity to DDR2 (unknown origin) by active-site dependent competition binding assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	Kd	nM	0.6	CHEMBL5122	Homo sapiens	Kd	nM	0.6
	15240081	CHEMBL3424170	Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-1-induced receptor auto-phosphorylation by Western blot method	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	171.0	CHEMBL5122	Homo sapiens	IC50	nM	171.0
	15240083	CHEMBL3424168	Inhibition of recombinant non-activated DDR2 tyrosine kinase domain (unknown origin) using histone H2B peptide substrate and [32P]ATP incubated for 15 mins	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	145.0	CHEMBL5122	Homo sapiens	IC50	nM	145.0
	15240084	CHEMBL3424167	Inhibition of recombinant activated DDR2 tyrosine kinase domain (unknown origin) using histone H2B peptide substrate and [32P]ATP incubated for 15 mins	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	6.0	CHEMBL5122	Homo sapiens	IC50	nM	6.0
	15240085	CHEMBL3424166	Binding affinity to DDR2 (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	57.0	CHEMBL5122	Homo sapiens	Kd	nM	57.0
	15240086	CHEMBL3424166	Binding affinity to DDR2 (unknown origin)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	33.0	CHEMBL5122	Homo sapiens	Kd	nM	33.0
	15240087	CHEMBL3424166	Binding affinity to DDR2 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	6.6	CHEMBL5122	Homo sapiens	Kd	nM	6.6
	15240091	CHEMBL3424164	Inhibition of DDR2 (unknown origin) assessed as reduction in collagen-induced DDR2 activation	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	55.0	CHEMBL5122	Homo sapiens	IC50	nM	55.0
	15240092	CHEMBL3424164	Inhibition of DDR2 (unknown origin) assessed as reduction in collagen-induced DDR2 activation	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	675.0	CHEMBL5122	Homo sapiens	IC50	nM	675.0
	15240093	CHEMBL3424164	Inhibition of DDR2 (unknown origin) assessed as reduction in collagen-induced DDR2 activation	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	1.4	CHEMBL5122	Homo sapiens	IC50	nM	1.4
	15240097	CHEMBL3424162	Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-1-induced DDR2 tyrosine phosphorylation pre-incubated for 30 mins by immunoblotting method	B	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O		CHEMBL1554	=	IC50	nM	9000.0	CHEMBL5122	Homo sapiens	IC50	uM	9.0
	15253815	CHEMBL3429879	Inhibition of human DDR2	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	128.0	CHEMBL5122	Homo sapiens	IC50	uM	0.128
	15692317	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	2.0	CHEMBL5122	Homo sapiens	IC50	uM	0.002
	15692318	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	O=C(NCc1cccc(NC(=O)c2cnc3ccccn23)c1)Nc1ccccc1		CHEMBL3608784	=	IC50	nM	280.0	CHEMBL5122	Homo sapiens	IC50	uM	0.28
	15692319	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1ccc(CNC(=O)Nc2ccccc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608785	=	IC50	nM	8.2	CHEMBL5122	Homo sapiens	IC50	uM	0.0082
	15692320	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608786	=	IC50	nM	3.3	CHEMBL5122	Homo sapiens	IC50	uM	0.0033
	15692321	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1ccc([C@H](C)NC(=O)Nc2ccccc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608787	=	IC50	nM	8.1	CHEMBL5122	Homo sapiens	IC50	uM	0.0081
	15692322	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1ccc([C@@H](C)NC(=O)Nc2ccccc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608788	=	IC50	nM	1300.0	CHEMBL5122	Homo sapiens	IC50	uM	1.3
	15692323	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1ccc([C@H](C)NC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608789	=	IC50	nM	4.5	CHEMBL5122	Homo sapiens	IC50	uM	0.0045
	15692324	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1ccc([C@H](C)NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608790	=	IC50	nM	5.8	CHEMBL5122	Homo sapiens	IC50	uM	0.0058
	15692325	CHEMBL3610834	Inhibition of DDR2 (unknown origin) after 1 hr by time resolved fluorescence method	B	Cc1ccc([C@H](C)Nc2nc3cc(F)ccc3o2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608791	=	IC50	nM	6.1	CHEMBL5122	Homo sapiens	IC50	uM	0.0061
	15692326	CHEMBL3610835	Inhibition of DDR2 (unknown origin) at 100 uM after 1 hr by time resolved fluorescence method	B	O=C(NCc1cccnc1)Nc1ccccc1Cl		CHEMBL1299308	=	Inhibition	%	32.0	CHEMBL5122	Homo sapiens	INH	%	32.0
Active	15692369	CHEMBL3611274	Inhibition of collagen I-induced DDR2 (unknown origin) phosphorylation expressed in HEK293 cells at 0.1 to 1 uM after 16 hrs by Western blotting	B	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608786		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	15692370	CHEMBL3611274	Inhibition of collagen I-induced DDR2 (unknown origin) phosphorylation expressed in HEK293 cells at 0.1 to 1 uM after 16 hrs by Western blotting	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	15692371	CHEMBL3611274	Inhibition of collagen I-induced DDR2 (unknown origin) phosphorylation expressed in HEK293 cells at 0.1 to 1 uM after 16 hrs by Western blotting	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	15692372	CHEMBL3611275	Inhibition of collagen I-induced DDR2 I638F mutant (unknown origin) phosphorylation expressed in HEK293 cells at 0.1 to 1 uM after 16 hrs by Western blotting	B	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608786		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	15692373	CHEMBL3611275	Inhibition of collagen I-induced DDR2 I638F mutant (unknown origin) phosphorylation expressed in HEK293 cells at 0.1 to 1 uM after 16 hrs by Western blotting	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	15692374	CHEMBL3611275	Inhibition of collagen I-induced DDR2 I638F mutant (unknown origin) phosphorylation expressed in HEK293 cells at 0.1 to 1 uM after 16 hrs by Western blotting	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	15692375	CHEMBL3611276	Inhibition of collagen I-induced DDR2 (unknown origin) phosphorylation expressed in HEK293 cells after 16 hrs by mesoscale discovery assay	B	Cc1ccc(CNC(=O)Nc2cccc(F)c2)cc1NC(=O)c1cnc2ccccn12		CHEMBL3608786	=	EC50	nM	8.7	CHEMBL5122	Homo sapiens	EC50	nM	8.7
	15728399	CHEMBL3624240	Inhibition of DDR2 (unknown origin) at 10 uM	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	>	Inhibition	%	90.0	CHEMBL5122	Homo sapiens	INH	%	90.0
	15756039	CHEMBL3630346	Inhibition of DDR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.04	CHEMBL5122	Homo sapiens	INH	%	99.04
	15757020	CHEMBL3630346	Inhibition of DDR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	98.01	CHEMBL5122	Homo sapiens	INH	%	98.01
	15758683	CHEMBL3630346	Inhibition of DDR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	28.19	CHEMBL5122	Homo sapiens	INH	%	28.19
	16431800	CHEMBL3749004	Inhibition of human DDR2 using [KKSRGDYMTMQIG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	16450811	CHEMBL3762329	Inhibition of DDR2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	23.4	CHEMBL5122	Homo sapiens	INH	%	23.4
	16495384	CHEMBL3778364	Inhibition of N-terminal His6-tagged recombinant human DDR2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	3.0	CHEMBL5122	Homo sapiens	Activity	%	3.0
	16508153	CHEMBL3778364	Inhibition of N-terminal His6-tagged recombinant human DDR2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	10.0	CHEMBL5122	Homo sapiens	Activity	%	10.0
	16509130	CHEMBL3778364	Inhibition of N-terminal His6-tagged recombinant human DDR2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-6.0	CHEMBL5122	Homo sapiens	Activity	%	-6.0
	16510438	CHEMBL3783997	Inhibition of recombinant human GST-tagged DDR2 expressed in Baculovirus expression system	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	IC50	nM	457.0	CHEMBL5122	Homo sapiens	IC50	nM	457.0
	16510494	CHEMBL3784004	Inhibition of TEL-DDR2 (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	>	GI50	nM	10000.0	CHEMBL5122	Homo sapiens	GI50	uM	10.0
	16510495	CHEMBL3784004	Inhibition of TEL-DDR2 (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	7700.0	CHEMBL5122	Homo sapiens	GI50	uM	7.7
	16510496	CHEMBL3784004	Inhibition of TEL-DDR2 (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	GI50	nM	1400.0	CHEMBL5122	Homo sapiens	GI50	uM	1.4
	16510497	CHEMBL3784004	Inhibition of TEL-DDR2 (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	GI50	nM	3000.0	CHEMBL5122	Homo sapiens	GI50	uM	3.0
	16510628	CHEMBL3784720	Inhibition of partial length human wild type DDR2 expressed in mammalian expression system assessed as residual activity at 1 uM relative to control	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	Activity	%	0.0	CHEMBL5122	Homo sapiens	Activity	%	0.0
	16614448	CHEMBL3817314	Inhibition of human DDR2 at 1 uM using [KKSRGDYMTMQIG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	5.0	CHEMBL5122	Homo sapiens	INH	%	5.0
	16654260	CHEMBL3829906	Inhibition of human DDR2 (467 to 854 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	79.0	CHEMBL5122	Homo sapiens	Activity	%	79.0
	16854251	CHEMBL3878997	Inhibition of BCR-fused DDR2 (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	GI50	nM	6080.0	CHEMBL5122	Homo sapiens	GI50	uM	6.08
	16854252	CHEMBL3878997	Inhibition of BCR-fused DDR2 (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	GI50	nM	10000.0	CHEMBL5122	Homo sapiens	GI50	uM	10.0
	16854263	CHEMBL3878989	Inhibition of recombinant His-tagged human DDR2 cytoplasmic domain expressed in baculovirus expression system measured after 1 hr by FRET based Z'Lyte assay	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	IC50	nM	325.0	CHEMBL5122	Homo sapiens	IC50	nM	325.0
	16854264	CHEMBL3878988	Inhibition of recombinant His-tagged human DDR2 cytoplasmic domain expressed in baculovirus expression system assessed as residual activity at 1 uM measured after 1 hr by FRET based Z'Lyte assay relative to control	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	Activity	%	0.65	CHEMBL5122	Homo sapiens	Activity	%	0.65
334780	17713022	CHEMBL3887353	Kinase Activity: The compounds prepared in Examples were tested for inhibitory activity against FMS, DDR1 and DDR2 kinases using Kinase Screening and Profiling Service (Invitrogen, U.S.).	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1NC(=O)c1csc2c(N)ncnc12		CHEMBL3969260	=	IC50	nM	5.0	CHEMBL5122	Homo sapiens	IC50	nM	5.0
334781	17713023	CHEMBL3887353	Kinase Activity: The compounds prepared in Examples were tested for inhibitory activity against FMS, DDR1 and DDR2 kinases using Kinase Screening and Profiling Service (Invitrogen, U.S.).	B	Cc1ccc2c(Nc3cccc(Cl)c3)nccc2c1NC(=O)c1csc2c(N)ncnc12		CHEMBL3954810	=	IC50	nM	93.0	CHEMBL5122	Homo sapiens	IC50	nM	93.0
334782	17713024	CHEMBL3887353	Kinase Activity: The compounds prepared in Examples were tested for inhibitory activity against FMS, DDR1 and DDR2 kinases using Kinase Screening and Profiling Service (Invitrogen, U.S.).	B	CC(=O)c1ccc(Nc2nccc3c(NC(=O)c4csc5c(N)ncnc45)c(C)ccc23)cc1		CHEMBL3944137	=	IC50	nM	10.0	CHEMBL5122	Homo sapiens	IC50	nM	10.0
334783	17713025	CHEMBL3887353	Kinase Activity: The compounds prepared in Examples were tested for inhibitory activity against FMS, DDR1 and DDR2 kinases using Kinase Screening and Profiling Service (Invitrogen, U.S.).	B	Cc1ccc2c(Nc3ccc(F)c(Cl)c3)nccc2c1NC(=O)c1csc2c(N)ncnc12		CHEMBL3915720	=	IC50	nM	181.0	CHEMBL5122	Homo sapiens	IC50	nM	181.0
334784	17713026	CHEMBL3887353	Kinase Activity: The compounds prepared in Examples were tested for inhibitory activity against FMS, DDR1 and DDR2 kinases using Kinase Screening and Profiling Service (Invitrogen, U.S.).	B	Cc1ccc2c(Nc3cccc(Cl)c3F)nccc2c1NC(=O)c1csc2c(N)ncnc12		CHEMBL3977543	=	IC50	nM	44.0	CHEMBL5122	Homo sapiens	IC50	nM	44.0
Inactive	17896186	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896187	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1913.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1913.0
Inactive	17896188	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896189	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896190	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896191	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896192	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896193	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896194	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896195	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896196	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896197	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	48.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	48.0
Inactive	17896198	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896199	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896200	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896201	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896202	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896203	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896204	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	1523.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1523.0
Inactive	17896205	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896206	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896207	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896208	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896209	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896210	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896211	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896212	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896213	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896214	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896215	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	39.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	39.0
Active	17896216	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	16.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	16.0
Active	17896217	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	2284.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	2284.0
Active	17896218	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Kd	nM	423.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	423.0
Inactive	17896219	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896220	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896221	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896222	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896223	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896224	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896225	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896226	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896227	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896228	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896229	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896230	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896231	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896232	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896233	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896234	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896235	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896236	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	=	Kd	nM	908.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	908.0
Inactive	17896237	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896238	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896239	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896240	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896241	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896242	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896243	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896244	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	421.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	421.0
Active	17896245	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	Kd	nM	94.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	94.0
Inactive	17896246	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896247	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896248	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896249	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896250	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896251	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896252	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896253	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	347.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	347.0
Inactive	17896254	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896255	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896256	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896257	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896258	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	121.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	121.0
Inactive	17896259	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896260	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	4963.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	4963.0
Active	17896261	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	12899.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	12899.0
Active	17896262	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	669.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	669.0
Inactive	17896263	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896264	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896265	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	1493.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1493.0
Inactive	17896266	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896267	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896268	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896269	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896270	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896271	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896272	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	28192.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	28192.0
Inactive	17896273	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896274	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896275	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Kd	nM	65.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	65.0
Inactive	17896276	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896277	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896278	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896279	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896280	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896281	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896282	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896283	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896284	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896285	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896286	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	1271.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1271.0
Active	17896287	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	592.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	592.0
Inactive	17896288	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896289	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	298.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	298.0
Inactive	17896290	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896291	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896292	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	183.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	183.0
Inactive	17896293	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896294	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896295	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896296	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	1163.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1163.0
Inactive	17896297	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896298	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896299	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896300	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896301	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	2331.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	2331.0
Inactive	17896302	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896303	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896304	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	Kd	nM	19290.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	19290.0
Inactive	17896305	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896306	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896307	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896308	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	3956.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	3956.0
Active	17896309	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	181.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	181.0
Inactive	17896310	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896311	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896312	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896313	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896314	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896315	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896316	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896317	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896318	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896319	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896320	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896321	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896322	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896323	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896324	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896325	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896326	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896327	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896328	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896329	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896330	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896331	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896332	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	3250.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	3250.0
Inactive	17896333	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896334	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896335	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	1138.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1138.0
Inactive	17896336	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896337	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896338	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896339	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896340	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	3421.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	3421.0
Inactive	17896341	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896342	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896343	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896344	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896345	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896346	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896347	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	4289.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	4289.0
Inactive	17896348	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896349	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896350	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896351	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896352	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896353	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896354	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896355	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896356	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896357	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896358	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896359	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896360	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896361	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896362	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896363	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896364	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896365	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896366	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	4.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	4.0
Inactive	17896367	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896368	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1950.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1950.0
Inactive	17896369	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896370	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896371	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896372	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896373	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896374	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896375	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896376	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	87.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	87.0
Inactive	17896377	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896378	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	850.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	850.0
Inactive	17896379	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896380	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896381	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896382	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896383	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896384	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	182.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	182.0
Inactive	17896385	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896386	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896387	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896388	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896389	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896390	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896391	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896392	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	139.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	139.0
Inactive	17896393	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896394	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896395	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896396	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896397	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896398	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896399	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896400	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896401	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	218.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	218.0
Inactive	17896402	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896403	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896404	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896405	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	501.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	501.0
Active	17896406	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	805.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	805.0
Inactive	17896407	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896408	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896409	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896410	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896411	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896412	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896413	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	70.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	70.0
Inactive	17896414	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896415	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896416	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896417	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896418	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896419	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896420	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896421	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896422	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896423	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896424	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	42280.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	42280.0
Inactive	17896425	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17896426	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	30000.0
Active	17896427	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1000.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	1000.0
Active	17896428	CHEMBL3991686	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	227.0	CHEMBL5122	Homo sapiens	Kd apparent	nM	227.0
	18033123	CHEMBL4007936	Inhibition of human DDR2 at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	7.0	CHEMBL5122	Homo sapiens	INH	%	7.0
	18058136	CHEMBL4012744	Binding affinity to human DDR2 (555 to 855 residues) expressed in mammalian expression system at 1 uM by kinome scan assay relative to control	B	Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1		CHEMBL3962812	=	Activity	%	86.0	CHEMBL5122	Homo sapiens	Activity	%	86.0
	18085956	CHEMBL4018633	Inhibition of recombinant DDR2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	0.8	CHEMBL5122	Homo sapiens	IC50	nM	0.8
	18086086	CHEMBL4018692	Inhibition of DDR2 I638F mutant in human NCI-H2286 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	317.2	CHEMBL5122	Homo sapiens	IC50	nM	317.2
Active	18086110	CHEMBL4018705	Inhibition of DDR2 I638F mutant phosphorylation in human NCI-H2286 cells at 0.25 to 1 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	18086121	CHEMBL4018721	Inhibition of DDR2 I638F mutant phosphorylation in human NCI-H2286 cells assessed as decrease in SRC phopshorylation at 0.25 to 1 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	18086122	CHEMBL4018722	Inhibition of DDR2 I638F mutant phosphorylation in human NCI-H2286 cells assessed as decrease in ERK phopshorylation at 0.25 to 1 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	18114403	CHEMBL4025091	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	93.0	CHEMBL5122	Homo sapiens	Activity	%	93.0
	18141783	CHEMBL4031398	Inhibition of human DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	Activity	%	0.0	CHEMBL5122	Homo sapiens	Activity	%	0.0
	18141806	CHEMBL4031419	Inhibition of GST-tagged human DDR2 (427 to 855 residues) expressed in Baculovirus expression system by Z'Lyte assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	IC50	nM	61.0	CHEMBL5122	Homo sapiens	IC50	nM	61.0
	18141845	CHEMBL4031443	Binding affinity to DDR2 (unknown origin) by KinomeSCan assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	690.0	CHEMBL5122	Homo sapiens	Kd	nM	690.0
	18200250	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1ccc2ccnn2c1		CHEMBL4077561	=	IC50	nM	203.0	CHEMBL5122	Homo sapiens	IC50	nM	203.0
	18200251	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CN1CCN(Cc2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)CC4)cc(C(F)(F)F)c2)CC1		CHEMBL4095191	=	IC50	nM	8000.0	CHEMBL5122	Homo sapiens	IC50	nM	8000.0
	18200252	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	C[C@H]1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4066114	=	IC50	nM	514.0	CHEMBL5122	Homo sapiens	IC50	nM	514.0
	18200253	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4087485	=	IC50	nM	1800.0	CHEMBL5122	Homo sapiens	IC50	nM	1800.0
	18200254	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CN1CCN(Cc2cc(NC(=O)c3ccc4c(c3)CN(c3ccncn3)CC4)cc(C(F)(F)F)c2)CC1		CHEMBL4103865	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18200255	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CN1CCN(Cc2cc(NC(=O)c3ccc4c(c3)CN(Cc3cncnc3)CC4)cc(C(F)(F)F)c2)CC1		CHEMBL4079610	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18200256	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1Cc2ccc(C(=O)Nc3cc(CN4CCN(C)CC4)cc(C(F)(F)F)c3)cc2CN1c1cncnc1		CHEMBL4096111	=	IC50	nM	7600.0	CHEMBL5122	Homo sapiens	IC50	nM	7600.0
	18200257	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CN1CCN(Cc2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)CC4(C)C)cc(C(F)(F)F)c2)CC1		CHEMBL4068810	=	IC50	nM	4500.0	CHEMBL5122	Homo sapiens	IC50	nM	4500.0
	18200258	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	C[C@H]1CN(c2cncnc2)Cc2cc(NC(=O)c3cc(CN4CCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4088388	=	IC50	nM	1400.0	CHEMBL5122	Homo sapiens	IC50	nM	1400.0
	18200259	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	C[C@@H]1CN(c2cncnc2)Cc2cc(NC(=O)c3cc(CN4CCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4060157	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18200260	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(NC(=O)Nc3cc(CN4CCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4102056	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18200261	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cccc(CN4CCN(C)CC4)c3)ccc21		CHEMBL4084076	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18200262	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CCc1cc(CN2CCN(C)CC2)cc(NC(=O)c2ccc3c(c2)CN(c2cncnc2)CC3C)c1		CHEMBL4064078	=	IC50	nM	1400.0	CHEMBL5122	Homo sapiens	IC50	nM	1400.0
	18200263	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC(C)c1cc(CN2CCN(C)CC2)cc(NC(=O)c2ccc3c(c2)CN(c2cncnc2)CC3C)c1		CHEMBL4091837	=	IC50	nM	682.0	CHEMBL5122	Homo sapiens	IC50	nM	682.0
	18200264	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCN(C)CC4)cc(C(C)(C)C)c3)ccc21		CHEMBL4077200	=	IC50	nM	940.0	CHEMBL5122	Homo sapiens	IC50	nM	940.0
	18200265	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCN(C)CC4)cc(C4CC4)c3)ccc21		CHEMBL4065684	=	IC50	nM	1100.0	CHEMBL5122	Homo sapiens	IC50	nM	1100.0
	18200266	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCN(C)CC4)cc(C4CCCCC4)c3)ccc21		CHEMBL4083149	=	IC50	nM	462.0	CHEMBL5122	Homo sapiens	IC50	nM	462.0
	18200267	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCN(C)CC4)cc(-c4ccccc4)c3)ccc21		CHEMBL4070502	=	IC50	nM	1400.0	CHEMBL5122	Homo sapiens	IC50	nM	1400.0
	18200268	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc21		CHEMBL4085787	=	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18200269	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3CN3CCN(C)CC3)ccc21		CHEMBL4063046	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18200270	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc21		CHEMBL4088784	=	IC50	nM	354.0	CHEMBL5122	Homo sapiens	IC50	nM	354.0
	18200271	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(N4CCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4060550	=	IC50	nM	2100.0	CHEMBL5122	Homo sapiens	IC50	nM	2100.0
	18200272	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CCN4CCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4096477	=	IC50	nM	1500.0	CHEMBL5122	Homo sapiens	IC50	nM	1500.0
	18200273	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CCN1CCN(Cc2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)CC4C)cc(C(F)(F)F)c2)CC1		CHEMBL4069234	=	IC50	nM	944.0	CHEMBL5122	Homo sapiens	IC50	nM	944.0
	18200274	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCN(C5CCCCC5)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4096896	=	IC50	nM	846.0	CHEMBL5122	Homo sapiens	IC50	nM	846.0
	18200275	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCOCC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4078110	=	IC50	nM	4500.0	CHEMBL5122	Homo sapiens	IC50	nM	4500.0
	18200276	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCSCC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4066530	=	IC50	nM	3700.0	CHEMBL5122	Homo sapiens	IC50	nM	3700.0
	18200277	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCCC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4087848	=	IC50	nM	2200.0	CHEMBL5122	Homo sapiens	IC50	nM	2200.0
	18200278	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4069922	=	IC50	nM	2600.0	CHEMBL5122	Homo sapiens	IC50	nM	2600.0
	18200279	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN(C)C)cc(C(F)(F)F)c3)ccc21		CHEMBL4086988	=	IC50	nM	6700.0	CHEMBL5122	Homo sapiens	IC50	nM	6700.0
	18200280	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	CC1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4075510	=	IC50	nM	604.0	CHEMBL5122	Homo sapiens	IC50	nM	604.0
	18200281	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	C[C@H]1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4097012	=	IC50	nM	255.0	CHEMBL5122	Homo sapiens	IC50	nM	255.0
	18200282	CHEMBL4042996	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain expressed in baculovirus expression system using Fluorescein-Poly GAT as substrate measured after 1 hr by TR-FRET assay	B	C[C@@H]1CN(c2cncnc2)Cc2cc(C(=O)Nc3cc(CN4CCCN(C)CC4)cc(C(F)(F)F)c3)ccc21		CHEMBL4059972	=	IC50	nM	2600.0	CHEMBL5122	Homo sapiens	IC50	nM	2600.0
	18200524	CHEMBL4043030	Inhibition of GST-tagged human DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system by LanthaScreen assay	B	Cc1ccc(-n2c(=O)ccc3ccc4ccc(-c5cnn(C)c5)cc4c32)cc1NC(=O)/C=C/CN(C)C		CHEMBL4064534	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	nM	10000.0
	18203615	CHEMBL4043902	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	77.0	CHEMBL5122	Homo sapiens	Activity	%	77.0
	18220907	CHEMBL4047630	Inhibition of wild type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity by Kinome scan assay relative to control	B	CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO		CHEMBL4075955	<	Activity	%	10.0	CHEMBL5122	Homo sapiens	Activity	%	10.0
	18232082	CHEMBL4050420	Inhibition of human DDR2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	117.0	CHEMBL5122	Homo sapiens	Activity	%	117.0
	18253783	CHEMBL4055176	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	18253784	CHEMBL4055176	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	18265929	CHEMBL4057379	Inhibition of DDR2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	66.0	CHEMBL5122	Homo sapiens	INH	%	66.0
	18266134	CHEMBL4057584	Inhibition of DDR2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	2.0	CHEMBL5122	Homo sapiens	INH	%	2.0
	18274430	CHEMBL4059361	Inhibition of human DDR2 assessed as remaining activity at 1 uM after 30 mins by qPCR method	B	CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1		CHEMBL4076112	<=	Activity	%	10.0	CHEMBL5122	Homo sapiens	Activity	%	10.0
	18282782	CHEMBL4120367	Inhibition of DDR2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	66.0	CHEMBL5122	Homo sapiens	INH	%	66.0
	18283009	CHEMBL4120594	Inhibition of DDR2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	5.3	CHEMBL5122	Homo sapiens	INH	%	5.3
	18283233	CHEMBL4120818	Inhibition of DDR2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	1.7	CHEMBL5122	Homo sapiens	INH	%	1.7
	18287449	CHEMBL4121737	Inhibition of DDR2 (unknown origin)	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C#N)cc3)ccnc2[nH]1		CHEMBL4129941	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	18287450	CHEMBL4121737	Inhibition of DDR2 (unknown origin)	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C#N)cc3)ccnc2[nH]1		CHEMBL4127076	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	18287451	CHEMBL4121737	Inhibition of DDR2 (unknown origin)	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C#N)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4128459	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	18287452	CHEMBL4121737	Inhibition of DDR2 (unknown origin)	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C#N)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4128540	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	18409044	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccccn12		CHEMBL4167237	=	IC50	nM	61.1	CHEMBL5122	Homo sapiens	IC50	nM	61.1
	18409045	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4172767	=	IC50	nM	47.4	CHEMBL5122	Homo sapiens	IC50	nM	47.4
	18409046	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CN1CCN(Cc2cc(NC(=O)c3ccc(C(C)(C)C)c(C#Cc4cnc5cnccn45)c3)cc(C(F)(F)F)c2)CC1		CHEMBL4164870	=	IC50	nM	2200.0	CHEMBL5122	Homo sapiens	IC50	nM	2200.0
	18409047	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CN1CCN(Cc2cc(NC(=O)c3ccc(C4CC4)c(C#Cc4cnc5cnccn45)c3)cc(C(F)(F)F)c2)CC1		CHEMBL4176145	=	IC50	nM	40.2	CHEMBL5122	Homo sapiens	IC50	nM	40.2
	18409048	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	=	IC50	nM	20.4	CHEMBL5122	Homo sapiens	IC50	nM	20.4
	18409049	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4161036	=	IC50	nM	3.1	CHEMBL5122	Homo sapiens	IC50	nM	3.1
	18409050	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccccn12		CHEMBL4171640	=	IC50	nM	10.4	CHEMBL5122	Homo sapiens	IC50	nM	10.4
	18409051	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4164448	=	IC50	nM	13.1	CHEMBL5122	Homo sapiens	IC50	nM	13.1
	18409052	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4175086	=	IC50	nM	7.0	CHEMBL5122	Homo sapiens	IC50	nM	7.0
	18409053	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc(C)n1C		CHEMBL4167877	=	IC50	nM	34.1	CHEMBL5122	Homo sapiens	IC50	nM	34.1
	18409054	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cncn1C		CHEMBL4159956	=	IC50	nM	94.2	CHEMBL5122	Homo sapiens	IC50	nM	94.2
	18409055	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1ccsc1		CHEMBL4176591	=	IC50	nM	3800.0	CHEMBL5122	Homo sapiens	IC50	nM	3800.0
	18409056	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1ccco1		CHEMBL4165977	=	IC50	nM	2100.0	CHEMBL5122	Homo sapiens	IC50	nM	2100.0
	18409057	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1ccoc1		CHEMBL4171235	=	IC50	nM	1540.0	CHEMBL5122	Homo sapiens	IC50	nM	1540.0
	18409058	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc(N(C)C)nc1		CHEMBL4160628	=	IC50	nM	4800.0	CHEMBL5122	Homo sapiens	IC50	nM	4800.0
	18409059	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc(NC)nc1		CHEMBL4174682	=	IC50	nM	83.1	CHEMBL5122	Homo sapiens	IC50	nM	83.1
	18409060	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc(N)nc1		CHEMBL4164030	=	IC50	nM	45.3	CHEMBL5122	Homo sapiens	IC50	nM	45.3
	18409061	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cncnc1		CHEMBL4159558	=	IC50	nM	221.0	CHEMBL5122	Homo sapiens	IC50	nM	221.0
	18409062	CHEMBL4151609	Inhibition of DDR2 (unknown origin) incubated for 1 hr using fluorescein-poly-GAT substrate by TR-FRET based LANCE ULTRA kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	IC50	nM	175.0	CHEMBL5122	Homo sapiens	IC50	nM	175.0
	18409078	CHEMBL4151612	Binding affinity to human DDR2	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	=	Kd	nM	8.0	CHEMBL5122	Homo sapiens	Kd	nM	8.0
	18409080	CHEMBL4151614	Inhibition of human DDR2 at 1 uM	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	=	Inhibition	%	100.0	CHEMBL5122	Homo sapiens	INH	%	100.0
Active	18409105	CHEMBL4151637	Inhibition of DDR2 phosphorylation in in collagen I stimulated human primary lung fibroblasts incubated for 8 hrs by immunoprecipitation and Western blot analysis	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	18440157	CHEMBL4156981	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	18449917	CHEMBL4178151	Inhibition of human DDR2 (467 to 854 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	91.0	CHEMBL5122	Homo sapiens	Activity	%	91.0
	18484597	CHEMBL4185760	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	89.0	CHEMBL5122	Homo sapiens	Activity	%	89.0
	18485024	CHEMBL4185760	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL5122	Homo sapiens	Activity	%	96.0
	18507823	CHEMBL4190939	Inhibition of recombinant human DDR2 (467 to end residues) at 1 uM using KKSRGDYMTMQIG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	4.0	CHEMBL5122	Homo sapiens	INH	%	4.0
	18558664	CHEMBL4201054	Inhibition of human DDR2 at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.1	CHEMBL5122	Homo sapiens	INH	%	98.1
	18653681	CHEMBL4230063	Inhibition of DDR2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	93.0	CHEMBL5122	Homo sapiens	INH	%	93.0
	18653682	CHEMBL4230063	Inhibition of DDR2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	96.0	CHEMBL5122	Homo sapiens	INH	%	96.0
	18655575	CHEMBL4230660	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	33.0	CHEMBL5122	Homo sapiens	Activity	%	33.0
	18737800	CHEMBL4261439	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) using KKSRGDYMTMQIG as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	116.0	CHEMBL5122	Homo sapiens	IC50	nM	116.0
	18751133	CHEMBL4263781	Inhibition of DDR2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	33.0	CHEMBL5122	Homo sapiens	INH	%	33.0
	18751654	CHEMBL4264249	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	97.0	CHEMBL5122	Homo sapiens	Activity	%	97.0
	18761469	CHEMBL4266547	Inhibition of recombinant human N-terminal 6His-tagged DDR2 (467 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	-4.0	CHEMBL5122	Homo sapiens	INH	%	-4.0
	18761765	CHEMBL4266547	Inhibition of recombinant human N-terminal 6His-tagged DDR2 (467 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	6.0	CHEMBL5122	Homo sapiens	INH	%	6.0
	18761928	CHEMBL4266547	Inhibition of recombinant human N-terminal 6His-tagged DDR2 (467 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-1.0	CHEMBL5122	Homo sapiens	INH	%	-1.0
	18857918	CHEMBL4307764	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	18890194	CHEMBL4314031	Inhibition of recombinant GST-tagged human DDR2 (427 to 855 residues) expressed in baculovirus expression system at 0.5 uM after 1 hr by Lantha screen assay relative to control	B	COc1cc(C(=O)NC2CCNCC2)ccc1Nc1nc(Nc2ccccc2P(C)(C)=O)c2cc[nH]c2n1		CHEMBL4448754	=	Inhibition	%	1.0	CHEMBL5122	Homo sapiens	INH	%	1.0
	18892850	CHEMBL4314816	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) assessed as residual activity at 10 uM using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	97.0	CHEMBL5122	Homo sapiens	Activity	%	97.0
	18924194	CHEMBL4324184	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	Inhibition	%	31.0	CHEMBL5122	Homo sapiens	INH	%	31.0
	18924208	CHEMBL4324192	Inhibition of DDR2 (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	IC50	nM	5600.0	CHEMBL5122	Homo sapiens	IC50	uM	5.6
	18924209	CHEMBL4324192	Inhibition of DDR2 (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775	=	IC50	nM	220.0	CHEMBL5122	Homo sapiens	IC50	uM	0.22
	18937861	CHEMBL4327662	Inhibition of human DDR2 assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.53	CHEMBL5122	Homo sapiens	Activity	%	101.53
	18937862	CHEMBL4327662	Inhibition of human DDR2 assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.49	CHEMBL5122	Homo sapiens	Activity	%	99.49
	18938501	CHEMBL4328021	Inhibition of human DDR2 assessed as residual activity at 100 uM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5122	Homo sapiens	Activity	%	65.0
	18938878	CHEMBL4328385	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.19	CHEMBL5122	Homo sapiens	IC50	10'-9M	1.19
	18950225	CHEMBL4331077	Inhibition of human DDR2 assessed as residual activity at 10 uM using KKSRGDYMTMQIG as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	20.57	CHEMBL5122	Homo sapiens	Activity	%	20.57
	18950280	CHEMBL4331127	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	3472.0	CHEMBL5122	Homo sapiens	IC50	nM	3472.0
	18950352	CHEMBL4331127	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	3162.28	CHEMBL5122	Homo sapiens	pIC50		5.5
	18951023	CHEMBL4331421	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay	B	Cc1ccc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1NC(=O)C1(c2ncnc3[nH]cnc23)CC1		CHEMBL4466555	=	IC50	nM	2.6	CHEMBL5122	Homo sapiens	IC50	nM	2.6
	18958835	CHEMBL4333354	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	18964229	CHEMBL4335052	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	108.0	CHEMBL5122	Homo sapiens	Activity	%	108.0
	18964230	CHEMBL4335052	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	105.0	CHEMBL5122	Homo sapiens	Activity	%	105.0
	18971869	CHEMBL4336879	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) assessed as residual activity at 10 uM using KKSRGDYMTMQIG as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	35.0	CHEMBL5122	Homo sapiens	Activity	%	35.0
	18978705	CHEMBL4338769	Inhibition of kinase tracer 178 binding to recombinant human GST-tagged DDR2 (427-855 residues) expressed in baculovirus expression system incubated for 60 mins by TR-FRET based LanthaScreen Eu kinase binding assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1cncc(C(N)=O)c1		CHEMBL552425	=	IC50	nM	18.6	CHEMBL5122	Homo sapiens	IC50	nM	18.6
	18978714	CHEMBL4338772	Inhibition of kinase tracer 178 binding to recombinant human His-tagged DDR2 expressed in baculovirus infected Sf9 cells incubated for 1 hr by TR-FRET based LanthaScreen Eu kinase binding assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NCc1cncc(C(N)=O)c1		CHEMBL4439970	=	IC50	nM	4.79	CHEMBL5122	Homo sapiens	IC50	nM	4.79
	18978715	CHEMBL4338772	Inhibition of kinase tracer 178 binding to recombinant human His-tagged DDR2 expressed in baculovirus infected Sf9 cells incubated for 1 hr by TR-FRET based LanthaScreen Eu kinase binding assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NCc1cncc(-c2ccc[nH]2)c1		CHEMBL4584937	=	IC50	nM	11.0	CHEMBL5122	Homo sapiens	IC50	nM	11.0
	18978716	CHEMBL4338772	Inhibition of kinase tracer 178 binding to recombinant human His-tagged DDR2 expressed in baculovirus infected Sf9 cells incubated for 1 hr by TR-FRET based LanthaScreen Eu kinase binding assay	B	Cc1ccc(C(=O)Nc2ccc(C)c(C(F)(F)F)c2)cc1NCc1cncc(-c2ccc[nH]2)c1		CHEMBL4483465	=	IC50	nM	44.1	CHEMBL5122	Homo sapiens	IC50	nM	44.1
	18978717	CHEMBL4338772	Inhibition of kinase tracer 178 binding to recombinant human His-tagged DDR2 expressed in baculovirus infected Sf9 cells incubated for 1 hr by TR-FRET based LanthaScreen Eu kinase binding assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NCc1cncc(-c2ccn(C)n2)c1		CHEMBL4546339	=	IC50	nM	4.56	CHEMBL5122	Homo sapiens	IC50	nM	4.56
	18978718	CHEMBL4338772	Inhibition of kinase tracer 178 binding to recombinant human His-tagged DDR2 expressed in baculovirus infected Sf9 cells incubated for 1 hr by TR-FRET based LanthaScreen Eu kinase binding assay	B	Cn1ccc(-c2cncc(CNc3cc(C(=O)Nc4cccc(OC(F)(F)F)c4)ccc3F)c2)n1		CHEMBL4539920	=	IC50	nM	7.39	CHEMBL5122	Homo sapiens	IC50	nM	7.39
	18978719	CHEMBL4338772	Inhibition of kinase tracer 178 binding to recombinant human His-tagged DDR2 expressed in baculovirus infected Sf9 cells incubated for 1 hr by TR-FRET based LanthaScreen Eu kinase binding assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NCc1cccnc1		CHEMBL4447700	=	IC50	nM	10.6	CHEMBL5122	Homo sapiens	IC50	nM	10.6
	18978720	CHEMBL4338772	Inhibition of kinase tracer 178 binding to recombinant human His-tagged DDR2 expressed in baculovirus infected Sf9 cells incubated for 1 hr by TR-FRET based LanthaScreen Eu kinase binding assay	B	COc1cncc(CNc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c1		CHEMBL4467377	=	IC50	nM	6.36	CHEMBL5122	Homo sapiens	IC50	nM	6.36
	18997705	CHEMBL4342935	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1		CHEMBL4583691	=	Activity	%	84.0	CHEMBL5122	Homo sapiens	Activity	%	84.0
	18997710	CHEMBL4342940	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system by Kinomescan method	B	Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1		CHEMBL4583691	=	Kd	nM	10.0	CHEMBL5122	Homo sapiens	Kd	nM	10.0
	19009676	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	IC50	nM	101.4	CHEMBL5122	Homo sapiens	IC50	nM	101.4
	19009677	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1-c1cccc(-c2cnc3ccnn3c2)c1		CHEMBL4559959	=	IC50	nM	196.7	CHEMBL5122	Homo sapiens	IC50	nM	196.7
	19009678	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4473475	=	IC50	nM	66.1	CHEMBL5122	Homo sapiens	IC50	nM	66.1
	19009679	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(CN3CCN(C)CC3)c2)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4544048	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19009680	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4438475	=	IC50	nM	725.0	CHEMBL5122	Homo sapiens	IC50	nM	725.0
	19009681	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4575992	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19009682	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2ccccc2C(F)(F)F)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4534464	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19009683	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2ccccc2)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4583808	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19009684	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4464080	=	IC50	nM	135.0	CHEMBL5122	Homo sapiens	IC50	nM	135.0
	19009685	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CC(C)c1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cccc(-c2cnc3cnccn23)c1		CHEMBL4519510	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19009686	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cccc(-c2cnc3cnccn23)c1C		CHEMBL4586565	=	IC50	nM	663.5	CHEMBL5122	Homo sapiens	IC50	nM	663.5
	19009687	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc(C)c(-c2cnc3cnccn23)c1		CHEMBL4470983	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19009688	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(C)cc(-c2cnc3cnccn23)c1		CHEMBL4555024	=	IC50	nM	1728.0	CHEMBL5122	Homo sapiens	IC50	nM	1728.0
	19009689	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(-c2cnc3cnccn23)ccc1C		CHEMBL4535081	=	IC50	nM	610.0	CHEMBL5122	Homo sapiens	IC50	nM	610.0
	19009690	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1cc(-c2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2CC)cc(-c2cnc3cnccn23)c1		CHEMBL4447486	=	IC50	nM	3227.0	CHEMBL5122	Homo sapiens	IC50	nM	3227.0
	19009691	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(-c2cnc3cnccn23)cc(C(C)C)c1		CHEMBL4590224	=	IC50	nM	2631.0	CHEMBL5122	Homo sapiens	IC50	nM	2631.0
	19009692	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(-c2cnc3cnccn23)cc(C(C)(C)C)c1		CHEMBL4565522	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19009693	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(OC)cc(-c2cnc3cnccn23)c1		CHEMBL4466438	=	IC50	nM	1018.0	CHEMBL5122	Homo sapiens	IC50	nM	1018.0
	19009694	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(C#N)cc(-c2cnc3cnccn23)c1		CHEMBL4583783	=	IC50	nM	947.0	CHEMBL5122	Homo sapiens	IC50	nM	947.0
	19009695	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(F)cc(-c2cnc3cnccn23)c1		CHEMBL4571430	=	IC50	nM	1326.0	CHEMBL5122	Homo sapiens	IC50	nM	1326.0
	19009696	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1cc(Cl)cc(-c2cnc3cnccn23)c1		CHEMBL4444612	=	IC50	nM	1080.0	CHEMBL5122	Homo sapiens	IC50	nM	1080.0
	19009697	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2F)cc1-c1cc(C)cc(-c2cnc3cnccn23)c1		CHEMBL4547295	>	IC50	nM	5000.0	CHEMBL5122	Homo sapiens	IC50	uM	5.0
	19009698	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2ccc(F)c(C(F)(F)F)c2)cc1-c1cc(C)cc(-c2cnc3cnccn23)c1		CHEMBL4438214	>	IC50	nM	5000.0	CHEMBL5122	Homo sapiens	IC50	uM	5.0
	19009699	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cc(F)cc(C(F)(F)F)c2)cc1-c1cc(C)cc(-c2cnc3cnccn23)c1		CHEMBL4519003	=	IC50	nM	1740.0	CHEMBL5122	Homo sapiens	IC50	nM	1740.0
	19009700	CHEMBL4345301	Inhibition of recombinant human GST-tagged DDR2 cytoplasmic domain (427 to 855 residues) expressed in baculovirus expression system using Fluorescein-poly GAT as substrate incubated for 1 hr in presence of ATP by LanthaScreen Eu kinase assay	B	CCc1ccc(C(=O)Nc2cc(C(F)(F)F)ccc2F)cc1-c1cc(C)cc(-c2cnc3cnccn23)c1		CHEMBL4440007	>	IC50	nM	5000.0	CHEMBL5122	Homo sapiens	IC50	uM	5.0
	19009755	CHEMBL4345308	Inhibition of wild type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual enzyme activity at 200 nM after 1 hr by Kinomescan method relative to control	B	CCc1ccc(C(=O)Nc2cc(F)cc(C(F)(F)F)c2)cc1-c1cc(C)cc(-c2cnc3cnccn23)c1		CHEMBL4519003	=	Activity	%	15.0	CHEMBL5122	Homo sapiens	Activity	%	15.0
	19009760	CHEMBL4345313	Binding affinity to wild type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system after 1 hr by Kinomescan method	B	CCc1ccc(C(=O)Nc2cc(F)cc(C(F)(F)F)c2)cc1-c1cc(C)cc(-c2cnc3cnccn23)c1		CHEMBL4519003	=	Kd	nM	86.0	CHEMBL5122	Homo sapiens	Kd	nM	86.0
	19021478	CHEMBL4347701	Inhibition of recombinant human DDR2 at 20 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 10 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	11.0	CHEMBL5122	Homo sapiens	INH	%	11.0
	19021479	CHEMBL4347702	Inhibition of recombinant human DDR2 at 200 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 10 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	11.0	CHEMBL5122	Homo sapiens	INH	%	11.0
Not Active	19039812	CHEMBL4351830	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) at 10 uM using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	19041079	CHEMBL4352340	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	19043755	CHEMBL4353221	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	80.76	CHEMBL5122	Homo sapiens	INH	%	80.76
	19059537	CHEMBL4357838	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	26.0	CHEMBL5122	Homo sapiens	Activity	%	26.0
	19090108	CHEMBL4365682	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5122	Homo sapiens	Activity	%	100.0
	19091894	CHEMBL4366368	Inhibition of human DDR2 at 100 nM using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-1.84	CHEMBL5122	Homo sapiens	INH	%	-1.84
	19092266	CHEMBL4366686	Inhibition of DDR2 (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	98.0	CHEMBL5122	Homo sapiens	INH	%	98.0
	19118510	CHEMBL4372354	Inhibition of recombinant human N-terminal His6-tagged DDR2 (467 to end residues) expressed in baculovirus infected Sf21 insect cells using Axltide as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	IC50	nM	64.0	CHEMBL5122	Homo sapiens	IC50	nM	64.0
	19118536	CHEMBL4372380	Inhibition of recombinant human N-terminal His6-tagged DDR2 (467 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using Axltide as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	>	Inhibition	%	60.0	CHEMBL5122	Homo sapiens	INH	%	60.0
	19144772	CHEMBL4377788	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) at 1 uM using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	17.0	CHEMBL5122	Homo sapiens	INH	%	17.0
	19147820	CHEMBL4379216	Inhibition of recombinant human DDR2 S642A mutant (467 to end residues) using KKSRGDYMTMQIG as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5122	Homo sapiens	IC50	uM	10.0
	19159365	CHEMBL4382469	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	77.0	CHEMBL5122	Homo sapiens	Activity	%	77.0
	19161585	CHEMBL4383431	Inhibition of BCR fused DDR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	1540.0	CHEMBL5122	Homo sapiens	GI50	uM	1.54
	19191642	CHEMBL4389188	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.55	CHEMBL5122	Homo sapiens	INH	%	0.55
	19191851	CHEMBL4389665	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	73.0	CHEMBL5122	Homo sapiens	INH	%	73.0
	19199931	CHEMBL4391291	Binding affinity to wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	4.2	CHEMBL5122	Homo sapiens	Activity	%	4.2
	19266390	CHEMBL4405340	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5122	Homo sapiens	INH	%	50.0
	19275156	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4482862	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275157	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(Cc3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4568103	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275158	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](Nc3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4558430	=	IC50	nM	21.5	CHEMBL5122	Homo sapiens	IC50	nM	21.5
	19275159	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@@H](Nc3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4472914	=	IC50	nM	634.0	CHEMBL5122	Homo sapiens	IC50	nM	634.0
	19275160	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CC(C)(Nc3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4443543	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275161	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4437631	=	IC50	nM	933.0	CHEMBL5122	Homo sapiens	IC50	nM	933.0
	19275162	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	CCN(c1cncnc1)[C@@H]1Cc2ccc(C(=O)Nc3cc(-n4cnc(C)c4)cc(C(F)(F)F)c3)cc2C1		CHEMBL4570381	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275163	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	CCCN(c1cncnc1)[C@@H]1Cc2ccc(C(=O)Nc3cc(-n4cnc(C)c4)cc(C(F)(F)F)c3)cc2C1		CHEMBL4470262	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275164	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cc(NC(=O)c2ccc3c(c2)C[C@H](N(C)c2cncnc2)C3)cc(-n2cnc(C)c2)c1		CHEMBL4585974	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275165	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	CCc1cc(NC(=O)c2ccc3c(c2)C[C@H](N(C)c2cncnc2)C3)cc(-n2cnc(C)c2)c1		CHEMBL4541139	=	IC50	nM	467.0	CHEMBL5122	Homo sapiens	IC50	nM	467.0
	19275166	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(C)C)c2)cn1		CHEMBL4441609	=	IC50	nM	207.3	CHEMBL5122	Homo sapiens	IC50	nM	207.3
	19275167	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(C)(C)C)c2)cn1		CHEMBL4472004	=	IC50	nM	102.2	CHEMBL5122	Homo sapiens	IC50	nM	102.2
	19275168	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C3CCCCC3)c2)cn1		CHEMBL4560079	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275169	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C34CC5CC(CC(C5)C3)C4)c2)cn1		CHEMBL4574620	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	19275170	CHEMBL4407670	Inhibition of GST-tagged recombinant human DDR2 expressed in baculovirus using fluorescein-poly GAT as substrate after 1 hr by FRET-based LanthaScreen Eu kinase binding assay	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)C[C@@H]4C)cc(C(F)(F)F)c2)cn1		CHEMBL4553037	=	IC50	nM	340.9	CHEMBL5122	Homo sapiens	IC50	nM	340.9
	19275217	CHEMBL4407675	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in HEK-293 cells at 1 uM after 1 hr by quantitative PCR based KINOMEscan assay relative to control	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4437631	>	Inhibition	%	90.0	CHEMBL5122	Homo sapiens	INH	%	90.0
	19275222	CHEMBL4407680	Inhibition of human DDR2	A	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)C[C@H](N(C)c3cncnc3)C4)cc(C(F)(F)F)c2)cn1		CHEMBL4437631	=	IC50	nM	933.0	CHEMBL5122	Homo sapiens	IC50	nM	933.0
	19275974	CHEMBL4407977	Inhibition of recombinant human DDR2 (467 to end residues) at 1 uM using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	55.0	CHEMBL5122	Homo sapiens	INH	%	55.0
	19295751	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	1.4	CHEMBL5122	Homo sapiens	IC50	nM	1.4
	19295752	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CCN(C)CC4)c3)n[nH]c2c1		CHEMBL4437449	=	IC50	nM	3.8	CHEMBL5122	Homo sapiens	IC50	nM	3.8
	19295753	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CCCCO4)c3)n[nH]c2c1		CHEMBL4580357	=	IC50	nM	5.2	CHEMBL5122	Homo sapiens	IC50	nM	5.2
	19295754	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CCOC4)c3)n[nH]c2c1		CHEMBL4459160	=	IC50	nM	6.2	CHEMBL5122	Homo sapiens	IC50	nM	6.2
	19295755	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CCN4CCOCC4)c3)n[nH]c2c1		CHEMBL4559322	=	IC50	nM	2.6	CHEMBL5122	Homo sapiens	IC50	nM	2.6
	19295756	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CC(=O)N(C)C)c3)n[nH]c2c1		CHEMBL4460782	=	IC50	nM	2.7	CHEMBL5122	Homo sapiens	IC50	nM	2.7
	19295757	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CC(C)O)c3)n[nH]c2c1		CHEMBL4458216	=	IC50	nM	3.7	CHEMBL5122	Homo sapiens	IC50	nM	3.7
	19295758	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CCO)c3)n[nH]c2c1		CHEMBL4572126	=	IC50	nM	2.9	CHEMBL5122	Homo sapiens	IC50	nM	2.9
	19295759	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	IC50	nM	3.2	CHEMBL5122	Homo sapiens	IC50	nM	3.2
	19295760	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C(C)C)c3)n[nH]c2c1		CHEMBL4590244	=	IC50	nM	7.7	CHEMBL5122	Homo sapiens	IC50	nM	7.7
	19295761	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	CCCn1cc(-c2n[nH]c3cc(-c4cc(C(=O)Nc5cccc(C(F)(F)F)c5)ccc4C)ccc23)cn1		CHEMBL4449358	=	IC50	nM	3.2	CHEMBL5122	Homo sapiens	IC50	nM	3.2
	19295762	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	CCn1cc(-c2n[nH]c3cc(-c4cc(C(=O)Nc5cccc(C(F)(F)F)c5)ccc4C)ccc23)cn1		CHEMBL4535267	=	IC50	nM	2.6	CHEMBL5122	Homo sapiens	IC50	nM	2.6
	19295763	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C)c3)n[nH]c2c1		CHEMBL4524697	=	IC50	nM	4.4	CHEMBL5122	Homo sapiens	IC50	nM	4.4
	19295764	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cn[nH]c3)n[nH]c2c1		CHEMBL4534609	=	IC50	nM	55.6	CHEMBL5122	Homo sapiens	IC50	nM	55.6
	19295765	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(N4CCC(N5CCOCC5)CC4)cc3)n[nH]c2c1		CHEMBL4587973	=	IC50	nM	8.7	CHEMBL5122	Homo sapiens	IC50	nM	8.7
	19295766	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(N4CCOCC4)cc3)n[nH]c2c1		CHEMBL4454757	=	IC50	nM	21.6	CHEMBL5122	Homo sapiens	IC50	nM	21.6
	19295767	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(CN4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4467046	=	IC50	nM	6.2	CHEMBL5122	Homo sapiens	IC50	nM	6.2
	19295768	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(C(=O)N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4456231	=	IC50	nM	6.5	CHEMBL5122	Homo sapiens	IC50	nM	6.5
	19295769	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4549057	=	IC50	nM	8.8	CHEMBL5122	Homo sapiens	IC50	nM	8.8
	19295770	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C4CCCC4)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4565181	=	IC50	nM	7.0	CHEMBL5122	Homo sapiens	IC50	nM	7.0
	19295771	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(CCO)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4538678	=	IC50	nM	3.4	CHEMBL5122	Homo sapiens	IC50	nM	3.4
	19295772	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5cn[nH]c5c4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL4521671	=	IC50	nM	3.9	CHEMBL5122	Homo sapiens	IC50	nM	3.9
	19295773	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4569749	=	IC50	nM	4.7	CHEMBL5122	Homo sapiens	IC50	nM	4.7
	19295774	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(CN3CCN(C)CC3)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4473922	=	IC50	nM	75.9	CHEMBL5122	Homo sapiens	IC50	nM	75.9
	19295775	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4468582	=	IC50	nM	6.7	CHEMBL5122	Homo sapiens	IC50	nM	6.7
	19295776	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)NCc2cccc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4446210	=	IC50	nM	8.0	CHEMBL5122	Homo sapiens	IC50	nM	8.0
	19295777	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C#N)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4525313	=	IC50	nM	2.7	CHEMBL5122	Homo sapiens	IC50	nM	2.7
	19295778	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4443643	=	IC50	nM	1.2	CHEMBL5122	Homo sapiens	IC50	nM	1.2
	19295779	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4448547	=	IC50	nM	1.5	CHEMBL5122	Homo sapiens	IC50	nM	1.5
	19295780	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	COc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4473495	=	IC50	nM	67.9	CHEMBL5122	Homo sapiens	IC50	nM	67.9
	19295781	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	O=C(Nc1ccc(Cl)c(-c2ccc3cn[nH]c3c2)c1)c1cccc(C(F)(F)F)c1		CHEMBL4441502	=	IC50	nM	9.5	CHEMBL5122	Homo sapiens	IC50	nM	9.5
	19295782	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	O=C(Nc1ccc(F)c(-c2ccc3cn[nH]c3c2)c1)c1cccc(C(F)(F)F)c1		CHEMBL4475050	=	IC50	nM	64.3	CHEMBL5122	Homo sapiens	IC50	nM	64.3
	19295783	CHEMBL4412316	Inhibition of DDR2 (unknown origin) using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4551450	=	IC50	nM	5.5	CHEMBL5122	Homo sapiens	IC50	nM	5.5
	19295784	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)NCc2cccc(N3CCN(C)CC3)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4475127	=	Inhibition	%	23.2	CHEMBL5122	Homo sapiens	INH	%	23.2
	19295785	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(N3CCN(C)CC3)cc2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4539769	=	Inhibition	%	25.8	CHEMBL5122	Homo sapiens	INH	%	25.8
	19295786	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cc1ccc(C(=O)Nc2cccc(N3CCN(C)CC3)c2)cc1-c1ccc2cn[nH]c2c1		CHEMBL4558274	=	Inhibition	%	37.3	CHEMBL5122	Homo sapiens	INH	%	37.3
	19295787	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cc1c(NC(=O)c2cccc(C(F)(F)F)c2)cccc1-c1ccc2cn[nH]c2c1		CHEMBL4474846	=	Inhibition	%	41.8	CHEMBL5122	Homo sapiens	INH	%	41.8
	19295788	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cc1ccc(-c2ccc3cn[nH]c3c2)cc1NC(=O)c1cccc(C(F)(F)F)c1		CHEMBL4588351	=	Inhibition	%	37.3	CHEMBL5122	Homo sapiens	INH	%	37.3
	19295789	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cc1cc(NC(=O)c2cccc(C(F)(F)F)c2)cc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4470310	=	Inhibition	%	27.4	CHEMBL5122	Homo sapiens	INH	%	27.4
	19295790	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4468220	=	Inhibition	%	58.2	CHEMBL5122	Homo sapiens	INH	%	58.2
	19295791	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(-c2ccc3cn[nH]c3c2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL4455871	=	Inhibition	%	20.1	CHEMBL5122	Homo sapiens	INH	%	20.1
	19295792	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Nc1n[nH]c2cc(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)ccc12		CHEMBL4554690	=	Inhibition	%	22.8	CHEMBL5122	Homo sapiens	INH	%	22.8
	19295793	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Nc1n[nH]c2ccc(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL4515189	=	Inhibition	%	13.1	CHEMBL5122	Homo sapiens	INH	%	13.1
	19295794	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cn1ncc2ccc(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc21		CHEMBL4475621	=	Inhibition	%	7.6	CHEMBL5122	Homo sapiens	INH	%	7.6
	19295795	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(-c2ccc3[nH]ncc3c2)c1)c1cccc(C(F)(F)F)c1		CHEMBL4574911	=	Inhibition	%	46.8	CHEMBL5122	Homo sapiens	INH	%	46.8
	19295796	CHEMBL4412315	Inhibition of DDR2 (unknown origin) at 100 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(-c2ccc3cn[nH]c3c2)c1)c1cccc(C(F)(F)F)c1		CHEMBL4540198	=	Inhibition	%	14.0	CHEMBL5122	Homo sapiens	INH	%	14.0
	19295797	CHEMBL4412314	Inhibition of DDR2 (unknown origin) at 1000 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4468220	=	Inhibition	%	84.7	CHEMBL5122	Homo sapiens	INH	%	84.7
	19295798	CHEMBL4412314	Inhibition of DDR2 (unknown origin) at 1000 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(-c2ccc3cn[nH]c3c2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL4455871	=	Inhibition	%	53.3	CHEMBL5122	Homo sapiens	INH	%	53.3
	19295799	CHEMBL4412314	Inhibition of DDR2 (unknown origin) at 1000 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Nc1n[nH]c2cc(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)ccc12		CHEMBL4554690	=	Inhibition	%	24.8	CHEMBL5122	Homo sapiens	INH	%	24.8
	19295800	CHEMBL4412314	Inhibition of DDR2 (unknown origin) at 1000 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Nc1n[nH]c2ccc(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL4515189	=	Inhibition	%	35.9	CHEMBL5122	Homo sapiens	INH	%	35.9
	19295801	CHEMBL4412314	Inhibition of DDR2 (unknown origin) at 1000 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cn1ncc2ccc(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc21		CHEMBL4475621	=	Inhibition	%	29.8	CHEMBL5122	Homo sapiens	INH	%	29.8
	19295802	CHEMBL4412314	Inhibition of DDR2 (unknown origin) at 1000 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(-c2ccc3[nH]ncc3c2)c1)c1cccc(C(F)(F)F)c1		CHEMBL4574911	=	Inhibition	%	90.8	CHEMBL5122	Homo sapiens	INH	%	90.8
	19295803	CHEMBL4412314	Inhibition of DDR2 (unknown origin) at 1000 nM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	O=C(Nc1cccc(-c2ccc3cn[nH]c3c2)c1)c1cccc(C(F)(F)F)c1		CHEMBL4540198	=	Inhibition	%	28.9	CHEMBL5122	Homo sapiens	INH	%	28.9
	19295804	CHEMBL4412313	Inhibition of DDR2 (unknown origin) at 20 uM using poly (Glu, Tyr) 4:1 substrate after 60 mins by ELISA relative to control	B	Cn1cccc(C(=O)Nc2cccc(-c3ccc4[nH]ncc4c3)c2)c1=O		CHEMBL4436248	=	Inhibition	%	76.0	CHEMBL5122	Homo sapiens	INH	%	76.0
Dose-dependent effect	19295947	CHEMBL4412424	Inhibition of DDR2 I638F mutant phosphorylation in human NCI-H2286 cells after 2 hrs by Western blot analysis	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	19295948	CHEMBL4412425	Inhibition of DDR2 I638F mutant in human NCI-H2286 cells assessed as decrease in AKT phosphorylation at 25 to 200 uM after 2 hrs by Western blot analysis	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	19295949	CHEMBL4412426	Inhibition of DDR2 I638F mutant in human NCI-H2286 cells assessed as decrease in ERK phosphorylation at 25 to 200 uM after 2 hrs by Western blot analysis	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	19295972	CHEMBL4412452	Inhibition of DDR2 I638F mutant phosphorylation in human NCI-H2286 cells at 100 nM after 2 hrs by Western blot analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	19403548	CHEMBL4425810	Inhibition of human recombinant GST-tagged DDR2 expressed in baculovirus infected Sf9 insect cells using fluorescein-poly GAT as substrate preincubated for 1 hr measured after 1 hr in presence of ATP by lance ultra kinase assay	B	Cc1cn(-c2cc(NC(=O)c3ccc4c(c3)CN(c3cncnc3)C[C@@H]4C)cc(C(F)(F)F)c2)cn1		CHEMBL4553037	=	IC50	nM	188.0	CHEMBL5122	Homo sapiens	IC50	nM	188.0
	19407715	CHEMBL4426902	Inhibition of DDR2 (unknown origin)	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	IC50	nM	349.6	CHEMBL5122	Homo sapiens	IC50	nM	349.6
	20598186	CHEMBL4602915	Inhibition of human DDR2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	uM	1.0
	20608957	CHEMBL4605662	Inhibition of DDR2 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	>	IC50	nM	20000.0	CHEMBL5122	Homo sapiens	IC50	uM	20.0
	20608968	CHEMBL4605651	Inhibition of DDR2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	Activity	%	70.0	CHEMBL5122	Homo sapiens	Activity	%	70.0
	20608999	CHEMBL4605651	Inhibition of DDR2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	Activity	%	14.0	CHEMBL5122	Homo sapiens	Activity	%	14.0
	20609010	CHEMBL4605662	Inhibition of DDR2 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	IC50	nM	286.2	CHEMBL5122	Homo sapiens	IC50	uM	0.2862
	20609031	CHEMBL4605651	Inhibition of DDR2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Activity	%	4.0	CHEMBL5122	Homo sapiens	Activity	%	4.0
	20609047	CHEMBL4605651	Inhibition of DDR2 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Activity	%	3.0	CHEMBL5122	Homo sapiens	Activity	%	3.0
	20635951	CHEMBL4611753	Inhibition of recombinant GST-tagged human DDR2 by FRET assay	B	CNC(=O)CN1CN(c2ccccc2)C2(CCN(C(=O)c3ccc4[nH]ncc4c3)CC2)C1=O	Outside typical range	CHEMBL4646682	>	IC50	nM	167000.0	CHEMBL5122	Homo sapiens	IC50	uM	167.0
	20635954	CHEMBL4611753	Inhibition of recombinant GST-tagged human DDR2 by FRET assay	B	O=C(CN1CN(c2ccccc2)C2(CCN(C(=O)c3cnc4[nH]ncc4c3)CC2)C1=O)NCC(F)(F)F		CHEMBL4649685	=	IC50	nM	6300.0	CHEMBL5122	Homo sapiens	IC50	uM	6.3
	20635957	CHEMBL4611753	Inhibition of recombinant GST-tagged human DDR2 by FRET assay	B	O=C(CN1C(=O)C2(CCN(C(=O)c3ccc4[nH]ncc4n3)CC2)c2c(Br)cccc21)NCC(F)(F)F		CHEMBL4635278	=	IC50	nM	1900.0	CHEMBL5122	Homo sapiens	IC50	uM	1.9
	22423681	CHEMBL4674416	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	99.97	CHEMBL5122	Homo sapiens	Activity	%	99.97
	22423682	CHEMBL4674416	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	108.25	CHEMBL5122	Homo sapiens	Activity	%	108.25
	22475894	CHEMBL4686319	Inhibition of human DDR2 incubated for 30 mins by Kinobead based assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3oc(C(=O)c4cc5cc(O)ccc5[nH]4)cc3c2)no1		CHEMBL4745937	=	EC50	nM	2494.0	CHEMBL5122	Homo sapiens	EC50	nM	2494.0
	22798250	CHEMBL4710993	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate in presence of [gamma-33P]ATP by scintillation counting method relative to control	B	CCN1CCN(c2cc(C(=O)Nc3cccc(Nc4ccc5c(OC)cccc5n4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL4795732	=	Inhibition	%	67.52	CHEMBL5122	Homo sapiens	INH	%	67.52
	22802129	CHEMBL4711707	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Activity	%	9.4	CHEMBL5122	Homo sapiens	Activity	%	9.4
	22802140	CHEMBL4711718	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system by Kinomescan method	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Kd	nM	40.0	CHEMBL5122	Homo sapiens	Kd	uM	0.04
	22802147	CHEMBL4711725	Inhibition of C-terminal NanoLuc-fused full length DDR2 (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	IC50	nM	4000.0	CHEMBL5122	Homo sapiens	IC50	uM	4.0
	22820462	CHEMBL4716233	Inhibition of recombinant N-terminal His6-tagged human DDR2 (467 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	98.0	CHEMBL5122	Homo sapiens	Activity	%	98.0
	22820463	CHEMBL4716233	Inhibition of recombinant N-terminal His6-tagged human DDR2 (467 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	97.0	CHEMBL5122	Homo sapiens	Activity	%	97.0
	22843778	CHEMBL4720764	Inhibition of human DDR2 using KKSRGDYMTMQIG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.367	CHEMBL5122	Homo sapiens	IC50	10^-10M	3.67
	22844132	CHEMBL4721118	Inhibition of human DDR2 assessed as residual activity using KKSRGDYMTMQIG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	64.33	CHEMBL5122	Homo sapiens	Activity	%	64.33
	22844681	CHEMBL4721356	Inhibition of wild-type human partial length DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	95.69	CHEMBL5122	Homo sapiens	Activity	%	95.69
	22950591	CHEMBL4766158	Inhibition of human recombinant DDR2 S642A mutant (467 to end residues) using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	65.0	CHEMBL5122	Homo sapiens	IC50	uM	0.065
	22952813	CHEMBL4766750	Inhibition of recombinant human DDR2 (467 to end residues) assessed as residual activity at 10 uM using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	0.0	CHEMBL5122	Homo sapiens	Activity	%	0.0
	22953087	CHEMBL4767024	Inhibition of recombinant human DDR2 (467 to end residues) using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	55.0	CHEMBL5122	Homo sapiens	IC50	uM	0.055
Active	22974754	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	O=C1Nc2ccccc2N/C1=C\C(=O)c1cccc2ccccc12		CHEMBL4531109		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974755	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	O=C1Nc2ccccc2N/C1=C\C(=O)c1ccccc1Cl		CHEMBL4782208		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974756	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	O=C1Nc2ccccc2N/C1=C\C(=O)c1ccccc1Br		CHEMBL4799531		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974757	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	Cc1ccccc1C(=O)/C=C1\Nc2ccccc2NC1=O		CHEMBL4789089		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974758	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	COc1ccccc1C(=O)/C=C1\Nc2ccccc2NC1=O		CHEMBL4785607		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974759	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	Nc1ccccc1C(=O)/C=C1\Nc2ccccc2NC1=O		CHEMBL4780101		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974760	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	O=C1Nc2ccccc2N/C1=C\C(=O)c1cccc(Cl)c1		CHEMBL4777530		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974761	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	Cc1cccc(C(=O)/C=C2\Nc3ccccc3NC2=O)c1		CHEMBL4788894		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974762	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	COc1cccc(C(=O)/C=C2\Nc3ccccc3NC2=O)c1		CHEMBL4781949		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974763	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	Nc1cccc(C(=O)/C=C2\Nc3ccccc3NC2=O)c1		CHEMBL4800639		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974764	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	CC(C)(C)OC(=O)N/C=C1\Nc2ccccc2NC1=O		CHEMBL4794586		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974765	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	O=C1Nc2ccccc2N/C1=C\C(=O)c1cccc(Cl)c1Cl		CHEMBL4782076		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974766	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	N#Cc1ccc2c(c1)N/C(=C\C(=O)c1cccc3ccccc13)C(=O)N2		CHEMBL4795574		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974767	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	N#Cc1ccc2c(c1)N/C(=C\C(=O)c1ccccc1Cl)C(=O)N2		CHEMBL4794035		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974768	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	N#Cc1ccc2c(c1)N/C(=C\C(=O)c1ccccc1Br)C(=O)N2		CHEMBL4793426		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
Active	22974769	CHEMBL4771358	Inhibition of human DDR2 at 10 uM using KKSRGDYMTMQIG as substrate after 40 mins by [gamma-33P]-ATP assay	B	COc1ccccc1C(=O)/C=C1\Nc2cc(C#N)ccc2NC1=O		CHEMBL4776996		Inhibition	%		CHEMBL5122	Homo sapiens	INH		
	23122523	CHEMBL4804874	Inhibition of human DDR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	64.0	CHEMBL5122	Homo sapiens	Activity	%	64.0
	23123218	CHEMBL4805462	Inhibition of human DDR2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	66.0	CHEMBL5122	Homo sapiens	Activity	%	66.0
	23123673	CHEMBL4805917	Inhibition of DNA-tagged human DDR2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	86.0	CHEMBL5122	Homo sapiens	Activity	%	86.0
	23124526	CHEMBL4806479	Inhibition of human DDR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL5122	Homo sapiens	Activity	%	80.0
	23124527	CHEMBL4806479	Inhibition of human DDR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	52.0	CHEMBL5122	Homo sapiens	Activity	%	52.0
	23128008	CHEMBL4807811	Inhibition of DDR2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL5122	Homo sapiens	Activity	%	25.0
	23128009	CHEMBL4807811	Inhibition of DDR2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL5122	Homo sapiens	Activity	%	25.0
	23128010	CHEMBL4807811	Inhibition of DDR2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL5122	Homo sapiens	Activity	%	25.0
	23128748	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	97.0	CHEMBL5122	Homo sapiens	INH	%	97.0
	23128749	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	58.0	CHEMBL5122	Homo sapiens	INH	%	58.0
	23128750	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	61.0	CHEMBL5122	Homo sapiens	INH	%	61.0
	23128751	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3n[nH]nc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4853006	=	Inhibition	%	76.0	CHEMBL5122	Homo sapiens	INH	%	76.0
	23128752	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(NC)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4855979	=	Inhibition	%	54.0	CHEMBL5122	Homo sapiens	INH	%	54.0
	23128753	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	26.0	CHEMBL5122	Homo sapiens	INH	%	26.0
	23128754	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	47.0	CHEMBL5122	Homo sapiens	INH	%	47.0
	23128755	CHEMBL4808054	Inhibition of DDR2 (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	48.0	CHEMBL5122	Homo sapiens	INH	%	48.0
	23128934	CHEMBL4808110	Inhibition of DDR2 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	IC50	nM	100.0	CHEMBL5122	Homo sapiens	IC50	nM	100.0
	23297787	CHEMBL4841267	Inhibition of DDR2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL5122	Homo sapiens	IC50	nM	1000.0
	23299278	CHEMBL4841739	Inhibition of DDR2 (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	17.0	CHEMBL5122	Homo sapiens	INH	%	17.0
	23299279	CHEMBL4841739	Inhibition of DDR2 (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	38.0	CHEMBL5122	Homo sapiens	INH	%	38.0
Not Active	23317358	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	91.0	CHEMBL5122	Homo sapiens	% Control	%	91.0
Not Active	23317826	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23318496	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23318976	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	95.0	CHEMBL5122	Homo sapiens	% Control	%	95.0
Not Active	23319613	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	76.6	CHEMBL5122	Homo sapiens	% Control	%	76.6
Not Active	23320088	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	99.1	CHEMBL5122	Homo sapiens	% Control	%	99.1
Not Active	23320766	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23321234	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	89.0	CHEMBL5122	Homo sapiens	% Control	%	89.0
Not Active	23321864	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	71.0	CHEMBL5122	Homo sapiens	% Control	%	71.0
Not Active	23322332	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	74.0	CHEMBL5122	Homo sapiens	% Control	%	74.0
Not Active	23323021	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	98.0	CHEMBL5122	Homo sapiens	% Control	%	98.0
Not Active	23323489	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	94.0	CHEMBL5122	Homo sapiens	% Control	%	94.0
Not Active	23323988	CHEMBL4880607	DDR2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	12.0	CHEMBL5122	Homo sapiens	% inhibition	%	12.0
Not Active	23324343	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	99.4	CHEMBL5122	Homo sapiens	% Control	%	99.4
Not Active	23324978	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23325446	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23326093	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	87.0	CHEMBL5122	Homo sapiens	% Control	%	87.0
Not Active	23326561	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	96.0	CHEMBL5122	Homo sapiens	% Control	%	96.0
Not Active	23327261	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	78.0	CHEMBL5122	Homo sapiens	% Control	%	78.0
Not Active	23327729	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	67.0	CHEMBL5122	Homo sapiens	% Control	%	67.0
Not Active	23328316	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	66.0	CHEMBL5122	Homo sapiens	% Control	%	66.0
Not Active	23328784	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	93.0	CHEMBL5122	Homo sapiens	% Control	%	93.0
Not Active	23329317	CHEMBL4881024	DDR2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	104.0	CHEMBL5122	Homo sapiens	% residual kinase activity	%	104.0
Not Active	23329730	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23330198	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	92.0	CHEMBL5122	Homo sapiens	% Control	%	92.0
Not Active	23330954	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23331422	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	74.0	CHEMBL5122	Homo sapiens	% Control	%	74.0
Active	23331876	CHEMBL4881416	KINOMEScan (DiscoveRx Corp) with DDR2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		Kd	nM	1.3	CHEMBL5122	Homo sapiens	Kd	nM	1.3
Active	23331888	CHEMBL4881428	NanoBRET assay (SGC) with DDR2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		IC50	nM	3.0	CHEMBL5122	Homo sapiens	IC50	nM	3.0
Not Active	23331895	CHEMBL4881435	NanoBRET assay (SGC) with DDR2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1	Non standard unit for type	CHEMBL4526351		IC50	µM	9.3	CHEMBL5122	Homo sapiens	IC50	µM	9.3
Active	23332009	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	1.8	CHEMBL5122	Homo sapiens	% Control	%	1.8
Active	23332836	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	18.2	CHEMBL5122	Homo sapiens	% Control	%	18.2
Not Active	23332837	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351	=	Kd	nM	63.0	CHEMBL5122	Homo sapiens	Kd	nM	63.0
Not Active	23333193	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	87.6	CHEMBL5122	Homo sapiens	% Control	%	87.6
Not Active	23333832	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	92.0	CHEMBL5122	Homo sapiens	% Control	%	92.0
Not Active	23334300	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	94.0	CHEMBL5122	Homo sapiens	% Control	%	94.0
Not Active	23335279	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	57.0	CHEMBL5122	Homo sapiens	% Control	%	57.0
Not Active	23335747	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	66.0	CHEMBL5122	Homo sapiens	% Control	%	66.0
Not Active	23336374	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	82.0	CHEMBL5122	Homo sapiens	% Control	%	82.0
Not Active	23336842	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	77.0	CHEMBL5122	Homo sapiens	% Control	%	77.0
Not Active	23337566	CHEMBL4881937	DDR2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	96.0	CHEMBL5122	Homo sapiens	% Ctrl	%	96.0
Not Active	23337923	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	89.0	CHEMBL5122	Homo sapiens	% Control	%	89.0
Not Active	23338391	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23339003	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	88.0	CHEMBL5122	Homo sapiens	% Control	%	88.0
Not Active	23339471	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23340108	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23340576	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23341233	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23341701	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	96.0	CHEMBL5122	Homo sapiens	% Control	%	96.0
Not Active	23342317	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23342785	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	92.0	CHEMBL5122	Homo sapiens	% Control	%	92.0
Not Active	23343415	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	76.0	CHEMBL5122	Homo sapiens	% Control	%	76.0
Not Active	23343883	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	75.0	CHEMBL5122	Homo sapiens	% Control	%	75.0
Not Active	23344521	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23345094	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	88.0	CHEMBL5122	Homo sapiens	% Control	%	88.0
Not Active	23345562	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23346139	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23346608	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23347216	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	98.5	CHEMBL5122	Homo sapiens	% Control	%	98.5
Not Active	23347699	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	94.3	CHEMBL5122	Homo sapiens	% Control	%	94.3
Not Active	23348278	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23348746	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	96.0	CHEMBL5122	Homo sapiens	% Control	%	96.0
Not Active	23349333	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23349951	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23350419	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	99.0	CHEMBL5122	Homo sapiens	% Control	%	99.0
Not Active	23351024	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	98.0	CHEMBL5122	Homo sapiens	% Control	%	98.0
Not Active	23351492	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	88.0	CHEMBL5122	Homo sapiens	% Control	%	88.0
Not Active	23352017	CHEMBL4882708	DDR2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.643	CHEMBL5122	Homo sapiens	% Inhibition	%	3.6426
Not Active	23352516	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	82.0	CHEMBL5122	Homo sapiens	% Control	%	82.0
Not Active	23352984	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	79.0	CHEMBL5122	Homo sapiens	% Control	%	79.0
Not Active	23353866	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23354334	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23355066	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23355534	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	97.0	CHEMBL5122	Homo sapiens	% Control	%	97.0
Not Active	23356170	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23356638	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23357247	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	96.0	CHEMBL5122	Homo sapiens	% Control	%	96.0
Not Active	23357894	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23358362	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	80.0	CHEMBL5122	Homo sapiens	% Control	%	80.0
Not Active	23358948	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	98.9	CHEMBL5122	Homo sapiens	% Control	%	98.9
Not Active	23359546	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23360014	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	88.0	CHEMBL5122	Homo sapiens	% Control	%	88.0
Not Active	23360599	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	80.0	CHEMBL5122	Homo sapiens	% Control	%	80.0
Not Active	23361067	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23361640	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	75.0	CHEMBL5122	Homo sapiens	% Control	%	75.0
Not Active	23362176	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23362644	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23364286	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23364754	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	90.0	CHEMBL5122	Homo sapiens	% Control	%	90.0
Not Active	23365493	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	83.0	CHEMBL5122	Homo sapiens	% Control	%	83.0
Not Active	23366036	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	87.0	CHEMBL5122	Homo sapiens	% Control	%	87.0
Not Active	23366504	CHEMBL4883797	NanoBRET (DDR2)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1	Non standard unit for type	CHEMBL4436748		IC50	µM	5.6	CHEMBL5122	Homo sapiens	IC50	µM	5.6
Not Active	23366512	CHEMBL4883797	NanoBRET (DDR2)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1	Non standard unit for type	CHEMBL4531775		IC50	µM	0.22	CHEMBL5122	Homo sapiens	IC50	µM	0.22
Not Active	23366626	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	56.0	CHEMBL5122	Homo sapiens	% Control	%	56.0
Not Active	23367094	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23367531	CHEMBL4883884	DDR2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	102.0	CHEMBL5122	Homo sapiens	% Residual activity with Skepinone-L	%	102.0
Not Active	23367972	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23368440	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23369039	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23369507	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	71.0	CHEMBL5122	Homo sapiens	% Control	%	71.0
Not Active	23370039	CHEMBL4884283	DDR2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	92.0	CHEMBL5122	Homo sapiens	% residual kinase activity	%	92.0
Not Active	23370475	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23370943	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	86.0	CHEMBL5122	Homo sapiens	% Control	%	86.0
Active	23371626	CHEMBL4884587	Enzyme kinetic assay (Reaction Biology) (DDR2)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		IC50	nM	0.75	CHEMBL5122	Homo sapiens	IC50	nM	0.75
Active	23371630	CHEMBL4884591	NanoBRET (SGC-Frankfurt) (DDR2)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		IC50	nM	18.0	CHEMBL5122	Homo sapiens	IC50	nM	18.0
Not Active	23371640	CHEMBL4884591	NanoBRET (SGC-Frankfurt) (DDR2)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1	Non standard unit for type	CHEMBL4568183		IC50	µM	15.5	CHEMBL5122	Homo sapiens	IC50	µM	15.5
Active	23371752	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	0.0	CHEMBL5122	Homo sapiens	% Control	%	0.0
Not Active	23372220	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23375230	CHEMBL4886212	discoidin domain receptor tyrosine kinase 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-5.0	CHEMBL5122	Homo sapiens	% inhibition	%	-5.0
Not Active	23375647	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23376115	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23376692	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23377161	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23378020	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	75.0	CHEMBL5122	Homo sapiens	% Control	%	75.0
Not Active	23378488	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23379655	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23380123	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23380817	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23381465	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23381933	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23382557	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23383025	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	94.0	CHEMBL5122	Homo sapiens	% Control	%	94.0
Not Active	23383761	CHEMBL4887403	DDR2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL5122	Homo sapiens	% Ctrl	%	99.0
Not Active	23384247	CHEMBL4887842	DDR2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	16.27	CHEMBL5122	Homo sapiens	% inhibition	%	16.27
Not Active	23384940	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
Not Active	23385407	CHEMBL4879664	KinomeScan assay: inhibition of DDR2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5122	Homo sapiens	% Control	%	100.0
